#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Disruption of frontal lobe neural synchrony during cognitive control by alcohol intoxication
#Text=Decision making relies on dynamic interactions of distributed, primarily frontal brain regions.
1-1	0-10	Disruption	_	
1-2	11-13	of	_	
1-3	14-21	frontal	_	
1-4	22-26	lobe	_	
1-5	27-33	neural	_	
1-6	34-43	synchrony	_	
1-7	44-50	during	_	
1-8	51-60	cognitive	_	
1-9	61-68	control	_	
1-10	69-71	by	_	
1-11	72-79	alcohol	_	
1-12	80-92	intoxication	_	
1-13	93-101	Decision	_	
1-14	102-108	making	_	
1-15	109-115	relies	_	
1-16	116-118	on	_	
1-17	119-126	dynamic	_	
1-18	127-139	interactions	_	
1-19	140-142	of	_	
1-20	143-154	distributed	_	
1-21	154-155	,	_	
1-22	156-165	primarily	_	
1-23	166-173	frontal	_	
1-24	174-179	brain	_	
1-25	180-187	regions	_	
1-26	187-188	.	_	

#Text=Extensive evidence from functional magnetic resonance imaging (fMRI) studies indicates that the anterior cingulate (ACC) and the lateral prefrontal cortices (latPFC) are essential nodes subserving cognitive control.
2-1	189-198	Extensive	_	
2-2	199-207	evidence	_	
2-3	208-212	from	_	
2-4	213-223	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[1]	
2-5	224-232	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[1]	
2-6	233-242	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[1]	
2-7	243-250	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[1]	
2-8	251-252	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[1]	
2-9	252-256	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[1]	
2-10	256-257	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[1]	
2-11	258-265	studies	_	
2-12	266-275	indicates	_	
2-13	276-280	that	_	
2-14	281-284	the	_	
2-15	285-293	anterior	_	
2-16	294-303	cingulate	_	
2-17	304-305	(	_	
2-18	305-308	ACC	_	
2-19	308-309	)	_	
2-20	310-313	and	_	
2-21	314-317	the	_	
2-22	318-325	lateral	_	
2-23	326-336	prefrontal	_	
2-24	337-345	cortices	_	
2-25	346-347	(	_	
2-26	347-353	latPFC	_	
2-27	353-354	)	_	
2-28	355-358	are	_	
2-29	359-368	essential	_	
2-30	369-374	nodes	_	
2-31	375-385	subserving	_	
2-32	386-395	cognitive	_	
2-33	396-403	control	_	
2-34	403-404	.	_	

#Text=However, because of its limited temporal resolution, fMRI cannot accurately reflect the timing and nature of their presumed interplay.
3-1	405-412	However	_	
3-2	412-413	,	_	
3-3	414-421	because	_	
3-4	422-424	of	_	
3-5	425-428	its	_	
3-6	429-436	limited	_	
3-7	437-445	temporal	_	
3-8	446-456	resolution	_	
3-9	456-457	,	_	
3-10	458-462	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
3-11	463-469	cannot	_	
3-12	470-480	accurately	_	
3-13	481-488	reflect	_	
3-14	489-492	the	_	
3-15	493-499	timing	_	
3-16	500-503	and	_	
3-17	504-510	nature	_	
3-18	511-513	of	_	
3-19	514-519	their	_	
3-20	520-528	presumed	_	
3-21	529-538	interplay	_	
3-22	538-539	.	_	

#Text=The present study combines distributed source modeling of the temporally precise MEG signal with structural MRI in the form of “brain movies” to estimate: 1) the cortical areas involved in cognitive control (“where”), 2) to characterize their temporal sequence (“when”), and 3) to quantify the oscillatory dynamics of their neural interactions in real time.
4-1	540-543	The	_	
4-2	544-551	present	_	
4-3	552-557	study	_	
4-4	558-566	combines	_	
4-5	567-578	distributed	_	
4-6	579-585	source	_	
4-7	586-594	modeling	_	
4-8	595-597	of	_	
4-9	598-601	the	_	
4-10	602-612	temporally	_	
4-11	613-620	precise	_	
4-12	621-624	MEG	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography	
4-13	625-631	signal	_	
4-14	632-636	with	_	
4-15	637-647	structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging[2]	
4-16	648-651	MRI	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging[2]	
4-17	652-654	in	_	
4-18	655-658	the	_	
4-19	659-663	form	_	
4-20	664-666	of	_	
4-21	667-668	“	_	
4-22	668-673	brain	_	
4-23	674-680	movies	_	
4-24	680-681	”	_	
4-25	682-684	to	_	
4-26	685-693	estimate	_	
4-27	693-694	:	_	
4-28	695-696	1	_	
4-29	696-697	)	_	
4-30	698-701	the	_	
4-31	702-710	cortical	_	
4-32	711-716	areas	_	
4-33	717-725	involved	_	
4-34	726-728	in	_	
4-35	729-738	cognitive	_	
4-36	739-746	control	_	
4-37	747-748	(	_	
4-38	748-749	“	_	
4-39	749-754	where	_	
4-40	754-755	”	_	
4-41	755-756	)	_	
4-42	756-757	,	_	
4-43	758-759	2	_	
4-44	759-760	)	_	
4-45	761-763	to	_	
4-46	764-776	characterize	_	
4-47	777-782	their	_	
4-48	783-791	temporal	_	
4-49	792-800	sequence	_	
4-50	801-802	(	_	
4-51	802-803	“	_	
4-52	803-807	when	_	
4-53	807-808	”	_	
4-54	808-809	)	_	
4-55	809-810	,	_	
4-56	811-814	and	_	
4-57	815-816	3	_	
4-58	816-817	)	_	
4-59	818-820	to	_	
4-60	821-829	quantify	_	
4-61	830-833	the	_	
4-62	834-845	oscillatory	_	
4-63	846-854	dynamics	_	
4-64	855-857	of	_	
4-65	858-863	their	_	
4-66	864-870	neural	_	
4-67	871-883	interactions	_	
4-68	884-886	in	_	
4-69	887-891	real	_	
4-70	892-896	time	_	
4-71	896-897	.	_	

#Text=Stroop interference was associated with greater event-related theta (4–7 Hz) power in the ACC during conflict detection followed by sustained sensitivity to cognitive demands in the ACC and latPFC during integration and response preparation.
5-1	898-904	Stroop	_	
5-2	905-917	interference	_	
5-3	918-921	was	_	
5-4	922-932	associated	_	
5-5	933-937	with	_	
5-6	938-945	greater	_	
5-7	946-959	event-related	_	
5-8	960-965	theta	_	
5-9	966-967	(	_	
5-10	967-968	4	_	
5-11	968-969	–	_	
5-12	969-970	7	_	
5-13	971-973	Hz	_	
5-14	973-974	)	_	
5-15	975-980	power	_	
5-16	981-983	in	_	
5-17	984-987	the	_	
5-18	988-991	ACC	_	
5-19	992-998	during	_	
5-20	999-1007	conflict	_	
5-21	1008-1017	detection	_	
5-22	1018-1026	followed	_	
5-23	1027-1029	by	_	
5-24	1030-1039	sustained	_	
5-25	1040-1051	sensitivity	_	
5-26	1052-1054	to	_	
5-27	1055-1064	cognitive	_	
5-28	1065-1072	demands	_	
5-29	1073-1075	in	_	
5-30	1076-1079	the	_	
5-31	1080-1083	ACC	_	
5-32	1084-1087	and	_	
5-33	1088-1094	latPFC	_	
5-34	1095-1101	during	_	
5-35	1102-1113	integration	_	
5-36	1114-1117	and	_	
5-37	1118-1126	response	_	
5-38	1127-1138	preparation	_	
5-39	1138-1139	.	_	

#Text=A phase-locking analysis revealed co-oscillatory interactions between these areas indicating their increased neural synchrony in theta band during conflict-inducing incongruous trials.
6-1	1140-1141	A	_	
6-2	1142-1155	phase-locking	_	
6-3	1156-1164	analysis	_	
6-4	1165-1173	revealed	_	
6-5	1174-1188	co-oscillatory	_	
6-6	1189-1201	interactions	_	
6-7	1202-1209	between	_	
6-8	1210-1215	these	_	
6-9	1216-1221	areas	_	
6-10	1222-1232	indicating	_	
6-11	1233-1238	their	_	
6-12	1239-1248	increased	_	
6-13	1249-1255	neural	_	
6-14	1256-1265	synchrony	_	
6-15	1266-1268	in	_	
6-16	1269-1274	theta	_	
6-17	1275-1279	band	_	
6-18	1280-1286	during	_	
6-19	1287-1304	conflict-inducing	_	
6-20	1305-1316	incongruous	_	
6-21	1317-1323	trials	_	
6-22	1323-1324	.	_	

#Text=These results confirm that theta oscillations are fundamental to long-range synchronization needed for integrating top-down influences during cognitive control.
7-1	1325-1330	These	_	
7-2	1331-1338	results	_	
7-3	1339-1346	confirm	_	
7-4	1347-1351	that	_	
7-5	1352-1357	theta	_	
7-6	1358-1370	oscillations	_	
7-7	1371-1374	are	_	
7-8	1375-1386	fundamental	_	
7-9	1387-1389	to	_	
7-10	1390-1400	long-range	_	
7-11	1401-1416	synchronization	_	
7-12	1417-1423	needed	_	
7-13	1424-1427	for	_	
7-14	1428-1439	integrating	_	
7-15	1440-1448	top-down	_	
7-16	1449-1459	influences	_	
7-17	1460-1466	during	_	
7-18	1467-1476	cognitive	_	
7-19	1477-1484	control	_	
7-20	1484-1485	.	_	

#Text=MEG reflects neural activity directly which makes it suitable for pharmacological manipulations in contrast to fMRI which is sensitive to vasoactive confounds.
8-1	1486-1489	MEG	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography	
8-2	1490-1498	reflects	_	
8-3	1499-1505	neural	_	
8-4	1506-1514	activity	_	
8-5	1515-1523	directly	_	
8-6	1524-1529	which	_	
8-7	1530-1535	makes	_	
8-8	1536-1538	it	_	
8-9	1539-1547	suitable	_	
8-10	1548-1551	for	_	
8-11	1552-1567	pharmacological	_	
8-12	1568-1581	manipulations	_	
8-13	1582-1584	in	_	
8-14	1585-1593	contrast	_	
8-15	1594-1596	to	_	
8-16	1597-1601	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
8-17	1602-1607	which	_	
8-18	1608-1610	is	_	
8-19	1611-1620	sensitive	_	
8-20	1621-1623	to	_	
8-21	1624-1634	vasoactive	_	
8-22	1635-1644	confounds	_	
8-23	1644-1645	.	_	

#Text=In the present study, healthy social drinkers were given a moderate alcohol dose and placebo in a within-subject design.
9-1	1646-1648	In	_	
9-2	1649-1652	the	_	
9-3	1653-1660	present	_	
9-4	1661-1666	study	_	
9-5	1666-1667	,	_	
9-6	1668-1675	healthy	_	
9-7	1676-1682	social	_	
9-8	1683-1691	drinkers	_	
9-9	1692-1696	were	_	
9-10	1697-1702	given	_	
9-11	1703-1704	a	_	
9-12	1705-1713	moderate	_	
9-13	1714-1721	alcohol	_	
9-14	1722-1726	dose	_	
9-15	1727-1730	and	_	
9-16	1731-1738	placebo	_	
9-17	1739-1741	in	_	
9-18	1742-1743	a	_	
9-19	1744-1758	within-subject	_	
9-20	1759-1765	design	_	
9-21	1765-1766	.	_	

#Text=Acute intoxication attenuated theta power to Stroop conflict and dysregulated co-oscillations between the ACC and latPFC confirming that alcohol is detrimental to neural synchrony subserving cognitive control.
10-1	1767-1772	Acute	_	
10-2	1773-1785	intoxication	_	
10-3	1786-1796	attenuated	_	
10-4	1797-1802	theta	_	
10-5	1803-1808	power	_	
10-6	1809-1811	to	_	
10-7	1812-1818	Stroop	_	
10-8	1819-1827	conflict	_	
10-9	1828-1831	and	_	
10-10	1832-1844	dysregulated	_	
10-11	1845-1860	co-oscillations	_	
10-12	1861-1868	between	_	
10-13	1869-1872	the	_	
10-14	1873-1876	ACC	_	
10-15	1877-1880	and	_	
10-16	1881-1887	latPFC	_	
10-17	1888-1898	confirming	_	
10-18	1899-1903	that	_	
10-19	1904-1911	alcohol	_	
10-20	1912-1914	is	_	
10-21	1915-1926	detrimental	_	
10-22	1927-1929	to	_	
10-23	1930-1936	neural	_	
10-24	1937-1946	synchrony	_	
10-25	1947-1957	subserving	_	
10-26	1958-1967	cognitive	_	
10-27	1968-1975	control	_	
10-28	1975-1976	.	_	

#Text=It interferes with goal-directed behavior which may result in deficient self-control, contributing to compulsive drinking.
11-1	1977-1979	It	_	
11-2	1980-1990	interferes	_	
11-3	1991-1995	with	_	
11-4	1996-2009	goal-directed	_	
11-5	2010-2018	behavior	_	
11-6	2019-2024	which	_	
11-7	2025-2028	may	_	
11-8	2029-2035	result	_	
11-9	2036-2038	in	_	
11-10	2039-2048	deficient	_	
11-11	2049-2061	self-control	_	
11-12	2061-2062	,	_	
11-13	2063-2075	contributing	_	
11-14	2076-2078	to	_	
11-15	2079-2089	compulsive	_	
11-16	2090-2098	drinking	_	
11-17	2098-2099	.	_	

#Text=In sum, this method can provide insight into real-time interactions during cognitive processing and can characterize the selective sensitivity to pharmacological challenge across relevant neural networks.
12-1	2100-2102	In	_	
12-2	2103-2106	sum	_	
12-3	2106-2107	,	_	
12-4	2108-2112	this	_	
12-5	2113-2119	method	_	
12-6	2120-2123	can	_	
12-7	2124-2131	provide	_	
12-8	2132-2139	insight	_	
12-9	2140-2144	into	_	
12-10	2145-2154	real-time	_	
12-11	2155-2167	interactions	_	
12-12	2168-2174	during	_	
12-13	2175-2184	cognitive	_	
12-14	2185-2195	processing	_	
12-15	2196-2199	and	_	
12-16	2200-2203	can	_	
12-17	2204-2216	characterize	_	
12-18	2217-2220	the	_	
12-19	2221-2230	selective	_	
12-20	2231-2242	sensitivity	_	
12-21	2243-2245	to	_	
12-22	2246-2261	pharmacological	_	
12-23	2262-2271	challenge	_	
12-24	2272-2278	across	_	
12-25	2279-2287	relevant	_	
12-26	2288-2294	neural	_	
12-27	2295-2303	networks	_	
12-28	2303-2304	.	_	

#Text=SHORT ABSTRACT:
#Text=This experiment uses an anatomically-constrained magnetoencephalography (aMEG) method to examine brain oscillatory dynamics and long-range functional synchrony during engagement of cognitive control as a function of acute alcohol intoxication.
13-1	2305-2310	SHORT	_	
13-2	2311-2319	ABSTRACT	_	
13-3	2319-2320	:	_	
13-4	2321-2325	This	_	
13-5	2326-2336	experiment	_	
13-6	2337-2341	uses	_	
13-7	2342-2344	an	_	
13-8	2345-2369	anatomically-constrained	_	
13-9	2370-2392	magnetoencephalography	_	
13-10	2393-2394	(	_	
13-11	2394-2398	aMEG	_	
13-12	2398-2399	)	_	
13-13	2400-2406	method	_	
13-14	2407-2409	to	_	
13-15	2410-2417	examine	_	
13-16	2418-2423	brain	_	
13-17	2424-2435	oscillatory	_	
13-18	2436-2444	dynamics	_	
13-19	2445-2448	and	_	
13-20	2449-2459	long-range	_	
13-21	2460-2470	functional	_	
13-22	2471-2480	synchrony	_	
13-23	2481-2487	during	_	
13-24	2488-2498	engagement	_	
13-25	2499-2501	of	_	
13-26	2502-2511	cognitive	_	
13-27	2512-2519	control	_	
13-28	2520-2522	as	_	
13-29	2523-2524	a	_	
13-30	2525-2533	function	_	
13-31	2534-2536	of	_	
13-32	2537-2542	acute	_	
13-33	2543-2550	alcohol	_	
13-34	2551-2563	intoxication	_	
13-35	2563-2564	.	_	

#Text=INTRODUCTION:
#Text=The overall goal of this experiment is to examine the effects of acute alcohol intoxication on spatio-temporal changes in the brain oscillatory dynamics and long-range functional integration during cognitive control.
14-1	2565-2577	INTRODUCTION	_	
14-2	2577-2578	:	_	
14-3	2579-2582	The	_	
14-4	2583-2590	overall	_	
14-5	2591-2595	goal	_	
14-6	2596-2598	of	_	
14-7	2599-2603	this	_	
14-8	2604-2614	experiment	_	
14-9	2615-2617	is	_	
14-10	2618-2620	to	_	
14-11	2621-2628	examine	_	
14-12	2629-2632	the	_	
14-13	2633-2640	effects	_	
14-14	2641-2643	of	_	
14-15	2644-2649	acute	_	
14-16	2650-2657	alcohol	_	
14-17	2658-2670	intoxication	_	
14-18	2671-2673	on	_	
14-19	2674-2689	spatio-temporal	_	
14-20	2690-2697	changes	_	
14-21	2698-2700	in	_	
14-22	2701-2704	the	_	
14-23	2705-2710	brain	_	
14-24	2711-2722	oscillatory	_	
14-25	2723-2731	dynamics	_	
14-26	2732-2735	and	_	
14-27	2736-2746	long-range	_	
14-28	2747-2757	functional	_	
14-29	2758-2769	integration	_	
14-30	2770-2776	during	_	
14-31	2777-2786	cognitive	_	
14-32	2787-2794	control	_	
14-33	2794-2795	.	_	

#Text=The employed multimodal imaging approach combines magnetoencephalography (MEG) and structural magnetic resonance imaging (MRI) to provide insight into the neural basis of decision making with high temporal precision and at the level of an interactive system.
15-1	2796-2799	The	_	
15-2	2800-2808	employed	_	
15-3	2809-2819	multimodal	_	
15-4	2820-2827	imaging	_	
15-5	2828-2836	approach	_	
15-6	2837-2845	combines	_	
15-7	2846-2868	magnetoencephalography	_	
15-8	2869-2870	(	_	
15-9	2870-2873	MEG	_	
15-10	2873-2874	)	_	
15-11	2875-2878	and	_	
15-12	2879-2889	structural	_	
15-13	2890-2898	magnetic	_	
15-14	2899-2908	resonance	_	
15-15	2909-2916	imaging	_	
15-16	2917-2918	(	_	
15-17	2918-2921	MRI	_	
15-18	2921-2922	)	_	
15-19	2923-2925	to	_	
15-20	2926-2933	provide	_	
15-21	2934-2941	insight	_	
15-22	2942-2946	into	_	
15-23	2947-2950	the	_	
15-24	2951-2957	neural	_	
15-25	2958-2963	basis	_	
15-26	2964-2966	of	_	
15-27	2967-2975	decision	_	
15-28	2976-2982	making	_	
15-29	2983-2987	with	_	
15-30	2988-2992	high	_	
15-31	2993-3001	temporal	_	
15-32	3002-3011	precision	_	
15-33	3012-3015	and	_	
15-34	3016-3018	at	_	
15-35	3019-3022	the	_	
15-36	3023-3028	level	_	
15-37	3029-3031	of	_	
15-38	3032-3034	an	_	
15-39	3035-3046	interactive	_	
15-40	3047-3053	system	_	
15-41	3053-3054	.	_	

#Text=Flexible behavior makes it possible to adapt to changing contextual demands and to switch strategically between different tasks and requirements in agreement with one’s intents and goals.
16-1	3055-3063	Flexible	_	
16-2	3064-3072	behavior	_	
16-3	3073-3078	makes	_	
16-4	3079-3081	it	_	
16-5	3082-3090	possible	_	
16-6	3091-3093	to	_	
16-7	3094-3099	adapt	_	
16-8	3100-3102	to	_	
16-9	3103-3111	changing	_	
16-10	3112-3122	contextual	_	
16-11	3123-3130	demands	_	
16-12	3131-3134	and	_	
16-13	3135-3137	to	_	
16-14	3138-3144	switch	_	
16-15	3145-3158	strategically	_	
16-16	3159-3166	between	_	
16-17	3167-3176	different	_	
16-18	3177-3182	tasks	_	
16-19	3183-3186	and	_	
16-20	3187-3199	requirements	_	
16-21	3200-3202	in	_	
16-22	3203-3212	agreement	_	
16-23	3213-3217	with	_	
16-24	3218-3221	one	_	
16-25	3221-3222	’	_	
16-26	3222-3223	s	_	
16-27	3224-3231	intents	_	
16-28	3232-3235	and	_	
16-29	3236-3241	goals	_	
16-30	3241-3242	.	_	

#Text=The capacity to suppress automatic responses in favor of goal-relevant but non-habitual actions is considered to be an essential aspect of cognitive control.
17-1	3243-3246	The	_	
17-2	3247-3255	capacity	_	
17-3	3256-3258	to	_	
17-4	3259-3267	suppress	_	
17-5	3268-3277	automatic	_	
17-6	3278-3287	responses	_	
17-7	3288-3290	in	_	
17-8	3291-3296	favor	_	
17-9	3297-3299	of	_	
17-10	3300-3313	goal-relevant	_	
17-11	3314-3317	but	_	
17-12	3318-3330	non-habitual	_	
17-13	3331-3338	actions	_	
17-14	3339-3341	is	_	
17-15	3342-3352	considered	_	
17-16	3353-3355	to	_	
17-17	3356-3358	be	_	
17-18	3359-3361	an	_	
17-19	3362-3371	essential	_	
17-20	3372-3378	aspect	_	
17-21	3379-3381	of	_	
17-22	3382-3391	cognitive	_	
17-23	3392-3399	control	_	
17-24	3399-3400	.	_	

#Text=Extensive evidence suggests that it is subserved by a predominantly frontal cortical network with the anterior cingulate cortex (ACC) as a central node in this interactive network.
18-1	3401-3410	Extensive	_	
18-2	3411-3419	evidence	_	
18-3	3420-3428	suggests	_	
18-4	3429-3433	that	_	
18-5	3434-3436	it	_	
18-6	3437-3439	is	_	
18-7	3440-3449	subserved	_	
18-8	3450-3452	by	_	
18-9	3453-3454	a	_	
18-10	3455-3468	predominantly	_	
18-11	3469-3476	frontal	_	
18-12	3477-3485	cortical	_	
18-13	3486-3493	network	_	
18-14	3494-3498	with	_	
18-15	3499-3502	the	_	
18-16	3503-3511	anterior	_	
18-17	3512-3521	cingulate	_	
18-18	3522-3528	cortex	_	
18-19	3529-3530	(	_	
18-20	3530-3533	ACC	_	
18-21	3533-3534	)	_	
18-22	3535-3537	as	_	
18-23	3538-3539	a	_	
18-24	3540-3547	central	_	
18-25	3548-3552	node	_	
18-26	3553-3555	in	_	
18-27	3556-3560	this	_	
18-28	3561-3572	interactive	_	
18-29	3573-3580	network	_	
18-30	3580-3581	.	_	

#Text=While the abundant anatomical connectivity between the ACC and lateral frontal cortices is well-described, the functional characteristics of communication between these regions during cognitive control, response selection and execution, are poorly understood.
19-1	3582-3587	While	_	
19-2	3588-3591	the	_	
19-3	3592-3600	abundant	_	
19-4	3601-3611	anatomical	_	
19-5	3612-3624	connectivity	_	
19-6	3625-3632	between	_	
19-7	3633-3636	the	_	
19-8	3637-3640	ACC	_	
19-9	3641-3644	and	_	
19-10	3645-3652	lateral	_	
19-11	3653-3660	frontal	_	
19-12	3661-3669	cortices	_	
19-13	3670-3672	is	_	
19-14	3673-3687	well-described	_	
19-15	3687-3688	,	_	
19-16	3689-3692	the	_	
19-17	3693-3703	functional	_	
19-18	3704-3719	characteristics	_	
19-19	3720-3722	of	_	
19-20	3723-3736	communication	_	
19-21	3737-3744	between	_	
19-22	3745-3750	these	_	
19-23	3751-3758	regions	_	
19-24	3759-3765	during	_	
19-25	3766-3775	cognitive	_	
19-26	3776-3783	control	_	
19-27	3783-3784	,	_	
19-28	3785-3793	response	_	
19-29	3794-3803	selection	_	
19-30	3804-3807	and	_	
19-31	3808-3817	execution	_	
19-32	3817-3818	,	_	
19-33	3819-3822	are	_	
19-34	3823-3829	poorly	_	
19-35	3830-3840	understood	_	
19-36	3840-3841	.	_	

#Text=The highly influential Conflict Monitoring theory proposes that cognitive control arises from a dynamic interaction between the medial and lateral prefrontal cortices.
20-1	3842-3845	The	_	
20-2	3846-3852	highly	_	
20-3	3853-3864	influential	_	
20-4	3865-3873	Conflict	_	
20-5	3874-3884	Monitoring	_	
20-6	3885-3891	theory	_	
20-7	3892-3900	proposes	_	
20-8	3901-3905	that	_	
20-9	3906-3915	cognitive	_	
20-10	3916-3923	control	_	
20-11	3924-3930	arises	_	
20-12	3931-3935	from	_	
20-13	3936-3937	a	_	
20-14	3938-3945	dynamic	_	
20-15	3946-3957	interaction	_	
20-16	3958-3965	between	_	
20-17	3966-3969	the	_	
20-18	3970-3976	medial	_	
20-19	3977-3980	and	_	
20-20	3981-3988	lateral	_	
20-21	3989-3999	prefrontal	_	
20-22	4000-4008	cortices	_	
20-23	4008-4009	.	_	

#Text=This account purports that the ACC monitors for conflict between competing representations and engages the lateral prefrontal cortex (latPFC) to implement response control and optimize performance.
21-1	4010-4014	This	_	
21-2	4015-4022	account	_	
21-3	4023-4031	purports	_	
21-4	4032-4036	that	_	
21-5	4037-4040	the	_	
21-6	4041-4044	ACC	_	
21-7	4045-4053	monitors	_	
21-8	4054-4057	for	_	
21-9	4058-4066	conflict	_	
21-10	4067-4074	between	_	
21-11	4075-4084	competing	_	
21-12	4085-4100	representations	_	
21-13	4101-4104	and	_	
21-14	4105-4112	engages	_	
21-15	4113-4116	the	_	
21-16	4117-4124	lateral	_	
21-17	4125-4135	prefrontal	_	
21-18	4136-4142	cortex	_	
21-19	4143-4144	(	_	
21-20	4144-4150	latPFC	_	
21-21	4150-4151	)	_	
21-22	4152-4154	to	_	
21-23	4155-4164	implement	_	
21-24	4165-4173	response	_	
21-25	4174-4181	control	_	
21-26	4182-4185	and	_	
21-27	4186-4194	optimize	_	
21-28	4195-4206	performance	_	
21-29	4206-4207	.	_	

#Text=However, this account is primarily based on the functional MRI (fMRI) studies using the Blood Oxygenation Level Dependent (BOLD) signal.
22-1	4208-4215	However	_	
22-2	4215-4216	,	_	
22-3	4217-4221	this	_	
22-4	4222-4229	account	_	
22-5	4230-4232	is	_	
22-6	4233-4242	primarily	_	
22-7	4243-4248	based	_	
22-8	4249-4251	on	_	
22-9	4252-4255	the	_	
22-10	4256-4266	functional	_	
22-11	4267-4270	MRI	_	
22-12	4271-4272	(	_	
22-13	4272-4276	fMRI	_	
22-14	4276-4277	)	_	
22-15	4278-4285	studies	_	
22-16	4286-4291	using	_	
22-17	4292-4295	the	_	
22-18	4296-4301	Blood	_	
22-19	4302-4313	Oxygenation	_	
22-20	4314-4319	Level	_	
22-21	4320-4329	Dependent	_	
22-22	4330-4331	(	_	
22-23	4331-4335	BOLD	_	
22-24	4335-4336	)	_	
22-25	4337-4343	signal	_	
22-26	4343-4344	.	_	

#Text=The fMRI-BOLD signal is an excellent spatial mapping tool but its temporal resolution is limited because it reflects regional hemodynamic changes mediated by neurovascular coupling.
23-1	4345-4348	The	_	
23-2	4349-4358	fMRI-BOLD	_	
23-3	4359-4365	signal	_	
23-4	4366-4368	is	_	
23-5	4369-4371	an	_	
23-6	4372-4381	excellent	_	
23-7	4382-4389	spatial	_	
23-8	4390-4397	mapping	_	
23-9	4398-4402	tool	_	
23-10	4403-4406	but	_	
23-11	4407-4410	its	_	
23-12	4411-4419	temporal	_	
23-13	4420-4430	resolution	_	
23-14	4431-4433	is	_	
23-15	4434-4441	limited	_	
23-16	4442-4449	because	_	
23-17	4450-4452	it	_	
23-18	4453-4461	reflects	_	
23-19	4462-4470	regional	_	
23-20	4471-4482	hemodynamic	_	
23-21	4483-4490	changes	_	
23-22	4491-4499	mediated	_	
23-23	4500-4502	by	_	
23-24	4503-4516	neurovascular	_	
23-25	4517-4525	coupling	_	
23-26	4525-4526	.	_	

#Text=As a result, the BOLD signal changes unfold on a much slower time scale (in seconds) than the underlying neural events (in msec).
24-1	4527-4529	As	_	
24-2	4530-4531	a	_	
24-3	4532-4538	result	_	
24-4	4538-4539	,	_	
24-5	4540-4543	the	_	
24-6	4544-4548	BOLD	_	
24-7	4549-4555	signal	_	
24-8	4556-4563	changes	_	
24-9	4564-4570	unfold	_	
24-10	4571-4573	on	_	
24-11	4574-4575	a	_	
24-12	4576-4580	much	_	
24-13	4581-4587	slower	_	
24-14	4588-4592	time	_	
24-15	4593-4598	scale	_	
24-16	4599-4600	(	_	
24-17	4600-4602	in	_	
24-18	4603-4610	seconds	_	
24-19	4610-4611	)	_	
24-20	4612-4616	than	_	
24-21	4617-4620	the	_	
24-22	4621-4631	underlying	_	
24-23	4632-4638	neural	_	
24-24	4639-4645	events	_	
24-25	4646-4647	(	_	
24-26	4647-4649	in	_	
24-27	4650-4654	msec	_	
24-28	4654-4655	)	_	
24-29	4655-4656	.	_	

#Text=Moreover, the BOLD signal is sensitive to alcohol’s vasoactive effects and may not accurately represent the magnitude of neural changes, which makes it less suitable for studies of acute alcohol intoxication.
25-1	4657-4665	Moreover	_	
25-2	4665-4666	,	_	
25-3	4667-4670	the	_	
25-4	4671-4675	BOLD	_	
25-5	4676-4682	signal	_	
25-6	4683-4685	is	_	
25-7	4686-4695	sensitive	_	
25-8	4696-4698	to	_	
25-9	4699-4706	alcohol	_	
25-10	4706-4707	’	_	
25-11	4707-4708	s	_	
25-12	4709-4719	vasoactive	_	
25-13	4720-4727	effects	_	
25-14	4728-4731	and	_	
25-15	4732-4735	may	_	
25-16	4736-4739	not	_	
25-17	4740-4750	accurately	_	
25-18	4751-4760	represent	_	
25-19	4761-4764	the	_	
25-20	4765-4774	magnitude	_	
25-21	4775-4777	of	_	
25-22	4778-4784	neural	_	
25-23	4785-4792	changes	_	
25-24	4792-4793	,	_	
25-25	4794-4799	which	_	
25-26	4800-4805	makes	_	
25-27	4806-4808	it	_	
25-28	4809-4813	less	_	
25-29	4814-4822	suitable	_	
25-30	4823-4826	for	_	
25-31	4827-4834	studies	_	
25-32	4835-4837	of	_	
25-33	4838-4843	acute	_	
25-34	4844-4851	alcohol	_	
25-35	4852-4864	intoxication	_	
25-36	4864-4865	.	_	

#Text=Therefore, the presumed interplay between the medial and lateral prefrontal cortices and its sensitivity to alcohol intoxication need to be examined by methods that record neural events in a temporally precise manner.
26-1	4866-4875	Therefore	_	
26-2	4875-4876	,	_	
26-3	4877-4880	the	_	
26-4	4881-4889	presumed	_	
26-5	4890-4899	interplay	_	
26-6	4900-4907	between	_	
26-7	4908-4911	the	_	
26-8	4912-4918	medial	_	
26-9	4919-4922	and	_	
26-10	4923-4930	lateral	_	
26-11	4931-4941	prefrontal	_	
26-12	4942-4950	cortices	_	
26-13	4951-4954	and	_	
26-14	4955-4958	its	_	
26-15	4959-4970	sensitivity	_	
26-16	4971-4973	to	_	
26-17	4974-4981	alcohol	_	
26-18	4982-4994	intoxication	_	
26-19	4995-4999	need	_	
26-20	5000-5002	to	_	
26-21	5003-5005	be	_	
26-22	5006-5014	examined	_	
26-23	5015-5017	by	_	
26-24	5018-5025	methods	_	
26-25	5026-5030	that	_	
26-26	5031-5037	record	_	
26-27	5038-5044	neural	_	
26-28	5045-5051	events	_	
26-29	5052-5054	in	_	
26-30	5055-5056	a	_	
26-31	5057-5067	temporally	_	
26-32	5068-5075	precise	_	
26-33	5076-5082	manner	_	
26-34	5082-5083	.	_	

#Text=MEG has an excellent temporal resolution since it directly reflects postsynaptic currents.
27-1	5084-5087	MEG	_	
27-2	5088-5091	has	_	
27-3	5092-5094	an	_	
27-4	5095-5104	excellent	_	
27-5	5105-5113	temporal	_	
27-6	5114-5124	resolution	_	
27-7	5125-5130	since	_	
27-8	5131-5133	it	_	
27-9	5134-5142	directly	_	
27-10	5143-5151	reflects	_	
27-11	5152-5164	postsynaptic	_	
27-12	5165-5173	currents	_	
27-13	5173-5174	.	_	

#Text=The anatomically-constrained MEG (aMEG) methodology employed here is a multimodal approach that combines distributed source modeling of the MEG signal with structural MRI.
28-1	5175-5178	The	_	
28-2	5179-5203	anatomically-constrained	_	
28-3	5204-5207	MEG	_	
28-4	5208-5209	(	_	
28-5	5209-5213	aMEG	_	
28-6	5213-5214	)	_	
28-7	5215-5226	methodology	_	
28-8	5227-5235	employed	_	
28-9	5236-5240	here	_	
28-10	5241-5243	is	_	
28-11	5244-5245	a	_	
28-12	5246-5256	multimodal	_	
28-13	5257-5265	approach	_	
28-14	5266-5270	that	_	
28-15	5271-5279	combines	_	
28-16	5280-5291	distributed	_	
28-17	5292-5298	source	_	
28-18	5299-5307	modeling	_	
28-19	5308-5310	of	_	
28-20	5311-5314	the	_	
28-21	5315-5318	MEG	_	
28-22	5319-5325	signal	_	
28-23	5326-5330	with	_	
28-24	5331-5341	structural	_	
28-25	5342-5345	MRI	_	
28-26	5345-5346	.	_	

#Text=It allows for the estimation of where the conflict- and beverage-related brain oscillatory changes are occurring and to understand the temporal sequence (“when”) of the involved neural components.
29-1	5347-5349	It	_	
29-2	5350-5356	allows	_	
29-3	5357-5360	for	_	
29-4	5361-5364	the	_	
29-5	5365-5375	estimation	_	
29-6	5376-5378	of	_	
29-7	5379-5384	where	_	
29-8	5385-5388	the	_	
29-9	5389-5397	conflict	_	
29-10	5397-5398	-	_	
29-11	5399-5402	and	_	
29-12	5403-5419	beverage-related	_	
29-13	5420-5425	brain	_	
29-14	5426-5437	oscillatory	_	
29-15	5438-5445	changes	_	
29-16	5446-5449	are	_	
29-17	5450-5459	occurring	_	
29-18	5460-5463	and	_	
29-19	5464-5466	to	_	
29-20	5467-5477	understand	_	
29-21	5478-5481	the	_	
29-22	5482-5490	temporal	_	
29-23	5491-5499	sequence	_	
29-24	5500-5501	(	_	
29-25	5501-5502	“	_	
29-26	5502-5506	when	_	
29-27	5506-5507	”	_	
29-28	5507-5508	)	_	
29-29	5509-5511	of	_	
29-30	5512-5515	the	_	
29-31	5516-5524	involved	_	
29-32	5525-5531	neural	_	
29-33	5532-5542	components	_	
29-34	5542-5543	.	_	

#Text=Decision making relies on interactions of distributed brain regions that are dynamically engaged to deal with increased demands on cognitive control.
30-1	5544-5552	Decision	_	
30-2	5553-5559	making	_	
30-3	5560-5566	relies	_	
30-4	5567-5569	on	_	
30-5	5570-5582	interactions	_	
30-6	5583-5585	of	_	
30-7	5586-5597	distributed	_	
30-8	5598-5603	brain	_	
30-9	5604-5611	regions	_	
30-10	5612-5616	that	_	
30-11	5617-5620	are	_	
30-12	5621-5632	dynamically	_	
30-13	5633-5640	engaged	_	
30-14	5641-5643	to	_	
30-15	5644-5648	deal	_	
30-16	5649-5653	with	_	
30-17	5654-5663	increased	_	
30-18	5664-5671	demands	_	
30-19	5672-5674	on	_	
30-20	5675-5684	cognitive	_	
30-21	5685-5692	control	_	
30-22	5692-5693	.	_	

#Text=One way to estimate event-related changes in long-range synchrony between two cortical regions is to calculate their phase coupling as an index of their co-oscillations.
31-1	5694-5697	One	_	
31-2	5698-5701	way	_	
31-3	5702-5704	to	_	
31-4	5705-5713	estimate	_	
31-5	5714-5727	event-related	_	
31-6	5728-5735	changes	_	
31-7	5736-5738	in	_	
31-8	5739-5749	long-range	_	
31-9	5750-5759	synchrony	_	
31-10	5760-5767	between	_	
31-11	5768-5771	two	_	
31-12	5772-5780	cortical	_	
31-13	5781-5788	regions	_	
31-14	5789-5791	is	_	
31-15	5792-5794	to	_	
31-16	5795-5804	calculate	_	
31-17	5805-5810	their	_	
31-18	5811-5816	phase	_	
31-19	5817-5825	coupling	_	
31-20	5826-5828	as	_	
31-21	5829-5831	an	_	
31-22	5832-5837	index	_	
31-23	5838-5840	of	_	
31-24	5841-5846	their	_	
31-25	5847-5862	co-oscillations	_	
31-26	5862-5863	.	_	

#Text=The present study applied a phase-locking analysis to test the basic tenet of the Conflict Monitoring theory by examining the co-oscillatory interactions between the ACC and latPFC.
32-1	5864-5867	The	_	
32-2	5868-5875	present	_	
32-3	5876-5881	study	_	
32-4	5882-5889	applied	_	
32-5	5890-5891	a	_	
32-6	5892-5905	phase-locking	_	
32-7	5906-5914	analysis	_	
32-8	5915-5917	to	_	
32-9	5918-5922	test	_	
32-10	5923-5926	the	_	
32-11	5927-5932	basic	_	
32-12	5933-5938	tenet	_	
32-13	5939-5941	of	_	
32-14	5942-5945	the	_	
32-15	5946-5954	Conflict	_	
32-16	5955-5965	Monitoring	_	
32-17	5966-5972	theory	_	
32-18	5973-5975	by	_	
32-19	5976-5985	examining	_	
32-20	5986-5989	the	_	
32-21	5990-6004	co-oscillatory	_	
32-22	6005-6017	interactions	_	
32-23	6018-6025	between	_	
32-24	6026-6029	the	_	
32-25	6030-6033	ACC	_	
32-26	6034-6037	and	_	
32-27	6038-6044	latPFC	_	
32-28	6044-6045	.	_	

#Text=Neural oscillations in theta range (4–7 Hz) are associated with cognitive control and have been proposed as a fundamental mechanism supporting the long-range synchronization needed for top-down cognitive processing.
33-1	6046-6052	Neural	_	
33-2	6053-6065	oscillations	_	
33-3	6066-6068	in	_	
33-4	6069-6074	theta	_	
33-5	6075-6080	range	_	
33-6	6081-6082	(	_	
33-7	6082-6083	4	_	
33-8	6083-6084	–	_	
33-9	6084-6085	7	_	
33-10	6086-6088	Hz	_	
33-11	6088-6089	)	_	
33-12	6090-6093	are	_	
33-13	6094-6104	associated	_	
33-14	6105-6109	with	_	
33-15	6110-6119	cognitive	_	
33-16	6120-6127	control	_	
33-17	6128-6131	and	_	
33-18	6132-6136	have	_	
33-19	6137-6141	been	_	
33-20	6142-6150	proposed	_	
33-21	6151-6153	as	_	
33-22	6154-6155	a	_	
33-23	6156-6167	fundamental	_	
33-24	6168-6177	mechanism	_	
33-25	6178-6188	supporting	_	
33-26	6189-6192	the	_	
33-27	6193-6203	long-range	_	
33-28	6204-6219	synchronization	_	
33-29	6220-6226	needed	_	
33-30	6227-6230	for	_	
33-31	6231-6239	top-down	_	
33-32	6240-6249	cognitive	_	
33-33	6250-6260	processing	_	
33-34	6260-6261	.	_	

#Text=They are generated in prefrontal areas as a function of task difficulty and are significantly attenuated by acute alcohol intoxication.
34-1	6262-6266	They	_	
34-2	6267-6270	are	_	
34-3	6271-6280	generated	_	
34-4	6281-6283	in	_	
34-5	6284-6294	prefrontal	_	
34-6	6295-6300	areas	_	
34-7	6301-6303	as	_	
34-8	6304-6305	a	_	
34-9	6306-6314	function	_	
34-10	6315-6317	of	_	
34-11	6318-6322	task	_	
34-12	6323-6333	difficulty	_	
34-13	6334-6337	and	_	
34-14	6338-6341	are	_	
34-15	6342-6355	significantly	_	
34-16	6356-6366	attenuated	_	
34-17	6367-6369	by	_	
34-18	6370-6375	acute	_	
34-19	6376-6383	alcohol	_	
34-20	6384-6396	intoxication	_	
34-21	6396-6397	.	_	

#Text=Long-term excessive alcohol intake is associated with a range of cognitive deficits with prefrontal circuitry being especially affected.
35-1	6398-6407	Long-term	_	
35-2	6408-6417	excessive	_	
35-3	6418-6425	alcohol	_	
35-4	6426-6432	intake	_	
35-5	6433-6435	is	_	
35-6	6436-6446	associated	_	
35-7	6447-6451	with	_	
35-8	6452-6453	a	_	
35-9	6454-6459	range	_	
35-10	6460-6462	of	_	
35-11	6463-6472	cognitive	_	
35-12	6473-6481	deficits	_	
35-13	6482-6486	with	_	
35-14	6487-6497	prefrontal	_	
35-15	6498-6507	circuitry	_	
35-16	6508-6513	being	_	
35-17	6514-6524	especially	_	
35-18	6525-6533	affected	_	
35-19	6533-6534	.	_	

#Text=Acute alcohol intoxication is detrimental to cognitive control under conditions of increased difficulty, ambiguity, or those that induce response incompatibility.
36-1	6535-6540	Acute	_	
36-2	6541-6548	alcohol	_	
36-3	6549-6561	intoxication	_	
36-4	6562-6564	is	_	
36-5	6565-6576	detrimental	_	
36-6	6577-6579	to	_	
36-7	6580-6589	cognitive	_	
36-8	6590-6597	control	_	
36-9	6598-6603	under	_	
36-10	6604-6614	conditions	_	
36-11	6615-6617	of	_	
36-12	6618-6627	increased	_	
36-13	6628-6638	difficulty	_	
36-14	6638-6639	,	_	
36-15	6640-6649	ambiguity	_	
36-16	6649-6650	,	_	
36-17	6651-6653	or	_	
36-18	6654-6659	those	_	
36-19	6660-6664	that	_	
36-20	6665-6671	induce	_	
36-21	6672-6680	response	_	
36-22	6681-6696	incompatibility	_	
36-23	6696-6697	.	_	

#Text=By affecting decision making, alcohol may interfere with goal-directed behavior, may result in poor self-control and increased drinking, and may also contribute to traffic- or work-related hazards.
37-1	6698-6700	By	_	
37-2	6701-6710	affecting	_	
37-3	6711-6719	decision	_	
37-4	6720-6726	making	_	
37-5	6726-6727	,	_	
37-6	6728-6735	alcohol	_	
37-7	6736-6739	may	_	
37-8	6740-6749	interfere	_	
37-9	6750-6754	with	_	
37-10	6755-6768	goal-directed	_	
37-11	6769-6777	behavior	_	
37-12	6777-6778	,	_	
37-13	6779-6782	may	_	
37-14	6783-6789	result	_	
37-15	6790-6792	in	_	
37-16	6793-6797	poor	_	
37-17	6798-6810	self-control	_	
37-18	6811-6814	and	_	
37-19	6815-6824	increased	_	
37-20	6825-6833	drinking	_	
37-21	6833-6834	,	_	
37-22	6835-6838	and	_	
37-23	6839-6842	may	_	
37-24	6843-6847	also	_	
37-25	6848-6858	contribute	_	
37-26	6859-6861	to	_	
37-27	6862-6869	traffic	_	
37-28	6869-6870	-	_	
37-29	6871-6873	or	_	
37-30	6874-6886	work-related	_	
37-31	6887-6894	hazards	_	
37-32	6894-6895	.	_	

#Text=The present study uses an aMEG approach to measure the oscillatory activity in theta band and synchrony between the principal executive areas with excellent temporal resolution.
38-1	6896-6899	The	_	
38-2	6900-6907	present	_	
38-3	6908-6913	study	_	
38-4	6914-6918	uses	_	
38-5	6919-6921	an	_	
38-6	6922-6926	aMEG	_	
38-7	6927-6935	approach	_	
38-8	6936-6938	to	_	
38-9	6939-6946	measure	_	
38-10	6947-6950	the	_	
38-11	6951-6962	oscillatory	_	
38-12	6963-6971	activity	_	
38-13	6972-6974	in	_	
38-14	6975-6980	theta	_	
38-15	6981-6985	band	_	
38-16	6986-6989	and	_	
38-17	6990-6999	synchrony	_	
38-18	7000-7007	between	_	
38-19	7008-7011	the	_	
38-20	7012-7021	principal	_	
38-21	7022-7031	executive	_	
38-22	7032-7037	areas	_	
38-23	7038-7042	with	_	
38-24	7043-7052	excellent	_	
38-25	7053-7061	temporal	_	
38-26	7062-7072	resolution	_	
38-27	7072-7073	.	_	

#Text=The effects of alcohol on theta activity and co-oscillations between the ACC and the latPFC are examined as a function of conflict elicited by the Stroop interference task.
39-1	7074-7077	The	_	
39-2	7078-7085	effects	_	
39-3	7086-7088	of	_	
39-4	7089-7096	alcohol	_	
39-5	7097-7099	on	_	
39-6	7100-7105	theta	_	
39-7	7106-7114	activity	_	
39-8	7115-7118	and	_	
39-9	7119-7134	co-oscillations	_	
39-10	7135-7142	between	_	
39-11	7143-7146	the	_	
39-12	7147-7150	ACC	_	
39-13	7151-7154	and	_	
39-14	7155-7158	the	_	
39-15	7159-7165	latPFC	_	
39-16	7166-7169	are	_	
39-17	7170-7178	examined	_	
39-18	7179-7181	as	_	
39-19	7182-7183	a	_	
39-20	7184-7192	function	_	
39-21	7193-7195	of	_	
39-22	7196-7204	conflict	_	
39-23	7205-7213	elicited	_	
39-24	7214-7216	by	_	
39-25	7217-7220	the	_	
39-26	7221-7227	Stroop	_	
39-27	7228-7240	interference	_	
39-28	7241-7245	task	_	
39-29	7245-7246	.	_	

#Text=We hypothesize that increased cognitive demands are associated with greater functional synchrony and that alcohol-induced dysregulation of synchronous activity of the medial and lateral prefrontal cortices underlies impairments in cognitive control.
40-1	7247-7249	We	_	
40-2	7250-7261	hypothesize	_	
40-3	7262-7266	that	_	
40-4	7267-7276	increased	_	
40-5	7277-7286	cognitive	_	
40-6	7287-7294	demands	_	
40-7	7295-7298	are	_	
40-8	7299-7309	associated	_	
40-9	7310-7314	with	_	
40-10	7315-7322	greater	_	
40-11	7323-7333	functional	_	
40-12	7334-7343	synchrony	_	
40-13	7344-7347	and	_	
40-14	7348-7352	that	_	
40-15	7353-7368	alcohol-induced	_	
40-16	7369-7382	dysregulation	_	
40-17	7383-7385	of	_	
40-18	7386-7397	synchronous	_	
40-19	7398-7406	activity	_	
40-20	7407-7409	of	_	
40-21	7410-7413	the	_	
40-22	7414-7420	medial	_	
40-23	7421-7424	and	_	
40-24	7425-7432	lateral	_	
40-25	7433-7443	prefrontal	_	
40-26	7444-7452	cortices	_	
40-27	7453-7462	underlies	_	
40-28	7463-7474	impairments	_	
40-29	7475-7477	in	_	
40-30	7478-7487	cognitive	_	
40-31	7488-7495	control	_	
40-32	7495-7496	.	_	

#Text=PROTOCOL:
#Text=Ethics statement:
#Text=This experimental protocol has been approved by the Human Subjects Protection Committee at the University of California, San Diego.
41-1	7497-7505	PROTOCOL	_	
41-2	7505-7506	:	_	
41-3	7507-7513	Ethics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-4	7514-7523	statement	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-5	7523-7524	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-6	7525-7529	This	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-7	7530-7542	experimental	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-8	7543-7551	protocol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-9	7552-7555	has	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-10	7556-7560	been	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-11	7561-7569	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-12	7570-7572	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-13	7573-7576	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-14	7577-7582	Human	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-15	7583-7591	Subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-16	7592-7602	Protection	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-17	7603-7612	Committee	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-18	7613-7615	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-19	7616-7619	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-20	7620-7630	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-21	7631-7633	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-22	7634-7644	California	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-23	7644-7645	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-24	7646-7649	San	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-25	7650-7655	Diego	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
41-26	7655-7656	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	

#Text=Human Subjects
#Text=1.1.
42-1	7657-7662	Human	http://www.case.edu/ProvCaRe/provcare#StudyMethod[4]	
42-2	7663-7671	Subjects	http://www.case.edu/ProvCaRe/provcare#StudyMethod[4]	
42-3	7672-7675	1.1	_	
42-4	7675-7676	.	_	

#Text=Recruit healthy right-handed adult volunteers, obtain their consent, and screen them on the inclusion/exclusion criteria.
43-1	7677-7684	Recruit	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-2	7685-7692	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-3	7693-7705	right-handed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-4	7706-7711	adult	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-5	7712-7722	volunteers	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-6	7722-7723	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-7	7724-7730	obtain	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-8	7731-7736	their	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-9	7737-7744	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-10	7744-7745	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-11	7746-7749	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-12	7750-7756	screen	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-13	7757-7761	them	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-14	7762-7764	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-15	7765-7768	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-16	7769-7778	inclusion	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-17	7778-7779	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-18	7779-7788	exclusion	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-19	7789-7797	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-20	7797-7798	.	_	

#Text=For example, in this experiment, twenty young, healthy individuals (mean ± SD age = 25.3 ± 4.4 years, 8 women) were recruited who drink in moderation, who have never been in treatment or arrested for drug or alcohol related offenses, who report no alcoholism-related symptoms on the Short Michigan Alcoholism Screening Test who do not smoke nor use illegal substances, who do not have a history of neuropsychiatric disorders or any current health problems, who are medication free, and have no internal ferromagnetic objects or implants.
44-1	7799-7802	For	_	
44-2	7803-7810	example	_	
44-3	7810-7811	,	_	
44-4	7812-7814	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-5	7815-7819	this	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-6	7820-7830	experiment	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-7	7830-7831	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-8	7832-7838	twenty	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-9	7839-7844	young	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-10	7844-7845	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-11	7846-7853	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[7]	
44-12	7854-7865	individuals	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[7]	
44-13	7866-7867	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-14	7867-7871	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-15	7872-7873	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-16	7874-7876	SD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-17	7877-7880	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-18	7881-7882	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-19	7883-7887	25.3	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-20	7888-7889	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-21	7890-7893	4.4	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-22	7894-7899	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-23	7899-7900	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-24	7901-7902	8	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-25	7903-7908	women	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-26	7908-7909	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-27	7910-7914	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-28	7915-7924	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-29	7925-7928	who	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-30	7929-7934	drink	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-31	7935-7937	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-32	7938-7948	moderation	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-33	7948-7949	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-34	7950-7953	who	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-35	7954-7958	have	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-36	7959-7964	never	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-37	7965-7969	been	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-38	7970-7972	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-39	7973-7982	treatment	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-40	7983-7985	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-41	7986-7994	arrested	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-42	7995-7998	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-43	7999-8003	drug	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-44	8004-8006	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-45	8007-8014	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-46	8015-8022	related	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-47	8023-8031	offenses	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-48	8031-8032	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-49	8033-8036	who	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-50	8037-8043	report	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-51	8044-8046	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-52	8047-8065	alcoholism-related	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-53	8066-8074	symptoms	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-54	8075-8077	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-55	8078-8081	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-56	8082-8087	Short	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-57	8088-8096	Michigan	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-58	8097-8107	Alcoholism	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-59	8108-8117	Screening	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-60	8118-8122	Test	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-61	8123-8126	who	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-62	8127-8129	do	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-63	8130-8133	not	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-64	8134-8139	smoke	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-65	8140-8143	nor	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-66	8144-8147	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-67	8148-8155	illegal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-68	8156-8166	substances	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-69	8166-8167	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-70	8168-8171	who	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-71	8172-8174	do	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-72	8175-8178	not	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-73	8179-8183	have	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-74	8184-8185	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-75	8186-8193	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-76	8194-8196	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-77	8197-8213	neuropsychiatric	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-78	8214-8223	disorders	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-79	8224-8226	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-80	8227-8230	any	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-81	8231-8238	current	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-82	8239-8245	health	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-83	8246-8254	problems	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-84	8254-8255	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-85	8256-8259	who	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-86	8260-8263	are	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-87	8264-8274	medication	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-88	8275-8279	free	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-89	8279-8280	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-90	8281-8284	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-91	8285-8289	have	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-92	8290-8292	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-93	8293-8301	internal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-94	8302-8315	ferromagnetic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-95	8316-8323	objects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-96	8324-8326	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-97	8327-8335	implants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-98	8335-8336	.	_	

#Text=Experimental Design
#Text=2.1.
45-1	8337-8349	Experimental	_	
45-2	8350-8356	Design	_	
45-3	8357-8360	2.1	_	
45-4	8360-8361	.	_	

#Text=Scan each participant four times, including three MEG sessions (a no-beverage introductory session and two experimental beverage sessions in which alcohol and placebo are administered in a counterbalanced manner), and one structural MRI scan.
46-1	8362-8366	Scan	_	
46-2	8367-8371	each	_	
46-3	8372-8383	participant	_	
46-4	8384-8388	four	_	
46-5	8389-8394	times	_	
46-6	8394-8395	,	_	
46-7	8396-8405	including	_	
46-8	8406-8411	three	_	
46-9	8412-8415	MEG	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography	
46-10	8416-8424	sessions	_	
46-11	8425-8426	(	_	
46-12	8426-8427	a	_	
46-13	8428-8439	no-beverage	_	
46-14	8440-8452	introductory	_	
46-15	8453-8460	session	_	
46-16	8461-8464	and	_	
46-17	8465-8468	two	_	
46-18	8469-8481	experimental	_	
46-19	8482-8490	beverage	_	
46-20	8491-8499	sessions	_	
46-21	8500-8502	in	_	
46-22	8503-8508	which	_	
46-23	8509-8516	alcohol	_	
46-24	8517-8520	and	_	
46-25	8521-8528	placebo	_	
46-26	8529-8532	are	_	
46-27	8533-8545	administered	_	
46-28	8546-8548	in	_	
46-29	8549-8550	a	_	
46-30	8551-8566	counterbalanced	_	
46-31	8567-8573	manner	_	
46-32	8573-8574	)	_	
46-33	8574-8575	,	_	
46-34	8576-8579	and	_	
46-35	8580-8583	one	_	
46-36	8584-8594	structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging[8]	
46-37	8595-8598	MRI	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging[8]	
46-38	8599-8603	scan	_	
46-39	8603-8604	.	_	

#Text=Note: In this within-subject design, participants serve as their own controls by participating in both alcohol and placebo sessions.
47-1	8605-8609	Note	_	
47-2	8609-8610	:	_	
47-3	8611-8613	In	_	
47-4	8614-8618	this	_	
47-5	8619-8633	within-subject	_	
47-6	8634-8640	design	_	
47-7	8640-8641	,	_	
47-8	8642-8654	participants	_	
47-9	8655-8660	serve	_	
47-10	8661-8663	as	_	
47-11	8664-8669	their	_	
47-12	8670-8673	own	_	
47-13	8674-8682	controls	_	
47-14	8683-8685	by	_	
47-15	8686-8699	participating	_	
47-16	8700-8702	in	_	
47-17	8703-8707	both	_	
47-18	8708-8715	alcohol	_	
47-19	8716-8719	and	_	
47-20	8720-8727	placebo	_	
47-21	8728-8736	sessions	_	
47-22	8736-8737	.	_	

#Text=This design reduces error variance and increases statistical power by minimizing influence of individual variability in brain anatomy, activity patterns, and alcohol metabolism.
48-1	8738-8742	This	_	
48-2	8743-8749	design	_	
48-3	8750-8757	reduces	_	
48-4	8758-8763	error	_	
48-5	8764-8772	variance	_	
48-6	8773-8776	and	_	
48-7	8777-8786	increases	_	
48-8	8787-8798	statistical	_	
48-9	8799-8804	power	_	
48-10	8805-8807	by	_	
48-11	8808-8818	minimizing	_	
48-12	8819-8828	influence	_	
48-13	8829-8831	of	_	
48-14	8832-8842	individual	_	
48-15	8843-8854	variability	_	
48-16	8855-8857	in	_	
48-17	8858-8863	brain	_	
48-18	8864-8871	anatomy	_	
48-19	8871-8872	,	_	
48-20	8873-8881	activity	_	
48-21	8882-8890	patterns	_	
48-22	8890-8891	,	_	
48-23	8892-8895	and	_	
48-24	8896-8903	alcohol	_	
48-25	8904-8914	metabolism	_	
48-26	8914-8915	.	_	

#Text=MEG scans
#Text=Familiarization Session
#Text=3.1.1.
49-1	8916-8919	MEG	_	
49-2	8920-8925	scans	_	
49-3	8926-8941	Familiarization	_	
49-4	8942-8949	Session	_	
49-5	8950-8955	3.1.1	_	
49-6	8955-8956	.	_	

#Text=During the initial introductory session, administer questionnaires to obtain more information about the participants’ medical history, their drinking patterns and severity of alcoholism-related symptoms, family history of alcoholism, and personality traits including impulsivity.
#Text=3.1.2.
50-1	8957-8963	During	_	
50-2	8964-8967	the	_	
50-3	8968-8975	initial	_	
50-4	8976-8988	introductory	_	
50-5	8989-8996	session	_	
50-6	8996-8997	,	_	
50-7	8998-9008	administer	_	
50-8	9009-9023	questionnaires	_	
50-9	9024-9026	to	_	
50-10	9027-9033	obtain	_	
50-11	9034-9038	more	_	
50-12	9039-9050	information	_	
50-13	9051-9056	about	_	
50-14	9057-9060	the	_	
50-15	9061-9073	participants	_	
50-16	9073-9074	’	_	
50-17	9075-9082	medical	_	
50-18	9083-9090	history	_	
50-19	9090-9091	,	_	
50-20	9092-9097	their	_	
50-21	9098-9106	drinking	_	
50-22	9107-9115	patterns	_	
50-23	9116-9119	and	_	
50-24	9120-9128	severity	_	
50-25	9129-9131	of	_	
50-26	9132-9150	alcoholism-related	_	
50-27	9151-9159	symptoms	_	
50-28	9159-9160	,	_	
50-29	9161-9167	family	_	
50-30	9168-9175	history	_	
50-31	9176-9178	of	_	
50-32	9179-9189	alcoholism	_	
50-33	9189-9190	,	_	
50-34	9191-9194	and	_	
50-35	9195-9206	personality	_	
50-36	9207-9213	traits	_	
50-37	9214-9223	including	_	
50-38	9224-9235	impulsivity	_	
50-39	9235-9236	.	_	
50-40	9237-9242	3.1.2	_	
50-41	9242-9243	.	_	

#Text=Carry out an initial recording in the MEG scanner following the protocol described below in sections 3.2, 3.3, and 3.5.
51-1	9244-9249	Carry	_	
51-2	9250-9253	out	_	
51-3	9254-9256	an	_	
51-4	9257-9264	initial	_	
51-5	9265-9274	recording	_	
51-6	9275-9277	in	_	
51-7	9278-9281	the	_	
51-8	9282-9285	MEG	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography	
51-9	9286-9293	scanner	_	
51-10	9294-9303	following	_	
51-11	9304-9307	the	_	
51-12	9308-9316	protocol	_	
51-13	9317-9326	described	_	
51-14	9327-9332	below	_	
51-15	9333-9335	in	_	
51-16	9336-9344	sections	_	
51-17	9345-9348	3.2	_	
51-18	9348-9349	,	_	
51-19	9350-9353	3.3	_	
51-20	9353-9354	,	_	
51-21	9355-9358	and	_	
51-22	9359-9362	3.5	_	
51-23	9362-9363	.	_	

#Text=Do not provide any beverage.
52-1	9364-9366	Do	_	
52-2	9367-9370	not	_	
52-3	9371-9378	provide	_	
52-4	9379-9382	any	_	
52-5	9383-9391	beverage	_	
52-6	9391-9392	.	_	

#Text=Explain the task and run the practice version allowing participants to get familiarized with it beforehand.
53-1	9393-9400	Explain	_	
53-2	9401-9404	the	_	
53-3	9405-9409	task	_	
53-4	9410-9413	and	_	
53-5	9414-9417	run	_	
53-6	9418-9421	the	_	
53-7	9422-9430	practice	_	
53-8	9431-9438	version	_	
53-9	9439-9447	allowing	_	
53-10	9448-9460	participants	_	
53-11	9461-9463	to	_	
53-12	9464-9467	get	_	
53-13	9468-9480	familiarized	_	
53-14	9481-9485	with	_	
53-15	9486-9488	it	_	
53-16	9489-9499	beforehand	_	
53-17	9499-9500	.	_	

#Text=Note: The acclimation to the experimental situation serves the purpose of minimizing potential effects of situation-induced arousal, thereby equating subsequent alcohol and placebo sessions on that dimension.
54-1	9501-9505	Note	_	
54-2	9505-9506	:	_	
54-3	9507-9510	The	_	
54-4	9511-9522	acclimation	_	
54-5	9523-9525	to	_	
54-6	9526-9529	the	_	
54-7	9530-9542	experimental	_	
54-8	9543-9552	situation	_	
54-9	9553-9559	serves	_	
54-10	9560-9563	the	_	
54-11	9564-9571	purpose	_	
54-12	9572-9574	of	_	
54-13	9575-9585	minimizing	_	
54-14	9586-9595	potential	_	
54-15	9596-9603	effects	_	
54-16	9604-9606	of	_	
54-17	9607-9624	situation-induced	_	
54-18	9625-9632	arousal	_	
54-19	9632-9633	,	_	
54-20	9634-9641	thereby	_	
54-21	9642-9650	equating	_	
54-22	9651-9661	subsequent	_	
54-23	9662-9669	alcohol	_	
54-24	9670-9673	and	_	
54-25	9674-9681	placebo	_	
54-26	9682-9690	sessions	_	
54-27	9691-9693	on	_	
54-28	9694-9698	that	_	
54-29	9699-9708	dimension	_	
54-30	9708-9709	.	_	

#Text=Alcohol/Placebo Experimental Sessions, general procedure
#Text=Follow the same experimental procedures during both alcohol and placebo sessions with the exception of the administered beverage.
55-1	9710-9717	Alcohol	_	
55-2	9717-9718	/	_	
55-3	9718-9725	Placebo	_	
55-4	9726-9738	Experimental	_	
55-5	9739-9747	Sessions	_	
55-6	9747-9748	,	_	
55-7	9749-9756	general	_	
55-8	9757-9766	procedure	_	
55-9	9767-9773	Follow	_	
55-10	9774-9777	the	_	
55-11	9778-9782	same	_	
55-12	9783-9795	experimental	_	
55-13	9796-9806	procedures	_	
55-14	9807-9813	during	_	
55-15	9814-9818	both	_	
55-16	9819-9826	alcohol	_	
55-17	9827-9830	and	_	
55-18	9831-9838	placebo	_	
55-19	9839-9847	sessions	_	
55-20	9848-9852	with	_	
55-21	9853-9856	the	_	
55-22	9857-9866	exception	_	
55-23	9867-9869	of	_	
55-24	9870-9873	the	_	
55-25	9874-9886	administered	_	
55-26	9887-9895	beverage	_	
55-27	9895-9896	.	_	

#Text=Counterbalance beverage order by administering alcohol beverage first to one half of participants and placebo to the other half in a random order.
#Text=3.2.1.
56-1	9897-9911	Counterbalance	_	
56-2	9912-9920	beverage	_	
56-3	9921-9926	order	_	
56-4	9927-9929	by	_	
56-5	9930-9943	administering	_	
56-6	9944-9951	alcohol	_	
56-7	9952-9960	beverage	_	
56-8	9961-9966	first	_	
56-9	9967-9969	to	_	
56-10	9970-9973	one	_	
56-11	9974-9978	half	_	
56-12	9979-9981	of	_	
56-13	9982-9994	participants	_	
56-14	9995-9998	and	_	
56-15	9999-10006	placebo	_	
56-16	10007-10009	to	_	
56-17	10010-10013	the	_	
56-18	10014-10019	other	_	
56-19	10020-10024	half	_	
56-20	10025-10027	in	_	
56-21	10028-10029	a	_	
56-22	10030-10036	random	_	
56-23	10037-10042	order	_	
56-24	10042-10043	.	_	
56-25	10044-10049	3.2.1	_	
56-26	10049-10050	.	_	

#Text=Upon their arrival to the MEG lab, run a brief test scan by putting the participant in the scanner and checking the channels for possible magnetization.
57-1	10051-10055	Upon	_	
57-2	10056-10061	their	_	
57-3	10062-10069	arrival	_	
57-4	10070-10072	to	_	
57-5	10073-10076	the	_	
57-6	10077-10080	MEG	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography	
57-7	10081-10084	lab	_	
57-8	10084-10085	,	_	
57-9	10086-10089	run	_	
57-10	10090-10091	a	_	
57-11	10092-10097	brief	_	
57-12	10098-10102	test	_	
57-13	10103-10107	scan	_	
57-14	10108-10110	by	_	
57-15	10111-10118	putting	_	
57-16	10119-10122	the	_	
57-17	10123-10134	participant	_	
57-18	10135-10137	in	_	
57-19	10138-10141	the	_	
57-20	10142-10149	scanner	_	
57-21	10150-10153	and	_	
57-22	10154-10162	checking	_	
57-23	10163-10166	the	_	
57-24	10167-10175	channels	_	
57-25	10176-10179	for	_	
57-26	10180-10188	possible	_	
57-27	10189-10202	magnetization	_	
57-28	10202-10203	.	_	

#Text=Measure their weight.
58-1	10204-10211	Measure	_	
58-2	10212-10217	their	_	
58-3	10218-10224	weight	_	
58-4	10224-10225	.	_	

#Text=Screen them with an electronic breathalyzer (Dräger, Inc.).
59-1	10226-10232	Screen	_	
59-2	10233-10237	them	_	
59-3	10238-10242	with	_	
59-4	10243-10245	an	_	
59-5	10246-10256	electronic	_	
59-6	10257-10269	breathalyzer	_	
59-7	10270-10271	(	_	
59-8	10271-10277	Dräger	_	
59-9	10277-10278	,	_	
59-10	10279-10282	Inc	_	
59-11	10282-10283	.	_	
59-12	10283-10284	)	_	
59-13	10284-10285	.	_	

#Text=Query them about compliance with the requirements to abstain from alcohol for 48 h and from food for 3 h prior to the experiment.
#Text=3.2.2.
60-1	10286-10291	Query	_	
60-2	10292-10296	them	_	
60-3	10297-10302	about	_	
60-4	10303-10313	compliance	_	
60-5	10314-10318	with	_	
60-6	10319-10322	the	_	
60-7	10323-10335	requirements	_	
60-8	10336-10338	to	_	
60-9	10339-10346	abstain	_	
60-10	10347-10351	from	_	
60-11	10352-10359	alcohol	_	
60-12	10360-10363	for	_	
60-13	10364-10366	48	_	
60-14	10367-10368	h	_	
60-15	10369-10372	and	_	
60-16	10373-10377	from	_	
60-17	10378-10382	food	_	
60-18	10383-10386	for	_	
60-19	10387-10388	3	_	
60-20	10389-10390	h	_	
60-21	10391-10396	prior	_	
60-22	10397-10399	to	_	
60-23	10400-10403	the	_	
60-24	10404-10414	experiment	_	
60-25	10414-10415	.	_	
60-26	10416-10421	3.2.2	_	
60-27	10421-10422	.	_	

#Text=Collect urine samples for a multi-drug test panel (American Screening, LLC) from all participants and exclude those who test positive for any drug.
61-1	10423-10430	Collect	_	
61-2	10431-10436	urine	_	
61-3	10437-10444	samples	_	
61-4	10445-10448	for	_	
61-5	10449-10450	a	_	
61-6	10451-10461	multi-drug	_	
61-7	10462-10466	test	_	
61-8	10467-10472	panel	_	
61-9	10473-10474	(	_	
61-10	10474-10482	American	_	
61-11	10483-10492	Screening	_	
61-12	10492-10493	,	_	
61-13	10494-10497	LLC	_	
61-14	10497-10498	)	_	
61-15	10499-10503	from	_	
61-16	10504-10507	all	_	
61-17	10508-10520	participants	_	
61-18	10521-10524	and	_	
61-19	10525-10532	exclude	_	
61-20	10533-10538	those	_	
61-21	10539-10542	who	_	
61-22	10543-10547	test	_	
61-23	10548-10556	positive	_	
61-24	10557-10560	for	_	
61-25	10561-10564	any	_	
61-26	10565-10569	drug	_	
61-27	10569-10570	.	_	

#Text=In addition, check female participants for pregnancy with a urine test and exclude those who test positive or if they suspect that they might be pregnant.
#Text=3.2.3.
62-1	10571-10573	In	_	
62-2	10574-10582	addition	_	
62-3	10582-10583	,	_	
62-4	10584-10589	check	_	
62-5	10590-10596	female	_	
62-6	10597-10609	participants	_	
62-7	10610-10613	for	_	
62-8	10614-10623	pregnancy	_	
62-9	10624-10628	with	_	
62-10	10629-10630	a	_	
62-11	10631-10636	urine	_	
62-12	10637-10641	test	_	
62-13	10642-10645	and	_	
62-14	10646-10653	exclude	_	
62-15	10654-10659	those	_	
62-16	10660-10663	who	_	
62-17	10664-10668	test	_	
62-18	10669-10677	positive	_	
62-19	10678-10680	or	_	
62-20	10681-10683	if	_	
62-21	10684-10688	they	_	
62-22	10689-10696	suspect	_	
62-23	10697-10701	that	_	
62-24	10702-10706	they	_	
62-25	10707-10712	might	_	
62-26	10713-10715	be	_	
62-27	10716-10724	pregnant	_	
62-28	10724-10725	.	_	
62-29	10726-10731	3.2.3	_	
62-30	10731-10732	.	_	

#Text=Assess dynamic changes in the subjective effects of alcohol by asking participants to rate their momentary feelings and states on a standardized scale prior to drinking and on two additional occasions during the experiment - on the ascending limb (~15 min after consuming beverage) and descending limb of the breath alcohol concentration curve (BrAC), after the MEG recording.
#Text=3.2.4.
63-1	10733-10739	Assess	_	
63-2	10740-10747	dynamic	_	
63-3	10748-10755	changes	_	
63-4	10756-10758	in	_	
63-5	10759-10762	the	_	
63-6	10763-10773	subjective	_	
63-7	10774-10781	effects	_	
63-8	10782-10784	of	_	
63-9	10785-10792	alcohol	_	
63-10	10793-10795	by	_	
63-11	10796-10802	asking	_	
63-12	10803-10815	participants	_	
63-13	10816-10818	to	_	
63-14	10819-10823	rate	_	
63-15	10824-10829	their	_	
63-16	10830-10839	momentary	_	
63-17	10840-10848	feelings	_	
63-18	10849-10852	and	_	
63-19	10853-10859	states	_	
63-20	10860-10862	on	_	
63-21	10863-10864	a	_	
63-22	10865-10877	standardized	_	
63-23	10878-10883	scale	_	
63-24	10884-10889	prior	_	
63-25	10890-10892	to	_	
63-26	10893-10901	drinking	_	
63-27	10902-10905	and	_	
63-28	10906-10908	on	_	
63-29	10909-10912	two	_	
63-30	10913-10923	additional	_	
63-31	10924-10933	occasions	_	
63-32	10934-10940	during	_	
63-33	10941-10944	the	_	
63-34	10945-10955	experiment	_	
63-35	10956-10957	-	_	
63-36	10958-10960	on	_	
63-37	10961-10964	the	_	
63-38	10965-10974	ascending	_	
63-39	10975-10979	limb	_	
63-40	10980-10981	(	_	
63-41	10981-10982	~	_	
63-42	10982-10984	15	_	
63-43	10985-10988	min	_	
63-44	10989-10994	after	_	
63-45	10995-11004	consuming	_	
63-46	11005-11013	beverage	_	
63-47	11013-11014	)	_	
63-48	11015-11018	and	_	
63-49	11019-11029	descending	_	
63-50	11030-11034	limb	_	
63-51	11035-11037	of	_	
63-52	11038-11041	the	_	
63-53	11042-11048	breath	_	
63-54	11049-11056	alcohol	_	
63-55	11057-11070	concentration	_	
63-56	11071-11076	curve	_	
63-57	11077-11078	(	_	
63-58	11078-11082	BrAC	_	
63-59	11082-11083	)	_	
63-60	11083-11084	,	_	
63-61	11085-11090	after	_	
63-62	11091-11094	the	_	
63-63	11095-11098	MEG	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography	
63-64	11099-11108	recording	_	
63-65	11108-11109	.	_	
63-66	11110-11115	3.2.4	_	
63-67	11115-11116	.	_	

#Text=Administer a practice run of the Stroop task on a laptop with stimulus presentation software to ensure that the participants understand the task before recording.
64-1	11117-11127	Administer	_	
64-2	11128-11129	a	_	
64-3	11130-11138	practice	_	
64-4	11139-11142	run	_	
64-5	11143-11145	of	_	
64-6	11146-11149	the	_	
64-7	11150-11156	Stroop	_	
64-8	11157-11161	task	_	
64-9	11162-11164	on	_	
64-10	11165-11166	a	_	
64-11	11167-11173	laptop	_	
64-12	11174-11178	with	_	
64-13	11179-11187	stimulus	_	
64-14	11188-11200	presentation	_	
64-15	11201-11209	software	_	
64-16	11210-11212	to	_	
64-17	11213-11219	ensure	_	
64-18	11220-11224	that	_	
64-19	11225-11228	the	_	
64-20	11229-11241	participants	_	
64-21	11242-11252	understand	_	
64-22	11253-11256	the	_	
64-23	11257-11261	task	_	
64-24	11262-11268	before	_	
64-25	11269-11278	recording	_	
64-26	11278-11279	.	_	

#Text=Note: This version of the Stroop task combines reading and color naming (Figure 1).
65-1	11280-11284	Note	_	
65-2	11284-11285	:	_	
65-3	11286-11290	This	_	
65-4	11291-11298	version	_	
65-5	11299-11301	of	_	
65-6	11302-11305	the	_	
65-7	11306-11312	Stroop	_	
65-8	11313-11317	task	_	
65-9	11318-11326	combines	_	
65-10	11327-11334	reading	_	
65-11	11335-11338	and	_	
65-12	11339-11344	color	_	
65-13	11345-11351	naming	_	
65-14	11352-11353	(	_	
65-15	11353-11359	Figure	_	
65-16	11360-11361	1	_	
65-17	11361-11362	)	_	
65-18	11362-11363	.	_	

#Text=The congruent condition consists of color words (i.e., red, green, blue, yellow) that are printed in the matching font color (i.e., the word “green” is printed in green).
66-1	11364-11367	The	_	
66-2	11368-11377	congruent	_	
66-3	11378-11387	condition	_	
66-4	11388-11396	consists	_	
66-5	11397-11399	of	_	
66-6	11400-11405	color	_	
66-7	11406-11411	words	_	
66-8	11412-11413	(	_	
66-9	11413-11416	i.e	_	
66-10	11416-11417	.	_	
66-11	11417-11418	,	_	
66-12	11419-11422	red	_	
66-13	11422-11423	,	_	
66-14	11424-11429	green	_	
66-15	11429-11430	,	_	
66-16	11431-11435	blue	_	
66-17	11435-11436	,	_	
66-18	11437-11443	yellow	_	
66-19	11443-11444	)	_	
66-20	11445-11449	that	_	
66-21	11450-11453	are	_	
66-22	11454-11461	printed	_	
66-23	11462-11464	in	_	
66-24	11465-11468	the	_	
66-25	11469-11477	matching	_	
66-26	11478-11482	font	_	
66-27	11483-11488	color	_	
66-28	11489-11490	(	_	
66-29	11490-11493	i.e	_	
66-30	11493-11494	.	_	
66-31	11494-11495	,	_	
66-32	11496-11499	the	_	
66-33	11500-11504	word	_	
66-34	11505-11506	“	_	
66-35	11506-11511	green	_	
66-36	11511-11512	”	_	
66-37	11513-11515	is	_	
66-38	11516-11523	printed	_	
66-39	11524-11526	in	_	
66-40	11527-11532	green	_	
66-41	11532-11533	)	_	
66-42	11533-11534	.	_	

#Text=In the incongruous condition, color words are printed in color that does not match their meaning (i.e., the word “green” is printed in yellow).
67-1	11535-11537	In	_	
67-2	11538-11541	the	_	
67-3	11542-11553	incongruous	_	
67-4	11554-11563	condition	_	
67-5	11563-11564	,	_	
67-6	11565-11570	color	_	
67-7	11571-11576	words	_	
67-8	11577-11580	are	_	
67-9	11581-11588	printed	_	
67-10	11589-11591	in	_	
67-11	11592-11597	color	_	
67-12	11598-11602	that	_	
67-13	11603-11607	does	_	
67-14	11608-11611	not	_	
67-15	11612-11617	match	_	
67-16	11618-11623	their	_	
67-17	11624-11631	meaning	_	
67-18	11632-11633	(	_	
67-19	11633-11636	i.e	_	
67-20	11636-11637	.	_	
67-21	11637-11638	,	_	
67-22	11639-11642	the	_	
67-23	11643-11647	word	_	
67-24	11648-11649	“	_	
67-25	11649-11654	green	_	
67-26	11654-11655	”	_	
67-27	11656-11658	is	_	
67-28	11659-11666	printed	_	
67-29	11667-11669	in	_	
67-30	11670-11676	yellow	_	
67-31	11676-11677	)	_	
67-32	11677-11678	.	_	

#Text=Ask the participants to press one of four buttons corresponding to the font color whenever a word is written in color, or, when a word is written in gray, to press a button corresponding to the meaning of the word.
68-1	11679-11682	Ask	_	
68-2	11683-11686	the	_	
68-3	11687-11699	participants	_	
68-4	11700-11702	to	_	
68-5	11703-11708	press	_	
68-6	11709-11712	one	_	
68-7	11713-11715	of	_	
68-8	11716-11720	four	_	
68-9	11721-11728	buttons	_	
68-10	11729-11742	corresponding	_	
68-11	11743-11745	to	_	
68-12	11746-11749	the	_	
68-13	11750-11754	font	_	
68-14	11755-11760	color	_	
68-15	11761-11769	whenever	_	
68-16	11770-11771	a	_	
68-17	11772-11776	word	_	
68-18	11777-11779	is	_	
68-19	11780-11787	written	_	
68-20	11788-11790	in	_	
68-21	11791-11796	color	_	
68-22	11796-11797	,	_	
68-23	11798-11800	or	_	
68-24	11800-11801	,	_	
68-25	11802-11806	when	_	
68-26	11807-11808	a	_	
68-27	11809-11813	word	_	
68-28	11814-11816	is	_	
68-29	11817-11824	written	_	
68-30	11825-11827	in	_	
68-31	11828-11832	gray	_	
68-32	11832-11833	,	_	
68-33	11834-11836	to	_	
68-34	11837-11842	press	_	
68-35	11843-11844	a	_	
68-36	11845-11851	button	_	
68-37	11852-11865	corresponding	_	
68-38	11866-11868	to	_	
68-39	11869-11872	the	_	
68-40	11873-11880	meaning	_	
68-41	11881-11883	of	_	
68-42	11884-11887	the	_	
68-43	11888-11892	word	_	
68-44	11892-11893	.	_	

#Text=Preparation for the MEG/EEG Recording
#Text=Details of MEG data acquisition have been described in previous JOVE publications.
#Text=3.3.1.
69-1	11894-11905	Preparation	_	
69-2	11906-11909	for	_	
69-3	11910-11913	the	_	
69-4	11914-11917	MEG	_	
69-5	11917-11918	/	_	
69-6	11918-11921	EEG	_	
69-7	11922-11931	Recording	_	
69-8	11932-11939	Details	_	
69-9	11940-11942	of	_	
69-10	11943-11946	MEG	_	
69-11	11947-11951	data	_	
69-12	11952-11963	acquisition	_	
69-13	11964-11968	have	_	
69-14	11969-11973	been	_	
69-15	11974-11983	described	_	
69-16	11984-11986	in	_	
69-17	11987-11995	previous	_	
69-18	11996-12000	JOVE	_	
69-19	12001-12013	publications	_	
69-20	12013-12014	.	_	
69-21	12015-12020	3.3.1	_	
69-22	12020-12021	.	_	

#Text=Position the EEG cap or individual EEG electrodes on the head and check that all impedances are below 5 kOhms.
#Text=3.3.2.
70-1	12022-12030	Position	_	
70-2	12031-12034	the	_	
70-3	12035-12038	EEG	_	
70-4	12039-12042	cap	_	
70-5	12043-12045	or	_	
70-6	12046-12056	individual	_	
70-7	12057-12060	EEG	_	
70-8	12061-12071	electrodes	_	
70-9	12072-12074	on	_	
70-10	12075-12078	the	_	
70-11	12079-12083	head	_	
70-12	12084-12087	and	_	
70-13	12088-12093	check	_	
70-14	12094-12098	that	_	
70-15	12099-12102	all	_	
70-16	12103-12113	impedances	_	
70-17	12114-12117	are	_	
70-18	12118-12123	below	_	
70-19	12124-12125	5	_	
70-20	12126-12131	kOhms	_	
70-21	12131-12132	.	_	
70-22	12133-12138	3.3.2	_	
70-23	12138-12139	.	_	

#Text=Attach the head position indicator (HPI) coils on either side of the forehead and behind each ear.
71-1	12140-12146	Attach	_	
71-2	12147-12150	the	_	
71-3	12151-12155	head	_	
71-4	12156-12164	position	_	
71-5	12165-12174	indicator	_	
71-6	12175-12176	(	_	
71-7	12176-12179	HPI	_	
71-8	12179-12180	)	_	
71-9	12181-12186	coils	_	
71-10	12187-12189	on	_	
71-11	12190-12196	either	_	
71-12	12197-12201	side	_	
71-13	12202-12204	of	_	
71-14	12205-12208	the	_	
71-15	12209-12217	forehead	_	
71-16	12218-12221	and	_	
71-17	12222-12228	behind	_	
71-18	12229-12233	each	_	
71-19	12234-12237	ear	_	
71-20	12237-12238	.	_	

#Text=Note: this step is specific to Neuromag systems.
#Text=3.3.3.
72-1	12239-12243	Note	_	
72-2	12243-12244	:	_	
72-3	12245-12249	this	_	
72-4	12250-12254	step	_	
72-5	12255-12257	is	_	
72-6	12258-12266	specific	_	
72-7	12267-12269	to	_	
72-8	12270-12278	Neuromag	_	
72-9	12279-12286	systems	_	
72-10	12286-12287	.	_	
72-11	12288-12293	3.3.3	_	
72-12	12293-12294	.	_	

#Text=Digitize positions of the fiducial points including the nasion and two preauricular points, positions of HPI coils, EEG electrodes, and obtain a large number of additional points (~200) delineating the head shape.
73-1	12295-12303	Digitize	_	
73-2	12304-12313	positions	_	
73-3	12314-12316	of	_	
73-4	12317-12320	the	_	
73-5	12321-12329	fiducial	_	
73-6	12330-12336	points	_	
73-7	12337-12346	including	_	
73-8	12347-12350	the	_	
73-9	12351-12357	nasion	_	
73-10	12358-12361	and	_	
73-11	12362-12365	two	_	
73-12	12366-12378	preauricular	_	
73-13	12379-12385	points	_	
73-14	12385-12386	,	_	
73-15	12387-12396	positions	_	
73-16	12397-12399	of	_	
73-17	12400-12403	HPI	_	
73-18	12404-12409	coils	_	
73-19	12409-12410	,	_	
73-20	12411-12414	EEG	_	
73-21	12415-12425	electrodes	_	
73-22	12425-12426	,	_	
73-23	12427-12430	and	_	
73-24	12431-12437	obtain	_	
73-25	12438-12439	a	_	
73-26	12440-12445	large	_	
73-27	12446-12452	number	_	
73-28	12453-12455	of	_	
73-29	12456-12466	additional	_	
73-30	12467-12473	points	_	
73-31	12474-12475	(	_	
73-32	12475-12476	~	_	
73-33	12476-12479	200	_	
73-34	12479-12480	)	_	
73-35	12481-12492	delineating	_	
73-36	12493-12496	the	_	
73-37	12497-12501	head	_	
73-38	12502-12507	shape	_	
73-39	12507-12508	.	_	

#Text=This information is used for the co-registration with anatomical MRI images.
74-1	12509-12513	This	_	
74-2	12514-12525	information	_	
74-3	12526-12528	is	_	
74-4	12529-12533	used	_	
74-5	12534-12537	for	_	
74-6	12538-12541	the	_	
74-7	12542-12557	co-registration	_	
74-8	12558-12562	with	_	
74-9	12563-12573	anatomical	_	
74-10	12574-12577	MRI	_	
74-11	12578-12584	images	_	
74-12	12584-12585	.	_	

#Text=(Figure 2)
#Text=Beverage Administration
#Text=3.4.1.
75-1	12586-12587	(	_	
75-2	12587-12593	Figure	_	
75-3	12594-12595	2	_	
75-4	12595-12596	)	_	
75-5	12597-12605	Beverage	_	
75-6	12606-12620	Administration	_	
75-7	12621-12626	3.4.1	_	
75-8	12626-12627	.	_	

#Text=Prepare alcohol beverage by mixing premium quality vodka with chilled orange juice (25% v/v), based on each participant’s gender and weight (0.60 g/kg alcohol for men, 0.55 g/kg alcohol for women), targeting a BrAC of 0.06%.
76-1	12628-12635	Prepare	_	
76-2	12636-12643	alcohol	_	
76-3	12644-12652	beverage	_	
76-4	12653-12655	by	_	
76-5	12656-12662	mixing	_	
76-6	12663-12670	premium	_	
76-7	12671-12678	quality	_	
76-8	12679-12684	vodka	_	
76-9	12685-12689	with	_	
76-10	12690-12697	chilled	_	
76-11	12698-12704	orange	_	
76-12	12705-12710	juice	_	
76-13	12711-12712	(	_	
76-14	12712-12715	25%	_	
76-15	12716-12717	v	_	
76-16	12717-12718	/	_	
76-17	12718-12719	v	_	
76-18	12719-12720	)	_	
76-19	12720-12721	,	_	
76-20	12722-12727	based	_	
76-21	12728-12730	on	_	
76-22	12731-12735	each	_	
76-23	12736-12747	participant	_	
76-24	12747-12748	’	_	
76-25	12748-12749	s	_	
76-26	12750-12756	gender	_	
76-27	12757-12760	and	_	
76-28	12761-12767	weight	_	
76-29	12768-12769	(	_	
76-30	12769-12773	0.60	_	
76-31	12774-12775	g	_	
76-32	12775-12776	/	_	
76-33	12776-12778	kg	_	
76-34	12779-12786	alcohol	_	
76-35	12787-12790	for	_	
76-36	12791-12794	men	_	
76-37	12794-12795	,	_	
76-38	12796-12800	0.55	_	
76-39	12801-12802	g	_	
76-40	12802-12803	/	_	
76-41	12803-12805	kg	_	
76-42	12806-12813	alcohol	_	
76-43	12814-12817	for	_	
76-44	12818-12823	women	_	
76-45	12823-12824	)	_	
76-46	12824-12825	,	_	
76-47	12826-12835	targeting	_	
76-48	12836-12837	a	_	
76-49	12838-12842	BrAC	_	
76-50	12843-12845	of	_	
76-51	12846-12851	0.06%	_	
76-52	12851-12852	.	_	

#Text=Serve the same volume of orange juice in glasses with rims swabbed with vodka as a placebo beverage.
77-1	12853-12858	Serve	_	
77-2	12859-12862	the	_	
77-3	12863-12867	same	_	
77-4	12868-12874	volume	_	
77-5	12875-12877	of	_	
77-6	12878-12884	orange	_	
77-7	12885-12890	juice	_	
77-8	12891-12893	in	_	
77-9	12894-12901	glasses	_	
77-10	12902-12906	with	_	
77-11	12907-12911	rims	_	
77-12	12912-12919	swabbed	_	
77-13	12920-12924	with	_	
77-14	12925-12930	vodka	_	
77-15	12931-12933	as	_	
77-16	12934-12935	a	_	
77-17	12936-12943	placebo	_	
77-18	12944-12952	beverage	_	
77-19	12952-12953	.	_	

#Text=Ask the participant to consume the beverage in approximately 10 min.
#Text=3.4.2.
78-1	12954-12957	Ask	_	
78-2	12958-12961	the	_	
78-3	12962-12973	participant	_	
78-4	12974-12976	to	_	
78-5	12977-12984	consume	_	
78-6	12985-12988	the	_	
78-7	12989-12997	beverage	_	
78-8	12998-13000	in	_	
78-9	13001-13014	approximately	_	
78-10	13015-13017	10	_	
78-11	13018-13021	min	_	
78-12	13021-13022	.	_	
78-13	13023-13028	3.4.2	_	
78-14	13028-13029	.	_	

#Text=Check the participants’ BrAC with the breathalyzer starting at ~15 min after drinking and then every 5 min until they enter the recording chamber.
79-1	13030-13035	Check	_	
79-2	13036-13039	the	_	
79-3	13040-13052	participants	_	
79-4	13052-13053	’	_	
79-5	13054-13058	BrAC	_	
79-6	13059-13063	with	_	
79-7	13064-13067	the	_	
79-8	13068-13080	breathalyzer	_	
79-9	13081-13089	starting	_	
79-10	13090-13092	at	_	
79-11	13093-13094	~	_	
79-12	13094-13096	15	_	
79-13	13097-13100	min	_	
79-14	13101-13106	after	_	
79-15	13107-13115	drinking	_	
79-16	13116-13119	and	_	
79-17	13120-13124	then	_	
79-18	13125-13130	every	_	
79-19	13131-13132	5	_	
79-20	13133-13136	min	_	
79-21	13137-13142	until	_	
79-22	13143-13147	they	_	
79-23	13148-13153	enter	_	
79-24	13154-13157	the	_	
79-25	13158-13167	recording	_	
79-26	13168-13175	chamber	_	
79-27	13175-13176	.	_	

#Text=Since electronic devices cannot be used in the shielded room, use a saliva alcohol test (Q.E.D.®, OraSure Technologies), which consists of a q-tip that is saturated in saliva and is inserted into a receptacle that provides a readout.
80-1	13177-13182	Since	_	
80-2	13183-13193	electronic	_	
80-3	13194-13201	devices	_	
80-4	13202-13208	cannot	_	
80-5	13209-13211	be	_	
80-6	13212-13216	used	_	
80-7	13217-13219	in	_	
80-8	13220-13223	the	_	
80-9	13224-13232	shielded	_	
80-10	13233-13237	room	_	
80-11	13237-13238	,	_	
80-12	13239-13242	use	_	
80-13	13243-13244	a	_	
80-14	13245-13251	saliva	_	
80-15	13252-13259	alcohol	_	
80-16	13260-13264	test	_	
80-17	13265-13266	(	_	
80-18	13266-13271	Q.E.D	_	
80-19	13271-13272	.	_	
80-20	13272-13273	®	_	
80-21	13273-13274	,	_	
80-22	13275-13282	OraSure	_	
80-23	13283-13295	Technologies	_	
80-24	13295-13296	)	_	
80-25	13296-13297	,	_	
80-26	13298-13303	which	_	
80-27	13304-13312	consists	_	
80-28	13313-13315	of	_	
80-29	13316-13317	a	_	
80-30	13318-13323	q-tip	_	
80-31	13324-13328	that	_	
80-32	13329-13331	is	_	
80-33	13332-13341	saturated	_	
80-34	13342-13344	in	_	
80-35	13345-13351	saliva	_	
80-36	13352-13355	and	_	
80-37	13356-13358	is	_	
80-38	13359-13367	inserted	_	
80-39	13368-13372	into	_	
80-40	13373-13374	a	_	
80-41	13375-13385	receptacle	_	
80-42	13386-13390	that	_	
80-43	13391-13399	provides	_	
80-44	13400-13401	a	_	
80-45	13402-13409	readout	_	
80-46	13409-13410	.	_	

#Text=MEG/EEG Data Acquisition
#Text=3.5.1.
81-1	13411-13414	MEG	_	
81-2	13414-13415	/	_	
81-3	13415-13418	EEG	_	
81-4	13419-13423	Data	_	
81-5	13424-13435	Acquisition	_	
81-6	13436-13441	3.5.1	_	
81-7	13441-13442	.	_	

#Text=Position the participant comfortably in the scanner.
82-1	13443-13451	Position	_	
82-2	13452-13455	the	_	
82-3	13456-13467	participant	_	
82-4	13468-13479	comfortably	_	
82-5	13480-13482	in	_	
82-6	13483-13486	the	_	
82-7	13487-13494	scanner	_	
82-8	13494-13495	.	_	

#Text=Since the prefrontal activity is of particular interest, ensure that the participants are positioned so that their head is touching the top of the helmet and is aligned along the front.
83-1	13496-13501	Since	_	
83-2	13502-13505	the	_	
83-3	13506-13516	prefrontal	_	
83-4	13517-13525	activity	_	
83-5	13526-13528	is	_	
83-6	13529-13531	of	_	
83-7	13532-13542	particular	_	
83-8	13543-13551	interest	_	
83-9	13551-13552	,	_	
83-10	13553-13559	ensure	_	
83-11	13560-13564	that	_	
83-12	13565-13568	the	_	
83-13	13569-13581	participants	_	
83-14	13582-13585	are	_	
83-15	13586-13596	positioned	_	
83-16	13597-13599	so	_	
83-17	13600-13604	that	_	
83-18	13605-13610	their	_	
83-19	13611-13615	head	_	
83-20	13616-13618	is	_	
83-21	13619-13627	touching	_	
83-22	13628-13631	the	_	
83-23	13632-13635	top	_	
83-24	13636-13638	of	_	
83-25	13639-13642	the	_	
83-26	13643-13649	helmet	_	
83-27	13650-13653	and	_	
83-28	13654-13656	is	_	
83-29	13657-13664	aligned	_	
83-30	13665-13670	along	_	
83-31	13671-13674	the	_	
83-32	13675-13680	front	_	
83-33	13680-13681	.	_	

#Text=Note: Head position can affect activity estimates in significant ways because the magnetic field gradients decrease with the cube of the distance between the sensors and the brain sources.
#Text=3.5.2.
84-1	13682-13686	Note	_	
84-2	13686-13687	:	_	
84-3	13688-13692	Head	_	
84-4	13693-13701	position	_	
84-5	13702-13705	can	_	
84-6	13706-13712	affect	_	
84-7	13713-13721	activity	_	
84-8	13722-13731	estimates	_	
84-9	13732-13734	in	_	
84-10	13735-13746	significant	_	
84-11	13747-13751	ways	_	
84-12	13752-13759	because	_	
84-13	13760-13763	the	_	
84-14	13764-13772	magnetic	_	
84-15	13773-13778	field	_	
84-16	13779-13788	gradients	_	
84-17	13789-13797	decrease	_	
84-18	13798-13802	with	_	
84-19	13803-13806	the	_	
84-20	13807-13811	cube	_	
84-21	13812-13814	of	_	
84-22	13815-13818	the	_	
84-23	13819-13827	distance	_	
84-24	13828-13835	between	_	
84-25	13836-13839	the	_	
84-26	13840-13847	sensors	_	
84-27	13848-13851	and	_	
84-28	13852-13855	the	_	
84-29	13856-13861	brain	_	
84-30	13862-13869	sources	_	
84-31	13869-13870	.	_	
84-32	13871-13876	3.5.2	_	
84-33	13876-13877	.	_	

#Text=Connect HPI coils and all of the electrodes to their respective inputs on the scanner.
85-1	13878-13885	Connect	_	
85-2	13886-13889	HPI	_	
85-3	13890-13895	coils	_	
85-4	13896-13899	and	_	
85-5	13900-13903	all	_	
85-6	13904-13906	of	_	
85-7	13907-13910	the	_	
85-8	13911-13921	electrodes	_	
85-9	13922-13924	to	_	
85-10	13925-13930	their	_	
85-11	13931-13941	respective	_	
85-12	13942-13948	inputs	_	
85-13	13949-13951	on	_	
85-14	13952-13955	the	_	
85-15	13956-13963	scanner	_	
85-16	13963-13964	.	_	

#Text=Position response pads so that the buttons can be pressed comfortably.
86-1	13965-13973	Position	_	
86-2	13974-13982	response	_	
86-3	13983-13987	pads	_	
86-4	13988-13990	so	_	
86-5	13991-13995	that	_	
86-6	13996-13999	the	_	
86-7	14000-14007	buttons	_	
86-8	14008-14011	can	_	
86-9	14012-14014	be	_	
86-10	14015-14022	pressed	_	
86-11	14023-14034	comfortably	_	
86-12	14034-14035	.	_	

#Text=Ascertain that the font is clearly legible on the projection screen in front of the participant.
#Text=3.5.3.
87-1	14036-14045	Ascertain	_	
87-2	14046-14050	that	_	
87-3	14051-14054	the	_	
87-4	14055-14059	font	_	
87-5	14060-14062	is	_	
87-6	14063-14070	clearly	_	
87-7	14071-14078	legible	_	
87-8	14079-14081	on	_	
87-9	14082-14085	the	_	
87-10	14086-14096	projection	_	
87-11	14097-14103	screen	_	
87-12	14104-14106	in	_	
87-13	14107-14112	front	_	
87-14	14113-14115	of	_	
87-15	14116-14119	the	_	
87-16	14120-14131	participant	_	
87-17	14131-14132	.	_	
87-18	14133-14138	3.5.3	_	
87-19	14138-14139	.	_	

#Text=Back in the console room, check that the intercom is functioning properly.
88-1	14140-14144	Back	_	
88-2	14145-14147	in	_	
88-3	14148-14151	the	_	
88-4	14152-14159	console	_	
88-5	14160-14164	room	_	
88-6	14164-14165	,	_	
88-7	14166-14171	check	_	
88-8	14172-14176	that	_	
88-9	14177-14180	the	_	
88-10	14181-14189	intercom	_	
88-11	14190-14192	is	_	
88-12	14193-14204	functioning	_	
88-13	14205-14213	properly	_	
88-14	14213-14214	.	_	

#Text=Remind the participant to minimize blinking and to avoid movements including head motion caused by talking.
89-1	14215-14221	Remind	_	
89-2	14222-14225	the	_	
89-3	14226-14237	participant	_	
89-4	14238-14240	to	_	
89-5	14241-14249	minimize	_	
89-6	14250-14258	blinking	_	
89-7	14259-14262	and	_	
89-8	14263-14265	to	_	
89-9	14266-14271	avoid	_	
89-10	14272-14281	movements	_	
89-11	14282-14291	including	_	
89-12	14292-14296	head	_	
89-13	14297-14303	motion	_	
89-14	14304-14310	caused	_	
89-15	14311-14313	by	_	
89-16	14314-14321	talking	_	
89-17	14321-14322	.	_	

#Text=Instruct the participant to reply to questions by pressing response buttons instead.
#Text=3.5.4.
90-1	14323-14331	Instruct	_	
90-2	14332-14335	the	_	
90-3	14336-14347	participant	_	
90-4	14348-14350	to	_	
90-5	14351-14356	reply	_	
90-6	14357-14359	to	_	
90-7	14360-14369	questions	_	
90-8	14370-14372	by	_	
90-9	14373-14381	pressing	_	
90-10	14382-14390	response	_	
90-11	14391-14398	buttons	_	
90-12	14399-14406	instead	_	
90-13	14406-14407	.	_	
90-14	14408-14413	3.5.4	_	
90-15	14413-14414	.	_	

#Text=Check that all response and stimulus triggers are recorded correctly.
91-1	14415-14420	Check	_	
91-2	14421-14425	that	_	
91-3	14426-14429	all	_	
91-4	14430-14438	response	_	
91-5	14439-14442	and	_	
91-6	14443-14451	stimulus	_	
91-7	14452-14460	triggers	_	
91-8	14461-14464	are	_	
91-9	14465-14473	recorded	_	
91-10	14474-14483	correctly	_	
91-11	14483-14484	.	_	

#Text=Examine all channels for artifacts and measure the head position in the scanner.
#Text=3.5.5.
92-1	14485-14492	Examine	_	
92-2	14493-14496	all	_	
92-3	14497-14505	channels	_	
92-4	14506-14509	for	_	
92-5	14510-14519	artifacts	_	
92-6	14520-14523	and	_	
92-7	14524-14531	measure	_	
92-8	14532-14535	the	_	
92-9	14536-14540	head	_	
92-10	14541-14549	position	_	
92-11	14550-14552	in	_	
92-12	14553-14556	the	_	
92-13	14557-14564	scanner	_	
92-14	14564-14565	.	_	
92-15	14566-14571	3.5.5	_	
92-16	14571-14572	.	_	

#Text=Start data acquisition and begin the task.
93-1	14573-14578	Start	_	
93-2	14579-14583	data	_	
93-3	14584-14595	acquisition	_	
93-4	14596-14599	and	_	
93-5	14600-14605	begin	_	
93-6	14606-14609	the	_	
93-7	14610-14614	task	_	
93-8	14614-14615	.	_	

#Text=Give breaks every ~2.5 min to rest the eyes.
94-1	14616-14620	Give	_	
94-2	14621-14627	breaks	_	
94-3	14628-14633	every	_	
94-4	14634-14635	~	_	
94-5	14635-14638	2.5	_	
94-6	14639-14642	min	_	
94-7	14643-14645	to	_	
94-8	14646-14650	rest	_	
94-9	14651-14654	the	_	
94-10	14655-14659	eyes	_	
94-11	14659-14660	.	_	

#Text=Save the data upon task completion and escort the participant out of the recording chamber.
#Text=3.5.6.
95-1	14661-14665	Save	_	
95-2	14666-14669	the	_	
95-3	14670-14674	data	_	
95-4	14675-14679	upon	_	
95-5	14680-14684	task	_	
95-6	14685-14695	completion	_	
95-7	14696-14699	and	_	
95-8	14700-14706	escort	_	
95-9	14707-14710	the	_	
95-10	14711-14722	participant	_	
95-11	14723-14726	out	_	
95-12	14727-14729	of	_	
95-13	14730-14733	the	_	
95-14	14734-14743	recording	_	
95-15	14744-14751	chamber	_	
95-16	14751-14752	.	_	
95-17	14753-14758	3.5.6	_	
95-18	14758-14759	.	_	

#Text=When the participant has exited the scanner, acquire approximately two min of data from the empty room as a measure of instrumental noise.
#Text=3.5.7.
96-1	14760-14764	When	_	
96-2	14765-14768	the	_	
96-3	14769-14780	participant	_	
96-4	14781-14784	has	_	
96-5	14785-14791	exited	_	
96-6	14792-14795	the	_	
96-7	14796-14803	scanner	_	
96-8	14803-14804	,	_	
96-9	14805-14812	acquire	_	
96-10	14813-14826	approximately	_	
96-11	14827-14830	two	_	
96-12	14831-14834	min	_	
96-13	14835-14837	of	_	
96-14	14838-14842	data	_	
96-15	14843-14847	from	_	
96-16	14848-14851	the	_	
96-17	14852-14857	empty	_	
96-18	14858-14862	room	_	
96-19	14863-14865	as	_	
96-20	14866-14867	a	_	
96-21	14868-14875	measure	_	
96-22	14876-14878	of	_	
96-23	14879-14891	instrumental	_	
96-24	14892-14897	noise	_	
96-25	14897-14898	.	_	
96-26	14899-14904	3.5.7	_	
96-27	14904-14905	.	_	

#Text=Ask the participant to rate perceived task difficulty, content of the imbibed beverage, how intoxicated they felt, as well as their momentary moods and feelings.
97-1	14906-14909	Ask	_	
97-2	14910-14913	the	_	
97-3	14914-14925	participant	_	
97-4	14926-14928	to	_	
97-5	14929-14933	rate	_	
97-6	14934-14943	perceived	_	
97-7	14944-14948	task	_	
97-8	14949-14959	difficulty	_	
97-9	14959-14960	,	_	
97-10	14961-14968	content	_	
97-11	14969-14971	of	_	
97-12	14972-14975	the	_	
97-13	14976-14983	imbibed	_	
97-14	14984-14992	beverage	_	
97-15	14992-14993	,	_	
97-16	14994-14997	how	_	
97-17	14998-15009	intoxicated	_	
97-18	15010-15014	they	_	
97-19	15015-15019	felt	_	
97-20	15019-15020	,	_	
97-21	15021-15023	as	_	
97-22	15024-15028	well	_	
97-23	15029-15031	as	_	
97-24	15032-15037	their	_	
97-25	15038-15047	momentary	_	
97-26	15048-15053	moods	_	
97-27	15054-15057	and	_	
97-28	15058-15066	feelings	_	
97-29	15066-15067	.	_	

#Text=Structural MRI - image acquisition and cortical reconstruction
#Text=4.1.
98-1	15068-15078	Structural	_	
98-2	15079-15082	MRI	_	
98-3	15083-15084	-	_	
98-4	15085-15090	image	_	
98-5	15091-15102	acquisition	_	
98-6	15103-15106	and	_	
98-7	15107-15115	cortical	_	
98-8	15116-15130	reconstruction	_	
98-9	15131-15134	4.1	_	
98-10	15134-15135	.	_	

#Text=Obtain a high-resolution anatomical MRI scan for each participant
#Text=4.2.
99-1	15136-15142	Obtain	_	
99-2	15143-15144	a	_	
99-3	15145-15160	high-resolution	_	
99-4	15161-15171	anatomical	_	
99-5	15172-15175	MRI	_	
99-6	15176-15180	scan	_	
99-7	15181-15184	for	_	
99-8	15185-15189	each	_	
99-9	15190-15201	participant	_	
99-10	15202-15205	4.2	_	
99-11	15205-15206	.	_	

#Text=Reconstruct each participant’s cortical surface with FreeSurfer software.
#Text=4.3.
100-1	15207-15218	Reconstruct	_	
100-2	15219-15223	each	_	
100-3	15224-15235	participant	_	
100-4	15235-15236	’	_	
100-5	15236-15237	s	_	
100-6	15238-15246	cortical	_	
100-7	15247-15254	surface	_	
100-8	15255-15259	with	_	
100-9	15260-15270	FreeSurfer	_	
100-10	15271-15279	software	_	
100-11	15279-15280	.	_	
100-12	15281-15284	4.3	_	
100-13	15284-15285	.	_	

#Text=Use the inner skull surface derived from the segmented structural MRI images to generate a boundary element model of the volume conductor, which is used to provide a model for the forward solution that is consistent with each individual’s brain anatomy.
101-1	15286-15289	Use	_	
101-2	15290-15293	the	_	
101-3	15294-15299	inner	_	
101-4	15300-15305	skull	_	
101-5	15306-15313	surface	_	
101-6	15314-15321	derived	_	
101-7	15322-15326	from	_	
101-8	15327-15330	the	_	
101-9	15331-15340	segmented	_	
101-10	15341-15351	structural	_	
101-11	15352-15355	MRI	_	
101-12	15356-15362	images	_	
101-13	15363-15365	to	_	
101-14	15366-15374	generate	_	
101-15	15375-15376	a	_	
101-16	15377-15385	boundary	_	
101-17	15386-15393	element	_	
101-18	15394-15399	model	_	
101-19	15400-15402	of	_	
101-20	15403-15406	the	_	
101-21	15407-15413	volume	_	
101-22	15414-15423	conductor	_	
101-23	15423-15424	,	_	
101-24	15425-15430	which	_	
101-25	15431-15433	is	_	
101-26	15434-15438	used	_	
101-27	15439-15441	to	_	
101-28	15442-15449	provide	_	
101-29	15450-15451	a	_	
101-30	15452-15457	model	_	
101-31	15458-15461	for	_	
101-32	15462-15465	the	_	
101-33	15466-15473	forward	_	
101-34	15474-15482	solution	_	
101-35	15483-15487	that	_	
101-36	15488-15490	is	_	
101-37	15491-15501	consistent	_	
101-38	15502-15506	with	_	
101-39	15507-15511	each	_	
101-40	15512-15522	individual	_	
101-41	15522-15523	’	_	
101-42	15523-15524	s	_	
101-43	15525-15530	brain	_	
101-44	15531-15538	anatomy	_	
101-45	15538-15539	.	_	

#Text=MEG Data Analysis
#Text=Analyze the data with the anatomically-constrained MEG approach which uses each participant’s reconstructed cortical surface to constrain source estimates to the cortical ribbon.
102-1	15540-15543	MEG	_	
102-2	15544-15548	Data	_	
102-3	15549-15557	Analysis	_	
102-4	15558-15565	Analyze	_	
102-5	15566-15569	the	_	
102-6	15570-15574	data	_	
102-7	15575-15579	with	_	
102-8	15580-15583	the	_	
102-9	15584-15608	anatomically-constrained	_	
102-10	15609-15612	MEG	_	
102-11	15613-15621	approach	_	
102-12	15622-15627	which	_	
102-13	15628-15632	uses	_	
102-14	15633-15637	each	_	
102-15	15638-15649	participant	_	
102-16	15649-15650	’	_	
102-17	15650-15651	s	_	
102-18	15652-15665	reconstructed	_	
102-19	15666-15674	cortical	_	
102-20	15675-15682	surface	_	
102-21	15683-15685	to	_	
102-22	15686-15695	constrain	_	
102-23	15696-15702	source	_	
102-24	15703-15712	estimates	_	
102-25	15713-15715	to	_	
102-26	15716-15719	the	_	
102-27	15720-15728	cortical	_	
102-28	15729-15735	ribbon	_	
102-29	15735-15736	.	_	

#Text=The analysis stream relies on custom MATLAB functions with dependencies on publicly available packages including FieldTrip, EEGLab, and MNE.
#Text=5.1.
103-1	15737-15740	The	_	
103-2	15741-15749	analysis	_	
103-3	15750-15756	stream	_	
103-4	15757-15763	relies	_	
103-5	15764-15766	on	_	
103-6	15767-15773	custom	_	
103-7	15774-15780	MATLAB	_	
103-8	15781-15790	functions	_	
103-9	15791-15795	with	_	
103-10	15796-15808	dependencies	_	
103-11	15809-15811	on	_	
103-12	15812-15820	publicly	_	
103-13	15821-15830	available	_	
103-14	15831-15839	packages	_	
103-15	15840-15849	including	_	
103-16	15850-15859	FieldTrip	_	
103-17	15859-15860	,	_	
103-18	15861-15867	EEGLab	_	
103-19	15867-15868	,	_	
103-20	15869-15872	and	_	
103-21	15873-15876	MNE	_	
103-22	15876-15877	.	_	
103-23	15878-15881	5.1	_	
103-24	15881-15882	.	_	

#Text=During data preprocessing, use a permissive band-pass filter (e.g., .1 – 100 Hz) and epoch data into segments that include padding intervals on each end (e.g., −600 to 1100 ms for an interval of interest that spans −300 to 800 ms after stimulus onset).
#Text=5.2.
104-1	15883-15889	During	_	
104-2	15890-15894	data	_	
104-3	15895-15908	preprocessing	_	
104-4	15908-15909	,	_	
104-5	15910-15913	use	_	
104-6	15914-15915	a	_	
104-7	15916-15926	permissive	_	
104-8	15927-15936	band-pass	_	
104-9	15937-15943	filter	_	
104-10	15944-15945	(	_	
104-11	15945-15948	e.g	_	
104-12	15948-15949	.	_	
104-13	15949-15950	,	_	
104-14	15951-15953	.1	_	
104-15	15954-15955	–	_	
104-16	15956-15959	100	_	
104-17	15960-15962	Hz	_	
104-18	15962-15963	)	_	
104-19	15964-15967	and	_	
104-20	15968-15973	epoch	_	
104-21	15974-15978	data	_	
104-22	15979-15983	into	_	
104-23	15984-15992	segments	_	
104-24	15993-15997	that	_	
104-25	15998-16005	include	_	
104-26	16006-16013	padding	_	
104-27	16014-16023	intervals	_	
104-28	16024-16026	on	_	
104-29	16027-16031	each	_	
104-30	16032-16035	end	_	
104-31	16036-16037	(	_	
104-32	16037-16040	e.g	_	
104-33	16040-16041	.	_	
104-34	16041-16042	,	_	
104-35	16043-16044	−	_	
104-36	16044-16047	600	_	
104-37	16048-16050	to	_	
104-38	16051-16055	1100	_	
104-39	16056-16058	ms	_	
104-40	16059-16062	for	_	
104-41	16063-16065	an	_	
104-42	16066-16074	interval	_	
104-43	16075-16077	of	_	
104-44	16078-16086	interest	_	
104-45	16087-16091	that	_	
104-46	16092-16097	spans	_	
104-47	16098-16099	−	_	
104-48	16099-16102	300	_	
104-49	16103-16105	to	_	
104-50	16106-16109	800	_	
104-51	16110-16112	ms	_	
104-52	16113-16118	after	_	
104-53	16119-16127	stimulus	_	
104-54	16128-16133	onset	_	
104-55	16133-16134	)	_	
104-56	16134-16135	.	_	
104-57	16136-16139	5.2	_	
104-58	16139-16140	.	_	

#Text=Remove noisy and flat channels, as well as trials containing artifacts by visual inspection and using threshold-based rejection.
105-1	16141-16147	Remove	_	
105-2	16148-16153	noisy	_	
105-3	16154-16157	and	_	
105-4	16158-16162	flat	_	
105-5	16163-16171	channels	_	
105-6	16171-16172	,	_	
105-7	16173-16175	as	_	
105-8	16176-16180	well	_	
105-9	16181-16183	as	_	
105-10	16184-16190	trials	_	
105-11	16191-16201	containing	_	
105-12	16202-16211	artifacts	_	
105-13	16212-16214	by	_	
105-14	16215-16221	visual	_	
105-15	16222-16232	inspection	_	
105-16	16233-16236	and	_	
105-17	16237-16242	using	_	
105-18	16243-16258	threshold-based	_	
105-19	16259-16268	rejection	_	
105-20	16268-16269	.	_	

#Text=Use independent component analysis to remove eyeblink and heartbeat artifacts.
106-1	16270-16273	Use	_	
106-2	16274-16285	independent	_	
106-3	16286-16295	component	_	
106-4	16296-16304	analysis	_	
106-5	16305-16307	to	_	
106-6	16308-16314	remove	_	
106-7	16315-16323	eyeblink	_	
106-8	16324-16327	and	_	
106-9	16328-16337	heartbeat	_	
106-10	16338-16347	artifacts	_	
106-11	16347-16348	.	_	

#Text=Eliminate trials with incorrect responses.
#Text=5.3.
107-1	16349-16358	Eliminate	_	
107-2	16359-16365	trials	_	
107-3	16366-16370	with	_	
107-4	16371-16380	incorrect	_	
107-5	16381-16390	responses	_	
107-6	16390-16391	.	_	
107-7	16392-16395	5.3	_	
107-8	16395-16396	.	_	

#Text=Apply Morlet wavelets (Figure 3) to calculate complex power spectrum for each trial in 1 Hz increments for theta frequency band (4 – 7 Hz).
108-1	16397-16402	Apply	_	
108-2	16403-16409	Morlet	_	
108-3	16410-16418	wavelets	_	
108-4	16419-16420	(	_	
108-5	16420-16426	Figure	_	
108-6	16427-16428	3	_	
108-7	16428-16429	)	_	
108-8	16430-16432	to	_	
108-9	16433-16442	calculate	_	
108-10	16443-16450	complex	_	
108-11	16451-16456	power	_	
108-12	16457-16465	spectrum	_	
108-13	16466-16469	for	_	
108-14	16470-16474	each	_	
108-15	16475-16480	trial	_	
108-16	16481-16483	in	_	
108-17	16484-16485	1	_	
108-18	16486-16488	Hz	_	
108-19	16489-16499	increments	_	
108-20	16500-16503	for	_	
108-21	16504-16509	theta	_	
108-22	16510-16519	frequency	_	
108-23	16520-16524	band	_	
108-24	16525-16526	(	_	
108-25	16526-16527	4	_	
108-26	16528-16529	–	_	
108-27	16530-16531	7	_	
108-28	16532-16534	Hz	_	
108-29	16534-16535	)	_	
108-30	16535-16536	.	_	

#Text=Remove any additional artifacts.
109-1	16537-16543	Remove	_	
109-2	16544-16547	any	_	
109-3	16548-16558	additional	_	
109-4	16559-16568	artifacts	_	
109-5	16568-16569	.	_	

#Text=Compute the noise covariance from empty room data.
#Text=5.4.
110-1	16570-16577	Compute	_	
110-2	16578-16581	the	_	
110-3	16582-16587	noise	_	
110-4	16588-16598	covariance	_	
110-5	16599-16603	from	_	
110-6	16604-16609	empty	_	
110-7	16610-16614	room	_	
110-8	16615-16619	data	_	
110-9	16619-16620	.	_	
110-10	16621-16624	5.4	_	
110-11	16624-16625	.	_	

#Text=Co-register the MEG data with MRI images using 3-D head digitization information (Figure 2).
#Text=5.4.1.
111-1	16626-16637	Co-register	_	
111-2	16638-16641	the	_	
111-3	16642-16645	MEG	_	
111-4	16646-16650	data	_	
111-5	16651-16655	with	_	
111-6	16656-16659	MRI	_	
111-7	16660-16666	images	_	
111-8	16667-16672	using	_	
111-9	16673-16674	3	_	
111-10	16674-16675	-	_	
111-11	16675-16676	D	_	
111-12	16677-16681	head	_	
111-13	16682-16694	digitization	_	
111-14	16695-16706	information	_	
111-15	16707-16708	(	_	
111-16	16708-16714	Figure	_	
111-17	16715-16716	2	_	
111-18	16716-16717	)	_	
111-19	16717-16718	.	_	
111-20	16719-16724	5.4.1	_	
111-21	16724-16725	.	_	

#Text=Open MRIlab module (Neuromag)
#Text=5.4.2.
112-1	16726-16730	Open	_	
112-2	16731-16737	MRIlab	_	
112-3	16738-16744	module	_	
112-4	16745-16746	(	_	
112-5	16746-16754	Neuromag	_	
112-6	16754-16755	)	_	
112-7	16756-16761	5.4.2	_	
112-8	16761-16762	.	_	

#Text=File → Open → Select subject’s structural MRI
#Text=5.4.3.
113-1	16763-16767	File	_	
113-2	16768-16769	→	_	
113-3	16770-16774	Open	_	
113-4	16775-16776	→	_	
113-5	16777-16783	Select	_	
113-6	16784-16791	subject	_	
113-7	16791-16792	’	_	
113-8	16792-16793	s	_	
113-9	16794-16804	structural	_	
113-10	16805-16808	MRI	_	
113-11	16809-16814	5.4.3	_	
113-12	16814-16815	.	_	

#Text=File → Import → Isotrak data → select raw data.fif file → Make Points
#Text=5.4.4.
114-1	16816-16820	File	_	
114-2	16821-16822	→	_	
114-3	16823-16829	Import	_	
114-4	16830-16831	→	_	
114-5	16832-16839	Isotrak	_	
114-6	16840-16844	data	_	
114-7	16845-16846	→	_	
114-8	16847-16853	select	_	
114-9	16854-16857	raw	_	
114-10	16858-16866	data.fif	_	
114-11	16867-16871	file	_	
114-12	16872-16873	→	_	
114-13	16874-16878	Make	_	
114-14	16879-16885	Points	_	
114-15	16886-16891	5.4.4	_	
114-16	16891-16892	.	_	

#Text=Windows→ Landmarks → Adjust fiducial landmarks until co-registration of Isotrak data and MRI are acceptable.
#Text=5.4.5.
115-1	16893-16900	Windows	_	
115-2	16900-16901	→	_	
115-3	16902-16911	Landmarks	_	
115-4	16912-16913	→	_	
115-5	16914-16920	Adjust	_	
115-6	16921-16929	fiducial	_	
115-7	16930-16939	landmarks	_	
115-8	16940-16945	until	_	
115-9	16946-16961	co-registration	_	
115-10	16962-16964	of	_	
115-11	16965-16972	Isotrak	_	
115-12	16973-16977	data	_	
115-13	16978-16981	and	_	
115-14	16982-16985	MRI	_	
115-15	16986-16989	are	_	
115-16	16990-17000	acceptable	_	
115-17	17000-17001	.	_	
115-18	17002-17007	5.4.5	_	
115-19	17007-17008	.	_	

#Text=File → Save
#Text=5.5.
116-1	17009-17013	File	_	
116-2	17014-17015	→	_	
116-3	17016-17020	Save	_	
116-4	17021-17024	5.5	_	
116-5	17024-17025	.	_	

#Text=Calculate noise-sensitivity normalized estimates of theta source power and phase with a spectral dynamic statistical mapping approach.
117-1	17026-17035	Calculate	_	
117-2	17036-17053	noise-sensitivity	_	
117-3	17054-17064	normalized	_	
117-4	17065-17074	estimates	_	
117-5	17075-17077	of	_	
117-6	17078-17083	theta	_	
117-7	17084-17090	source	_	
117-8	17091-17096	power	_	
117-9	17097-17100	and	_	
117-10	17101-17106	phase	_	
117-11	17107-17111	with	_	
117-12	17112-17113	a	_	
117-13	17114-17122	spectral	_	
117-14	17123-17130	dynamic	_	
117-15	17131-17142	statistical	_	
117-16	17143-17150	mapping	_	
117-17	17151-17159	approach	_	
117-18	17159-17160	.	_	

#Text=Express event-related theta source power as percent signal change relative to baseline.
#Text=5.6.
118-1	17161-17168	Express	_	
118-2	17169-17182	event-related	_	
118-3	17183-17188	theta	_	
118-4	17189-17195	source	_	
118-5	17196-17201	power	_	
118-6	17202-17204	as	_	
118-7	17205-17212	percent	_	
118-8	17213-17219	signal	_	
118-9	17220-17226	change	_	
118-10	17227-17235	relative	_	
118-11	17236-17238	to	_	
118-12	17239-17247	baseline	_	
118-13	17247-17248	.	_	
118-14	17249-17252	5.6	_	
118-15	17252-17253	.	_	

#Text=Create group averages of event-related theta source power by morphing each participant’s estimates onto an average cortical representation.
#Text=5.7.
119-1	17254-17260	Create	_	
119-2	17261-17266	group	_	
119-3	17267-17275	averages	_	
119-4	17276-17278	of	_	
119-5	17279-17292	event-related	_	
119-6	17293-17298	theta	_	
119-7	17299-17305	source	_	
119-8	17306-17311	power	_	
119-9	17312-17314	by	_	
119-10	17315-17323	morphing	_	
119-11	17324-17328	each	_	
119-12	17329-17340	participant	_	
119-13	17340-17341	’	_	
119-14	17341-17342	s	_	
119-15	17343-17352	estimates	_	
119-16	17353-17357	onto	_	
119-17	17358-17360	an	_	
119-18	17361-17368	average	_	
119-19	17369-17377	cortical	_	
119-20	17378-17392	representation	_	
119-21	17392-17393	.	_	
119-22	17394-17397	5.7	_	
119-23	17397-17398	.	_	

#Text=Visualize the source estimates on an inflated average surface to enhance visibility of sulcal estimates (Figure 4).
#Text=5.7.1.
120-1	17399-17408	Visualize	_	
120-2	17409-17412	the	_	
120-3	17413-17419	source	_	
120-4	17420-17429	estimates	_	
120-5	17430-17432	on	_	
120-6	17433-17435	an	_	
120-7	17436-17444	inflated	_	
120-8	17445-17452	average	_	
120-9	17453-17460	surface	_	
120-10	17461-17463	to	_	
120-11	17464-17471	enhance	_	
120-12	17472-17482	visibility	_	
120-13	17483-17485	of	_	
120-14	17486-17492	sulcal	_	
120-15	17493-17502	estimates	_	
120-16	17503-17504	(	_	
120-17	17504-17510	Figure	_	
120-18	17511-17512	4	_	
120-19	17512-17513	)	_	
120-20	17513-17514	.	_	
120-21	17515-17520	5.7.1	_	
120-22	17520-17521	.	_	

#Text=Open MNE Analyze software.
#Text=5.7.2.
121-1	17522-17526	Open	_	
121-2	17527-17530	MNE	_	
121-3	17531-17538	Analyze	_	
121-4	17539-17547	software	_	
121-5	17547-17548	.	_	
121-6	17549-17554	5.7.2	_	
121-7	17554-17555	.	_	

#Text=File → Load Surface → Load inflated group-average FreeSurfer cortical surface
#Text=5.7.3.
122-1	17556-17560	File	_	
122-2	17561-17562	→	_	
122-3	17563-17567	Load	_	
122-4	17568-17575	Surface	_	
122-5	17576-17577	→	_	
122-6	17578-17582	Load	_	
122-7	17583-17591	inflated	_	
122-8	17592-17605	group-average	_	
122-9	17606-17616	FreeSurfer	_	
122-10	17617-17625	cortical	_	
122-11	17626-17633	surface	_	
122-12	17634-17639	5.7.3	_	
122-13	17639-17640	.	_	

#Text=File → Manage overlays → Load stc → Load group-averaged data → Select loaded file from available overlays.
#Text=5.7.4.
123-1	17641-17645	File	_	
123-2	17646-17647	→	_	
123-3	17648-17654	Manage	_	
123-4	17655-17663	overlays	_	
123-5	17664-17665	→	_	
123-6	17666-17670	Load	_	
123-7	17671-17674	stc	_	
123-8	17675-17676	→	_	
123-9	17677-17681	Load	_	
123-10	17682-17696	group-averaged	_	
123-11	17697-17701	data	_	
123-12	17702-17703	→	_	
123-13	17704-17710	Select	_	
123-14	17711-17717	loaded	_	
123-15	17718-17722	file	_	
123-16	17723-17727	from	_	
123-17	17728-17737	available	_	
123-18	17738-17746	overlays	_	
123-19	17746-17747	.	_	
123-20	17748-17753	5.7.4	_	
123-21	17753-17754	.	_	

#Text=Select overlay type as “Other.”
#Text=5.7.5.
124-1	17755-17761	Select	_	
124-2	17762-17769	overlay	_	
124-3	17770-17774	type	_	
124-4	17775-17777	as	_	
124-5	17778-17779	“	_	
124-6	17779-17784	Other	_	
124-7	17784-17785	.	_	
124-8	17785-17786	”	_	
124-9	17787-17792	5.7.5	_	
124-10	17792-17793	.	_	

#Text=Adjust Color Scale thresholding. → Show
#Text=5.7.6.
125-1	17794-17800	Adjust	_	
125-2	17801-17806	Color	_	
125-3	17807-17812	Scale	_	
125-4	17813-17825	thresholding	_	
125-5	17825-17826	.	_	
125-6	17827-17828	→	_	
125-7	17829-17833	Show	_	
125-8	17834-17839	5.7.6	_	
125-9	17839-17840	.	_	

#Text=View “brain movies” and examine spatio-temporal stages of processing by identifying areas and time windows characterized by highest activation.
#Text=5.8.
126-1	17841-17845	View	_	
126-2	17846-17847	“	_	
126-3	17847-17852	brain	_	
126-4	17853-17859	movies	_	
126-5	17859-17860	”	_	
126-6	17861-17864	and	_	
126-7	17865-17872	examine	_	
126-8	17873-17888	spatio-temporal	_	
126-9	17889-17895	stages	_	
126-10	17896-17898	of	_	
126-11	17899-17909	processing	_	
126-12	17910-17912	by	_	
126-13	17913-17924	identifying	_	
126-14	17925-17930	areas	_	
126-15	17931-17934	and	_	
126-16	17935-17939	time	_	
126-17	17940-17947	windows	_	
126-18	17948-17961	characterized	_	
126-19	17962-17964	by	_	
126-20	17965-17972	highest	_	
126-21	17973-17983	activation	_	
126-22	17983-17984	.	_	
126-23	17985-17988	5.8	_	
126-24	17988-17989	.	_	

#Text=Create unbiased regions of interest (ROIs) based on overall group-averaged estimates to incorporate cortical locations with most notable source power.
127-1	17990-17996	Create	_	
127-2	17997-18005	unbiased	_	
127-3	18006-18013	regions	_	
127-4	18014-18016	of	_	
127-5	18017-18025	interest	_	
127-6	18026-18027	(	_	
127-7	18027-18031	ROIs	_	
127-8	18031-18032	)	_	
127-9	18033-18038	based	_	
127-10	18039-18041	on	_	
127-11	18042-18049	overall	_	
127-12	18050-18064	group-averaged	_	
127-13	18065-18074	estimates	_	
127-14	18075-18077	to	_	
127-15	18078-18089	incorporate	_	
127-16	18090-18098	cortical	_	
127-17	18099-18108	locations	_	
127-18	18109-18113	with	_	
127-19	18114-18118	most	_	
127-20	18119-18126	notable	_	
127-21	18127-18133	source	_	
127-22	18134-18139	power	_	
127-23	18139-18140	.	_	

#Text=Calculate timecourses for each subject, condition, and ROI (Figure 5).
#Text=5.9.
128-1	18141-18150	Calculate	_	
128-2	18151-18162	timecourses	_	
128-3	18163-18166	for	_	
128-4	18167-18171	each	_	
128-5	18172-18179	subject	_	
128-6	18179-18180	,	_	
128-7	18181-18190	condition	_	
128-8	18190-18191	,	_	
128-9	18192-18195	and	_	
128-10	18196-18199	ROI	_	
128-11	18200-18201	(	_	
128-12	18201-18207	Figure	_	
128-13	18208-18209	5	_	
128-14	18209-18210	)	_	
128-15	18210-18211	.	_	
128-16	18212-18215	5.9	_	
128-17	18215-18216	.	_	

#Text=Submit the obtained theta source power estimates to the statistical analysis.
#Text=5.9.1.
129-1	18217-18223	Submit	_	
129-2	18224-18227	the	_	
129-3	18228-18236	obtained	_	
129-4	18237-18242	theta	_	
129-5	18243-18249	source	_	
129-6	18250-18255	power	_	
129-7	18256-18265	estimates	_	
129-8	18266-18268	to	_	
129-9	18269-18272	the	_	
129-10	18273-18284	statistical	_	
129-11	18285-18293	analysis	_	
129-12	18293-18294	.	_	
129-13	18295-18300	5.9.1	_	
129-14	18300-18301	.	_	

#Text=Extract time windows of interest from each ROI time course and perform ANOVAs with beverage (alcohol, placebo) and trial type (CONG, INC) as within subject factors.
130-1	18302-18309	Extract	_	
130-2	18310-18314	time	_	
130-3	18315-18322	windows	_	
130-4	18323-18325	of	_	
130-5	18326-18334	interest	_	
130-6	18335-18339	from	_	
130-7	18340-18344	each	_	
130-8	18345-18348	ROI	_	
130-9	18349-18353	time	_	
130-10	18354-18360	course	_	
130-11	18361-18364	and	_	
130-12	18365-18372	perform	_	
130-13	18373-18379	ANOVAs	_	
130-14	18380-18384	with	_	
130-15	18385-18393	beverage	_	
130-16	18394-18395	(	_	
130-17	18395-18402	alcohol	_	
130-18	18402-18403	,	_	
130-19	18404-18411	placebo	_	
130-20	18411-18412	)	_	
130-21	18413-18416	and	_	
130-22	18417-18422	trial	_	
130-23	18423-18427	type	_	
130-24	18428-18429	(	_	
130-25	18429-18433	CONG	_	
130-26	18433-18434	,	_	
130-27	18435-18438	INC	_	
130-28	18438-18439	)	_	
130-29	18440-18442	as	_	
130-30	18443-18449	within	_	
130-31	18450-18457	subject	_	
130-32	18458-18465	factors	_	
130-33	18465-18466	.	_	

#Text=Use a nonparametric cluster-based permutation test to examine beverage and condition comparisons of event-related theta power as well as PLVs.
#Text=5.10.
131-1	18467-18470	Use	_	
131-2	18471-18472	a	_	
131-3	18473-18486	nonparametric	_	
131-4	18487-18500	cluster-based	_	
131-5	18501-18512	permutation	_	
131-6	18513-18517	test	_	
131-7	18518-18520	to	_	
131-8	18521-18528	examine	_	
131-9	18529-18537	beverage	_	
131-10	18538-18541	and	_	
131-11	18542-18551	condition	_	
131-12	18552-18563	comparisons	_	
131-13	18564-18566	of	_	
131-14	18567-18580	event-related	_	
131-15	18581-18586	theta	_	
131-16	18587-18592	power	_	
131-17	18593-18595	as	_	
131-18	18596-18600	well	_	
131-19	18601-18603	as	_	
131-20	18604-18608	PLVs	_	
131-21	18608-18609	.	_	
131-22	18610-18614	5.10	_	
131-23	18614-18615	.	_	

#Text=Estimate task-related changes in the long-range synchronization between the main activation foci in the ACC and the latPFC by computing the Phase-Locking Value (PLV).
132-1	18616-18624	Estimate	_	
132-2	18625-18637	task-related	_	
132-3	18638-18645	changes	_	
132-4	18646-18648	in	_	
132-5	18649-18652	the	_	
132-6	18653-18663	long-range	_	
132-7	18664-18679	synchronization	_	
132-8	18680-18687	between	_	
132-9	18688-18691	the	_	
132-10	18692-18696	main	_	
132-11	18697-18707	activation	_	
132-12	18708-18712	foci	_	
132-13	18713-18715	in	_	
132-14	18716-18719	the	_	
132-15	18720-18723	ACC	_	
132-16	18724-18727	and	_	
132-17	18728-18731	the	_	
132-18	18732-18738	latPFC	_	
132-19	18739-18741	by	_	
132-20	18742-18751	computing	_	
132-21	18752-18755	the	_	
132-22	18756-18769	Phase-Locking	_	
132-23	18770-18775	Value	_	
132-24	18776-18777	(	_	
132-25	18777-18780	PLV	_	
132-26	18780-18781	)	_	
132-27	18781-18782	.	_	

#Text=Express the PLV as percent change relative to baseline.
133-1	18783-18790	Express	_	
133-2	18791-18794	the	_	
133-3	18795-18798	PLV	_	
133-4	18799-18801	as	_	
133-5	18802-18809	percent	_	
133-6	18810-18816	change	_	
133-7	18817-18825	relative	_	
133-8	18826-18828	to	_	
133-9	18829-18837	baseline	_	
133-10	18837-18838	.	_	

#Text=Note: The PLV is an indicator of consistency of the phase angle between the two ROIs across trials as it measures the extent to which they co-oscillate at a particular frequency and in real time (Movie 1).
#Text=5.11.
134-1	18839-18843	Note	_	
134-2	18843-18844	:	_	
134-3	18845-18848	The	_	
134-4	18849-18852	PLV	_	
134-5	18853-18855	is	_	
134-6	18856-18858	an	_	
134-7	18859-18868	indicator	_	
134-8	18869-18871	of	_	
134-9	18872-18883	consistency	_	
134-10	18884-18886	of	_	
134-11	18887-18890	the	_	
134-12	18891-18896	phase	_	
134-13	18897-18902	angle	_	
134-14	18903-18910	between	_	
134-15	18911-18914	the	_	
134-16	18915-18918	two	_	
134-17	18919-18923	ROIs	_	
134-18	18924-18930	across	_	
134-19	18931-18937	trials	_	
134-20	18938-18940	as	_	
134-21	18941-18943	it	_	
134-22	18944-18952	measures	_	
134-23	18953-18956	the	_	
134-24	18957-18963	extent	_	
134-25	18964-18966	to	_	
134-26	18967-18972	which	_	
134-27	18973-18977	they	_	
134-28	18978-18990	co-oscillate	_	
134-29	18991-18993	at	_	
134-30	18994-18995	a	_	
134-31	18996-19006	particular	_	
134-32	19007-19016	frequency	_	
134-33	19017-19020	and	_	
134-34	19021-19023	in	_	
134-35	19024-19028	real	_	
134-36	19029-19033	time	_	
134-37	19034-19035	(	_	
134-38	19035-19040	Movie	_	
134-39	19041-19042	1	_	
134-40	19042-19043	)	_	
134-41	19043-19044	.	_	
134-42	19045-19049	5.11	_	
134-43	19049-19050	.	_	

#Text=Calculate correlations between ROI MEG activity estimates, indices of behavioral performance, and questionnaire scores to inform interpretation of the observed results.
135-1	19051-19060	Calculate	_	
135-2	19061-19073	correlations	_	
135-3	19074-19081	between	_	
135-4	19082-19085	ROI	_	
135-5	19086-19089	MEG	_	
135-6	19090-19098	activity	_	
135-7	19099-19108	estimates	_	
135-8	19108-19109	,	_	
135-9	19110-19117	indices	_	
135-10	19118-19120	of	_	
135-11	19121-19131	behavioral	_	
135-12	19132-19143	performance	_	
135-13	19143-19144	,	_	
135-14	19145-19148	and	_	
135-15	19149-19162	questionnaire	_	
135-16	19163-19169	scores	_	
135-17	19170-19172	to	_	
135-18	19173-19179	inform	_	
135-19	19180-19194	interpretation	_	
135-20	19195-19197	of	_	
135-21	19198-19201	the	_	
135-22	19202-19210	observed	_	
135-23	19211-19218	results	_	
135-24	19218-19219	.	_	

#Text=REPRESENTATIVE RESULTS:
#Text=Behavioral results indicate that the Stroop task successfully manipulated response interference because the accuracy was the lowest and the response times the longest on incongruous trials (Figure 6).
136-1	19220-19234	REPRESENTATIVE	_	
136-2	19235-19242	RESULTS	_	
136-3	19242-19243	:	_	
136-4	19244-19254	Behavioral	_	
136-5	19255-19262	results	_	
136-6	19263-19271	indicate	_	
136-7	19272-19276	that	_	
136-8	19277-19280	the	_	
136-9	19281-19287	Stroop	_	
136-10	19288-19292	task	_	
136-11	19293-19305	successfully	_	
136-12	19306-19317	manipulated	_	
136-13	19318-19326	response	_	
136-14	19327-19339	interference	_	
136-15	19340-19347	because	_	
136-16	19348-19351	the	_	
136-17	19352-19360	accuracy	_	
136-18	19361-19364	was	_	
136-19	19365-19368	the	_	
136-20	19369-19375	lowest	_	
136-21	19376-19379	and	_	
136-22	19380-19383	the	_	
136-23	19384-19392	response	_	
136-24	19393-19398	times	_	
136-25	19399-19402	the	_	
136-26	19403-19410	longest	_	
136-27	19411-19413	on	_	
136-28	19414-19425	incongruous	_	
136-29	19426-19432	trials	_	
136-30	19433-19434	(	_	
136-31	19434-19440	Figure	_	
136-32	19441-19442	6	_	
136-33	19442-19443	)	_	
136-34	19443-19444	.	_	

#Text=Alcohol intoxication lowered accuracy but did not affect reaction times.
137-1	19445-19452	Alcohol	_	
137-2	19453-19465	intoxication	_	
137-3	19466-19473	lowered	_	
137-4	19474-19482	accuracy	_	
137-5	19483-19486	but	_	
137-6	19487-19490	did	_	
137-7	19491-19494	not	_	
137-8	19495-19501	affect	_	
137-9	19502-19510	reaction	_	
137-10	19511-19516	times	_	
137-11	19516-19517	.	_	

#Text=The spatio-temporal sequence of activity in theta frequency band revealed with the aMEG approach is in overall agreement with generally accepted models of cognitive functions in this type of task.
138-1	19518-19521	The	_	
138-2	19522-19537	spatio-temporal	_	
138-3	19538-19546	sequence	_	
138-4	19547-19549	of	_	
138-5	19550-19558	activity	_	
138-6	19559-19561	in	_	
138-7	19562-19567	theta	_	
138-8	19568-19577	frequency	_	
138-9	19578-19582	band	_	
138-10	19583-19591	revealed	_	
138-11	19592-19596	with	_	
138-12	19597-19600	the	_	
138-13	19601-19605	aMEG	_	
138-14	19606-19614	approach	_	
138-15	19615-19617	is	_	
138-16	19618-19620	in	_	
138-17	19621-19628	overall	_	
138-18	19629-19638	agreement	_	
138-19	19639-19643	with	_	
138-20	19644-19653	generally	_	
138-21	19654-19662	accepted	_	
138-22	19663-19669	models	_	
138-23	19670-19672	of	_	
138-24	19673-19682	cognitive	_	
138-25	19683-19692	functions	_	
138-26	19693-19695	in	_	
138-27	19696-19700	this	_	
138-28	19701-19705	type	_	
138-29	19706-19708	of	_	
138-30	19709-19713	task	_	
138-31	19713-19714	.	_	

#Text=As illustrated in the brain movies (Movie 2a–b), the visual cortex is activated at around 100 msec after stimulus onset, followed by posterior-to-anterior activation pattern which engages primarily frontal cortices during cognitive integration stages after ~300ms.
139-1	19715-19717	As	_	
139-2	19718-19729	illustrated	_	
139-3	19730-19732	in	_	
139-4	19733-19736	the	_	
139-5	19737-19742	brain	_	
139-6	19743-19749	movies	_	
139-7	19750-19751	(	_	
139-8	19751-19756	Movie	_	
139-9	19757-19761	2a–b	_	
139-10	19761-19762	)	_	
139-11	19762-19763	,	_	
139-12	19764-19767	the	_	
139-13	19768-19774	visual	_	
139-14	19775-19781	cortex	_	
139-15	19782-19784	is	_	
139-16	19785-19794	activated	_	
139-17	19795-19797	at	_	
139-18	19798-19804	around	_	
139-19	19805-19808	100	_	
139-20	19809-19813	msec	_	
139-21	19814-19819	after	_	
139-22	19820-19828	stimulus	_	
139-23	19829-19834	onset	_	
139-24	19834-19835	,	_	
139-25	19836-19844	followed	_	
139-26	19845-19847	by	_	
139-27	19848-19869	posterior-to-anterior	_	
139-28	19870-19880	activation	_	
139-29	19881-19888	pattern	_	
139-30	19889-19894	which	_	
139-31	19895-19902	engages	_	
139-32	19903-19912	primarily	_	
139-33	19913-19920	frontal	_	
139-34	19921-19929	cortices	_	
139-35	19930-19936	during	_	
139-36	19937-19946	cognitive	_	
139-37	19947-19958	integration	_	
139-38	19959-19965	stages	_	
139-39	19966-19971	after	_	
139-40	19972-19973	~	_	
139-41	19973-19978	300ms	_	
139-42	19978-19979	.	_	

#Text=The ACC is particularly sensitive to incongruous, high-conflict trials, indicating its engagement during conflict monitoring.
140-1	19980-19983	The	_	
140-2	19984-19987	ACC	_	
140-3	19988-19990	is	_	
140-4	19991-20003	particularly	_	
140-5	20004-20013	sensitive	_	
140-6	20014-20016	to	_	
140-7	20017-20028	incongruous	_	
140-8	20028-20029	,	_	
140-9	20030-20043	high-conflict	_	
140-10	20044-20050	trials	_	
140-11	20050-20051	,	_	
140-12	20052-20062	indicating	_	
140-13	20063-20066	its	_	
140-14	20067-20077	engagement	_	
140-15	20078-20084	during	_	
140-16	20085-20093	conflict	_	
140-17	20094-20104	monitoring	_	
140-18	20104-20105	.	_	

#Text=The ACC is the principal generator of theta oscillations during tasks probing cognitive control but the latPFC is also active during the integration stage at around 350–600 ms.
141-1	20106-20109	The	_	
141-2	20110-20113	ACC	_	
141-3	20114-20116	is	_	
141-4	20117-20120	the	_	
141-5	20121-20130	principal	_	
141-6	20131-20140	generator	_	
141-7	20141-20143	of	_	
141-8	20144-20149	theta	_	
141-9	20150-20162	oscillations	_	
141-10	20163-20169	during	_	
141-11	20170-20175	tasks	_	
141-12	20176-20183	probing	_	
141-13	20184-20193	cognitive	_	
141-14	20194-20201	control	_	
141-15	20202-20205	but	_	
141-16	20206-20209	the	_	
141-17	20210-20216	latPFC	_	
141-18	20217-20219	is	_	
141-19	20220-20224	also	_	
141-20	20225-20231	active	_	
141-21	20232-20238	during	_	
141-22	20239-20242	the	_	
141-23	20243-20254	integration	_	
141-24	20255-20260	stage	_	
141-25	20261-20263	at	_	
141-26	20264-20270	around	_	
141-27	20271-20274	350	_	
141-28	20274-20275	–	_	
141-29	20275-20278	600	_	
141-30	20279-20281	ms	_	
141-31	20281-20282	.	_	

#Text=Activation of the motor cortex is visible after ~600ms during the response preparation stage (Movie 2b).
142-1	20283-20293	Activation	_	
142-2	20294-20296	of	_	
142-3	20297-20300	the	_	
142-4	20301-20306	motor	_	
142-5	20307-20313	cortex	_	
142-6	20314-20316	is	_	
142-7	20317-20324	visible	_	
142-8	20325-20330	after	_	
142-9	20331-20332	~	_	
142-10	20332-20337	600ms	_	
142-11	20338-20344	during	_	
142-12	20345-20348	the	_	
142-13	20349-20357	response	_	
142-14	20358-20369	preparation	_	
142-15	20370-20375	stage	_	
142-16	20376-20377	(	_	
142-17	20377-20382	Movie	_	
142-18	20383-20385	2b	_	
142-19	20385-20386	)	_	
142-20	20386-20387	.	_	

#Text=Event-related theta power is greatest on incongruous trials, which is consistent with its sensitivity to conflict demands (Figure 5), especially in the prefrontal cortex.
143-1	20388-20401	Event-related	_	
143-2	20402-20407	theta	_	
143-3	20408-20413	power	_	
143-4	20414-20416	is	_	
143-5	20417-20425	greatest	_	
143-6	20426-20428	on	_	
143-7	20429-20440	incongruous	_	
143-8	20441-20447	trials	_	
143-9	20447-20448	,	_	
143-10	20449-20454	which	_	
143-11	20455-20457	is	_	
143-12	20458-20468	consistent	_	
143-13	20469-20473	with	_	
143-14	20474-20477	its	_	
143-15	20478-20489	sensitivity	_	
143-16	20490-20492	to	_	
143-17	20493-20501	conflict	_	
143-18	20502-20509	demands	_	
143-19	20510-20511	(	_	
143-20	20511-20517	Figure	_	
143-21	20518-20519	5	_	
143-22	20519-20520	)	_	
143-23	20520-20521	,	_	
143-24	20522-20532	especially	_	
143-25	20533-20535	in	_	
143-26	20536-20539	the	_	
143-27	20540-20550	prefrontal	_	
143-28	20551-20557	cortex	_	
143-29	20557-20558	.	_	

#Text=Theta power is decreased by acute alcohol intoxication overall.
144-1	20559-20564	Theta	_	
144-2	20565-20570	power	_	
144-3	20571-20573	is	_	
144-4	20574-20583	decreased	_	
144-5	20584-20586	by	_	
144-6	20587-20592	acute	_	
144-7	20593-20600	alcohol	_	
144-8	20601-20613	intoxication	_	
144-9	20614-20621	overall	_	
144-10	20621-20622	.	_	

#Text=However, when compared to congruous trials, alcohol decreases theta power on incongruous (high conflict) trials selectively in the ACC and latPFC.
145-1	20623-20630	However	_	
145-2	20630-20631	,	_	
145-3	20632-20636	when	_	
145-4	20637-20645	compared	_	
145-5	20646-20648	to	_	
145-6	20649-20658	congruous	_	
145-7	20659-20665	trials	_	
145-8	20665-20666	,	_	
145-9	20667-20674	alcohol	_	
145-10	20675-20684	decreases	_	
145-11	20685-20690	theta	_	
145-12	20691-20696	power	_	
145-13	20697-20699	on	_	
145-14	20700-20711	incongruous	_	
145-15	20712-20713	(	_	
145-16	20713-20717	high	_	
145-17	20718-20726	conflict	_	
145-18	20726-20727	)	_	
145-19	20728-20734	trials	_	
145-20	20735-20746	selectively	_	
145-21	20747-20749	in	_	
145-22	20750-20753	the	_	
145-23	20754-20757	ACC	_	
145-24	20758-20761	and	_	
145-25	20762-20768	latPFC	_	
145-26	20768-20769	.	_	

#Text=The present study extends the results from by focusing on dynamic interactions between these areas during the processing of Stroop interference in light of a prevailing account of the cognitive control network.
146-1	20770-20773	The	_	
146-2	20774-20781	present	_	
146-3	20782-20787	study	_	
146-4	20788-20795	extends	_	
146-5	20796-20799	the	_	
146-6	20800-20807	results	_	
146-7	20808-20812	from	_	
146-8	20813-20815	by	_	
146-9	20816-20824	focusing	_	
146-10	20825-20827	on	_	
146-11	20828-20835	dynamic	_	
146-12	20836-20848	interactions	_	
146-13	20849-20856	between	_	
146-14	20857-20862	these	_	
146-15	20863-20868	areas	_	
146-16	20869-20875	during	_	
146-17	20876-20879	the	_	
146-18	20880-20890	processing	_	
146-19	20891-20893	of	_	
146-20	20894-20900	Stroop	_	
146-21	20901-20913	interference	_	
146-22	20914-20916	in	_	
146-23	20917-20922	light	_	
146-24	20923-20925	of	_	
146-25	20926-20927	a	_	
146-26	20928-20938	prevailing	_	
146-27	20939-20946	account	_	
146-28	20947-20949	of	_	
146-29	20950-20953	the	_	
146-30	20954-20963	cognitive	_	
146-31	20964-20971	control	_	
146-32	20972-20979	network	_	
146-33	20979-20980	.	_	

#Text=To better understand the timing, degree, and nature of the interactions between these two principally engaged cortical areas, the PLV was calculated for each beverage and task condition, and for each participant.
147-1	20981-20983	To	_	
147-2	20984-20990	better	_	
147-3	20991-21001	understand	_	
147-4	21002-21005	the	_	
147-5	21006-21012	timing	_	
147-6	21012-21013	,	_	
147-7	21014-21020	degree	_	
147-8	21020-21021	,	_	
147-9	21022-21025	and	_	
147-10	21026-21032	nature	_	
147-11	21033-21035	of	_	
147-12	21036-21039	the	_	
147-13	21040-21052	interactions	_	
147-14	21053-21060	between	_	
147-15	21061-21066	these	_	
147-16	21067-21070	two	_	
147-17	21071-21082	principally	_	
147-18	21083-21090	engaged	_	
147-19	21091-21099	cortical	_	
147-20	21100-21105	areas	_	
147-21	21105-21106	,	_	
147-22	21107-21110	the	_	
147-23	21111-21114	PLV	_	
147-24	21115-21118	was	_	
147-25	21119-21129	calculated	_	
147-26	21130-21133	for	_	
147-27	21134-21138	each	_	
147-28	21139-21147	beverage	_	
147-29	21148-21151	and	_	
147-30	21152-21156	task	_	
147-31	21157-21166	condition	_	
147-32	21166-21167	,	_	
147-33	21168-21171	and	_	
147-34	21172-21175	for	_	
147-35	21176-21180	each	_	
147-36	21181-21192	participant	_	
147-37	21192-21193	.	_	

#Text=As shown in a group average in Figure 7, co-oscillations between the ACC and latPFC vary across time with an overall early increase in co-oscillations during a stimulus processing stage.
148-1	21194-21196	As	_	
148-2	21197-21202	shown	_	
148-3	21203-21205	in	_	
148-4	21206-21207	a	_	
148-5	21208-21213	group	_	
148-6	21214-21221	average	_	
148-7	21222-21224	in	_	
148-8	21225-21231	Figure	_	
148-9	21232-21233	7	_	
148-10	21233-21234	,	_	
148-11	21235-21250	co-oscillations	_	
148-12	21251-21258	between	_	
148-13	21259-21262	the	_	
148-14	21263-21266	ACC	_	
148-15	21267-21270	and	_	
148-16	21271-21277	latPFC	_	
148-17	21278-21282	vary	_	
148-18	21283-21289	across	_	
148-19	21290-21294	time	_	
148-20	21295-21299	with	_	
148-21	21300-21302	an	_	
148-22	21303-21310	overall	_	
148-23	21311-21316	early	_	
148-24	21317-21325	increase	_	
148-25	21326-21328	in	_	
148-26	21329-21344	co-oscillations	_	
148-27	21345-21351	during	_	
148-28	21352-21353	a	_	
148-29	21354-21362	stimulus	_	
148-30	21363-21373	processing	_	
148-31	21374-21379	stage	_	
148-32	21379-21380	.	_	

#Text=Under placebo, this is followed by a sustained increase after ~400ms on incongruous trials during the integration and response preparation stage.
149-1	21381-21386	Under	_	
149-2	21387-21394	placebo	_	
149-3	21394-21395	,	_	
149-4	21396-21400	this	_	
149-5	21401-21403	is	_	
149-6	21404-21412	followed	_	
149-7	21413-21415	by	_	
149-8	21416-21417	a	_	
149-9	21418-21427	sustained	_	
149-10	21428-21436	increase	_	
149-11	21437-21442	after	_	
149-12	21443-21444	~	_	
149-13	21444-21449	400ms	_	
149-14	21450-21452	on	_	
149-15	21453-21464	incongruous	_	
149-16	21465-21471	trials	_	
149-17	21472-21478	during	_	
149-18	21479-21482	the	_	
149-19	21483-21494	integration	_	
149-20	21495-21498	and	_	
149-21	21499-21507	response	_	
149-22	21508-21519	preparation	_	
149-23	21520-21525	stage	_	
149-24	21525-21526	.	_	

#Text=Thus, synchronized co-oscillations between the medial and lateral prefrontal cortices are observed only on the more difficult, incongruous trials evoking response conflict F(1,19) = 5.5, p < .05.
150-1	21527-21531	Thus	_	
150-2	21531-21532	,	_	
150-3	21533-21545	synchronized	_	
150-4	21546-21561	co-oscillations	_	
150-5	21562-21569	between	_	
150-6	21570-21573	the	_	
150-7	21574-21580	medial	_	
150-8	21581-21584	and	_	
150-9	21585-21592	lateral	_	
150-10	21593-21603	prefrontal	_	
150-11	21604-21612	cortices	_	
150-12	21613-21616	are	_	
150-13	21617-21625	observed	_	
150-14	21626-21630	only	_	
150-15	21631-21633	on	_	
150-16	21634-21637	the	_	
150-17	21638-21642	more	_	
150-18	21643-21652	difficult	_	
150-19	21652-21653	,	_	
150-20	21654-21665	incongruous	_	
150-21	21666-21672	trials	_	
150-22	21673-21680	evoking	_	
150-23	21681-21689	response	_	
150-24	21690-21698	conflict	_	
150-25	21699-21700	F	_	
150-26	21700-21701	(	_	
150-27	21701-21705	1,19	_	
150-28	21705-21706	)	_	
150-29	21707-21708	=	_	
150-30	21709-21712	5.5	_	
150-31	21712-21713	,	_	
150-32	21714-21715	p	_	
150-33	21716-21717	<	_	
150-34	21718-21721	.05	_	
150-35	21721-21722	.	_	

#Text=This evidence supports the proposal that the ACC and the latPFC functionally interact in real time to subserve cognitive control.
151-1	21723-21727	This	_	
151-2	21728-21736	evidence	_	
151-3	21737-21745	supports	_	
151-4	21746-21749	the	_	
151-5	21750-21758	proposal	_	
151-6	21759-21763	that	_	
151-7	21764-21767	the	_	
151-8	21768-21771	ACC	_	
151-9	21772-21775	and	_	
151-10	21776-21779	the	_	
151-11	21780-21786	latPFC	_	
151-12	21787-21799	functionally	_	
151-13	21800-21808	interact	_	
151-14	21809-21811	in	_	
151-15	21812-21816	real	_	
151-16	21817-21821	time	_	
151-17	21822-21824	to	_	
151-18	21825-21833	subserve	_	
151-19	21834-21843	cognitive	_	
151-20	21844-21851	control	_	
151-21	21851-21852	.	_	

#Text=In contrast, acute alcohol intoxication significantly dysregulates the co-oscillations, yielding a Condition x Beverage interaction, F(1,19) = 5.1, p < .05 in which incongruous trials specifically were affected by alcohol F(1,19) = 8.8, p < .01 (Figure 7).
152-1	21853-21855	In	_	
152-2	21856-21864	contrast	_	
152-3	21864-21865	,	_	
152-4	21866-21871	acute	_	
152-5	21872-21879	alcohol	_	
152-6	21880-21892	intoxication	_	
152-7	21893-21906	significantly	_	
152-8	21907-21919	dysregulates	_	
152-9	21920-21923	the	_	
152-10	21924-21939	co-oscillations	_	
152-11	21939-21940	,	_	
152-12	21941-21949	yielding	_	
152-13	21950-21951	a	_	
152-14	21952-21961	Condition	_	
152-15	21962-21963	x	_	
152-16	21964-21972	Beverage	_	
152-17	21973-21984	interaction	_	
152-18	21984-21985	,	_	
152-19	21986-21987	F	_	
152-20	21987-21988	(	_	
152-21	21988-21992	1,19	_	
152-22	21992-21993	)	_	
152-23	21994-21995	=	_	
152-24	21996-21999	5.1	_	
152-25	21999-22000	,	_	
152-26	22001-22002	p	_	
152-27	22003-22004	<	_	
152-28	22005-22008	.05	_	
152-29	22009-22011	in	_	
152-30	22012-22017	which	_	
152-31	22018-22029	incongruous	_	
152-32	22030-22036	trials	_	
152-33	22037-22049	specifically	_	
152-34	22050-22054	were	_	
152-35	22055-22063	affected	_	
152-36	22064-22066	by	_	
152-37	22067-22074	alcohol	_	
152-38	22075-22076	F	_	
152-39	22076-22077	(	_	
152-40	22077-22081	1,19	_	
152-41	22081-22082	)	_	
152-42	22083-22084	=	_	
152-43	22085-22088	8.8	_	
152-44	22088-22089	,	_	
152-45	22090-22091	p	_	
152-46	22092-22093	<	_	
152-47	22094-22097	.01	_	
152-48	22098-22099	(	_	
152-49	22099-22105	Figure	_	
152-50	22106-22107	7	_	
152-51	22107-22108	)	_	
152-52	22108-22109	.	_	

#Text=This may underlie alcohol-induced impairments of inhibitory control and indicates the vulnerability of top-down regulative functions of the prefrontal cortex to acute intoxication.
153-1	22110-22114	This	_	
153-2	22115-22118	may	_	
153-3	22119-22127	underlie	_	
153-4	22128-22143	alcohol-induced	_	
153-5	22144-22155	impairments	_	
153-6	22156-22158	of	_	
153-7	22159-22169	inhibitory	_	
153-8	22170-22177	control	_	
153-9	22178-22181	and	_	
153-10	22182-22191	indicates	_	
153-11	22192-22195	the	_	
153-12	22196-22209	vulnerability	_	
153-13	22210-22212	of	_	
153-14	22213-22221	top-down	_	
153-15	22222-22232	regulative	_	
153-16	22233-22242	functions	_	
153-17	22243-22245	of	_	
153-18	22246-22249	the	_	
153-19	22250-22260	prefrontal	_	
153-20	22261-22267	cortex	_	
153-21	22268-22270	to	_	
153-22	22271-22276	acute	_	
153-23	22277-22289	intoxication	_	
153-24	22289-22290	.	_	

#Text=DISCUSSION:
#Text=The multimodal imaging method used in this study comprises distributed source modeling of the temporally precise MEG signal along with spatial constraints of inverse estimates derived from each participant’s structural MRI.
154-1	22291-22301	DISCUSSION	_	
154-2	22301-22302	:	_	
154-3	22303-22306	The	_	
154-4	22307-22317	multimodal	_	
154-5	22318-22325	imaging	_	
154-6	22326-22332	method	_	
154-7	22333-22337	used	_	
154-8	22338-22340	in	_	
154-9	22341-22345	this	_	
154-10	22346-22351	study	_	
154-11	22352-22361	comprises	_	
154-12	22362-22373	distributed	_	
154-13	22374-22380	source	_	
154-14	22381-22389	modeling	_	
154-15	22390-22392	of	_	
154-16	22393-22396	the	_	
154-17	22397-22407	temporally	_	
154-18	22408-22415	precise	_	
154-19	22416-22419	MEG	_	
154-20	22420-22426	signal	_	
154-21	22427-22432	along	_	
154-22	22433-22437	with	_	
154-23	22438-22445	spatial	_	
154-24	22446-22457	constraints	_	
154-25	22458-22460	of	_	
154-26	22461-22468	inverse	_	
154-27	22469-22478	estimates	_	
154-28	22479-22486	derived	_	
154-29	22487-22491	from	_	
154-30	22492-22496	each	_	
154-31	22497-22508	participant	_	
154-32	22508-22509	’	_	
154-33	22509-22510	s	_	
154-34	22511-22521	structural	_	
154-35	22522-22525	MRI	_	
154-36	22525-22526	.	_	

#Text=The aMEG approach combines the strengths of these techniques to provide insight into the spatio-temporal stages of oscillatory dynamics and the long-range integration subserving cognitive control.
155-1	22527-22530	The	_	
155-2	22531-22535	aMEG	_	
155-3	22536-22544	approach	_	
155-4	22545-22553	combines	_	
155-5	22554-22557	the	_	
155-6	22558-22567	strengths	_	
155-7	22568-22570	of	_	
155-8	22571-22576	these	_	
155-9	22577-22587	techniques	_	
155-10	22588-22590	to	_	
155-11	22591-22598	provide	_	
155-12	22599-22606	insight	_	
155-13	22607-22611	into	_	
155-14	22612-22615	the	_	
155-15	22616-22631	spatio-temporal	_	
155-16	22632-22638	stages	_	
155-17	22639-22641	of	_	
155-18	22642-22653	oscillatory	_	
155-19	22654-22662	dynamics	_	
155-20	22663-22666	and	_	
155-21	22667-22670	the	_	
155-22	22671-22681	long-range	_	
155-23	22682-22693	integration	_	
155-24	22694-22704	subserving	_	
155-25	22705-22714	cognitive	_	
155-26	22715-22722	control	_	
155-27	22722-22723	.	_	

#Text=This method provides greater temporal precision than other neuroimaging techniques such as fMRI-BOLD whose temporal resolution is on the magnitude of seconds due to its indirect sensitivity to neural changes via neurovascular coupling.
156-1	22724-22728	This	_	
156-2	22729-22735	method	_	
156-3	22736-22744	provides	_	
156-4	22745-22752	greater	_	
156-5	22753-22761	temporal	_	
156-6	22762-22771	precision	_	
156-7	22772-22776	than	_	
156-8	22777-22782	other	_	
156-9	22783-22795	neuroimaging	_	
156-10	22796-22806	techniques	_	
156-11	22807-22811	such	_	
156-12	22812-22814	as	_	
156-13	22815-22824	fMRI-BOLD	_	
156-14	22825-22830	whose	_	
156-15	22831-22839	temporal	_	
156-16	22840-22850	resolution	_	
156-17	22851-22853	is	_	
156-18	22854-22856	on	_	
156-19	22857-22860	the	_	
156-20	22861-22870	magnitude	_	
156-21	22871-22873	of	_	
156-22	22874-22881	seconds	_	
156-23	22882-22885	due	_	
156-24	22886-22888	to	_	
156-25	22889-22892	its	_	
156-26	22893-22901	indirect	_	
156-27	22902-22913	sensitivity	_	
156-28	22914-22916	to	_	
156-29	22917-22923	neural	_	
156-30	22924-22931	changes	_	
156-31	22932-22935	via	_	
156-32	22936-22949	neurovascular	_	
156-33	22950-22958	coupling	_	
156-34	22958-22959	.	_	

#Text=In comparison, the millisecond precision of MEG signal allows for the investigation of neural processing stages, as demonstrated by the present study.
157-1	22960-22962	In	_	
157-2	22963-22973	comparison	_	
157-3	22973-22974	,	_	
157-4	22975-22978	the	_	
157-5	22979-22990	millisecond	_	
157-6	22991-23000	precision	_	
157-7	23001-23003	of	_	
157-8	23004-23007	MEG	_	
157-9	23008-23014	signal	_	
157-10	23015-23021	allows	_	
157-11	23022-23025	for	_	
157-12	23026-23029	the	_	
157-13	23030-23043	investigation	_	
157-14	23044-23046	of	_	
157-15	23047-23053	neural	_	
157-16	23054-23064	processing	_	
157-17	23065-23071	stages	_	
157-18	23071-23072	,	_	
157-19	23073-23075	as	_	
157-20	23076-23088	demonstrated	_	
157-21	23089-23091	by	_	
157-22	23092-23095	the	_	
157-23	23096-23103	present	_	
157-24	23104-23109	study	_	
157-25	23109-23110	.	_	

#Text=The aMEG model assumes distributed sources of the MEG signal along the cortical surface which, when reconstructed from structural MRI images, provides spatial constraints for activity estimates.
158-1	23111-23114	The	_	
158-2	23115-23119	aMEG	_	
158-3	23120-23125	model	_	
158-4	23126-23133	assumes	_	
158-5	23134-23145	distributed	_	
158-6	23146-23153	sources	_	
158-7	23154-23156	of	_	
158-8	23157-23160	the	_	
158-9	23161-23164	MEG	_	
158-10	23165-23171	signal	_	
158-11	23172-23177	along	_	
158-12	23178-23181	the	_	
158-13	23182-23190	cortical	_	
158-14	23191-23198	surface	_	
158-15	23199-23204	which	_	
158-16	23204-23205	,	_	
158-17	23206-23210	when	_	
158-18	23211-23224	reconstructed	_	
158-19	23225-23229	from	_	
158-20	23230-23240	structural	_	
158-21	23241-23244	MRI	_	
158-22	23245-23251	images	_	
158-23	23251-23252	,	_	
158-24	23253-23261	provides	_	
158-25	23262-23269	spatial	_	
158-26	23270-23281	constraints	_	
158-27	23282-23285	for	_	
158-28	23286-23294	activity	_	
158-29	23295-23304	estimates	_	
158-30	23304-23305	.	_	

#Text=These spatial estimates can be used to investigate not only local activation but long-range communication at an interactive network level in the form of phase-locking.
159-1	23306-23311	These	_	
159-2	23312-23319	spatial	_	
159-3	23320-23329	estimates	_	
159-4	23330-23333	can	_	
159-5	23334-23336	be	_	
159-6	23337-23341	used	_	
159-7	23342-23344	to	_	
159-8	23345-23356	investigate	_	
159-9	23357-23360	not	_	
159-10	23361-23365	only	_	
159-11	23366-23371	local	_	
159-12	23372-23382	activation	_	
159-13	23383-23386	but	_	
159-14	23387-23397	long-range	_	
159-15	23398-23411	communication	_	
159-16	23412-23414	at	_	
159-17	23415-23417	an	_	
159-18	23418-23429	interactive	_	
159-19	23430-23437	network	_	
159-20	23438-23443	level	_	
159-21	23444-23446	in	_	
159-22	23447-23450	the	_	
159-23	23451-23455	form	_	
159-24	23456-23458	of	_	
159-25	23459-23472	phase-locking	_	
159-26	23472-23473	.	_	

#Text=Moreover, the aMEG approach is well suited for investigating the effects of pharmacological manipulation on neural functions given that the fMRI-BOLD signal is confounded by the vasoactive effects of pharmacological manipulations such as alcohol and may not accurately reflect the magnitude of neural changes.
160-1	23474-23482	Moreover	_	
160-2	23482-23483	,	_	
160-3	23484-23487	the	_	
160-4	23488-23492	aMEG	_	
160-5	23493-23501	approach	_	
160-6	23502-23504	is	_	
160-7	23505-23509	well	_	
160-8	23510-23516	suited	_	
160-9	23517-23520	for	_	
160-10	23521-23534	investigating	_	
160-11	23535-23538	the	_	
160-12	23539-23546	effects	_	
160-13	23547-23549	of	_	
160-14	23550-23565	pharmacological	_	
160-15	23566-23578	manipulation	_	
160-16	23579-23581	on	_	
160-17	23582-23588	neural	_	
160-18	23589-23598	functions	_	
160-19	23599-23604	given	_	
160-20	23605-23609	that	_	
160-21	23610-23613	the	_	
160-22	23614-23623	fMRI-BOLD	_	
160-23	23624-23630	signal	_	
160-24	23631-23633	is	_	
160-25	23634-23644	confounded	_	
160-26	23645-23647	by	_	
160-27	23648-23651	the	_	
160-28	23652-23662	vasoactive	_	
160-29	23663-23670	effects	_	
160-30	23671-23673	of	_	
160-31	23674-23689	pharmacological	_	
160-32	23690-23703	manipulations	_	
160-33	23704-23708	such	_	
160-34	23709-23711	as	_	
160-35	23712-23719	alcohol	_	
160-36	23720-23723	and	_	
160-37	23724-23727	may	_	
160-38	23728-23731	not	_	
160-39	23732-23742	accurately	_	
160-40	23743-23750	reflect	_	
160-41	23751-23754	the	_	
160-42	23755-23764	magnitude	_	
160-43	23765-23767	of	_	
160-44	23768-23774	neural	_	
160-45	23775-23782	changes	_	
160-46	23782-23783	.	_	

#Text=The high sensitivity of this method to minute neural changes means that it is also sensitive to non-neural noise including muscle movements or eye blinks so the various artifacts need to be detected and carefully removed from the raw signal.
161-1	23784-23787	The	_	
161-2	23788-23792	high	_	
161-3	23793-23804	sensitivity	_	
161-4	23805-23807	of	_	
161-5	23808-23812	this	_	
161-6	23813-23819	method	_	
161-7	23820-23822	to	_	
161-8	23823-23829	minute	_	
161-9	23830-23836	neural	_	
161-10	23837-23844	changes	_	
161-11	23845-23850	means	_	
161-12	23851-23855	that	_	
161-13	23856-23858	it	_	
161-14	23859-23861	is	_	
161-15	23862-23866	also	_	
161-16	23867-23876	sensitive	_	
161-17	23877-23879	to	_	
161-18	23880-23890	non-neural	_	
161-19	23891-23896	noise	_	
161-20	23897-23906	including	_	
161-21	23907-23913	muscle	_	
161-22	23914-23923	movements	_	
161-23	23924-23926	or	_	
161-24	23927-23930	eye	_	
161-25	23931-23937	blinks	_	
161-26	23938-23940	so	_	
161-27	23941-23944	the	_	
161-28	23945-23952	various	_	
161-29	23953-23962	artifacts	_	
161-30	23963-23967	need	_	
161-31	23968-23970	to	_	
161-32	23971-23973	be	_	
161-33	23974-23982	detected	_	
161-34	23983-23986	and	_	
161-35	23987-23996	carefully	_	
161-36	23997-24004	removed	_	
161-37	24005-24009	from	_	
161-38	24010-24013	the	_	
161-39	24014-24017	raw	_	
161-40	24018-24024	signal	_	
161-41	24024-24025	.	_	

#Text=Moreover, head position can have significant effects on activity estimates due to sensor sensitivity to magnetic field gradients.
162-1	24026-24034	Moreover	_	
162-2	24034-24035	,	_	
162-3	24036-24040	head	_	
162-4	24041-24049	position	_	
162-5	24050-24053	can	_	
162-6	24054-24058	have	_	
162-7	24059-24070	significant	_	
162-8	24071-24078	effects	_	
162-9	24079-24081	on	_	
162-10	24082-24090	activity	_	
162-11	24091-24100	estimates	_	
162-12	24101-24104	due	_	
162-13	24105-24107	to	_	
162-14	24108-24114	sensor	_	
162-15	24115-24126	sensitivity	_	
162-16	24127-24129	to	_	
162-17	24130-24138	magnetic	_	
162-18	24139-24144	field	_	
162-19	24145-24154	gradients	_	
162-20	24154-24155	.	_	

#Text=Given the aMEG model assumptions, source estimates are constrained to the cortical surface so the activity elicited from subcortical structures cannot be estimated.
163-1	24156-24161	Given	_	
163-2	24162-24165	the	_	
163-3	24166-24170	aMEG	_	
163-4	24171-24176	model	_	
163-5	24177-24188	assumptions	_	
163-6	24188-24189	,	_	
163-7	24190-24196	source	_	
163-8	24197-24206	estimates	_	
163-9	24207-24210	are	_	
163-10	24211-24222	constrained	_	
163-11	24223-24225	to	_	
163-12	24226-24229	the	_	
163-13	24230-24238	cortical	_	
163-14	24239-24246	surface	_	
163-15	24247-24249	so	_	
163-16	24250-24253	the	_	
163-17	24254-24262	activity	_	
163-18	24263-24271	elicited	_	
163-19	24272-24276	from	_	
163-20	24277-24288	subcortical	_	
163-21	24289-24299	structures	_	
163-22	24300-24306	cannot	_	
163-23	24307-24309	be	_	
163-24	24310-24319	estimated	_	
163-25	24319-24320	.	_	

#Text=Based on previously published results, the present study has illustrated changes in event-related theta (4 – 7 Hz) power during Stroop-induced conflict as a function of acute alcohol intoxication in healthy social drinkers.
164-1	24321-24326	Based	_	
164-2	24327-24329	on	_	
164-3	24330-24340	previously	_	
164-4	24341-24350	published	_	
164-5	24351-24358	results	_	
164-6	24358-24359	,	_	
164-7	24360-24363	the	_	
164-8	24364-24371	present	_	
164-9	24372-24377	study	_	
164-10	24378-24381	has	_	
164-11	24382-24393	illustrated	_	
164-12	24394-24401	changes	_	
164-13	24402-24404	in	_	
164-14	24405-24418	event-related	_	
164-15	24419-24424	theta	_	
164-16	24425-24426	(	_	
164-17	24426-24427	4	_	
164-18	24428-24429	–	_	
164-19	24430-24431	7	_	
164-20	24432-24434	Hz	_	
164-21	24434-24435	)	_	
164-22	24436-24441	power	_	
164-23	24442-24448	during	_	
164-24	24449-24463	Stroop-induced	_	
164-25	24464-24472	conflict	_	
164-26	24473-24475	as	_	
164-27	24476-24477	a	_	
164-28	24478-24486	function	_	
164-29	24487-24489	of	_	
164-30	24490-24495	acute	_	
164-31	24496-24503	alcohol	_	
164-32	24504-24516	intoxication	_	
164-33	24517-24519	in	_	
164-34	24520-24527	healthy	_	
164-35	24528-24534	social	_	
164-36	24535-24543	drinkers	_	
164-37	24543-24544	.	_	

#Text=As shown in Figure 5, theta power is differentially sensitive to cognitive demands imposed by the Stroop task conditions.
165-1	24545-24547	As	_	
165-2	24548-24553	shown	_	
165-3	24554-24556	in	_	
165-4	24557-24563	Figure	_	
165-5	24564-24565	5	_	
165-6	24565-24566	,	_	
165-7	24567-24572	theta	_	
165-8	24573-24578	power	_	
165-9	24579-24581	is	_	
165-10	24582-24596	differentially	_	
165-11	24597-24606	sensitive	_	
165-12	24607-24609	to	_	
165-13	24610-24619	cognitive	_	
165-14	24620-24627	demands	_	
165-15	24628-24635	imposed	_	
165-16	24636-24638	by	_	
165-17	24639-24642	the	_	
165-18	24643-24649	Stroop	_	
165-19	24650-24654	task	_	
165-20	24655-24665	conditions	_	
165-21	24665-24666	.	_	

#Text=Incongruity is especially effective in engaging cognitive control as reflected in greater theta power in the prefrontal cortex compared to prestimulus baseline.
166-1	24667-24678	Incongruity	_	
166-2	24679-24681	is	_	
166-3	24682-24692	especially	_	
166-4	24693-24702	effective	_	
166-5	24703-24705	in	_	
166-6	24706-24714	engaging	_	
166-7	24715-24724	cognitive	_	
166-8	24725-24732	control	_	
166-9	24733-24735	as	_	
166-10	24736-24745	reflected	_	
166-11	24746-24748	in	_	
166-12	24749-24756	greater	_	
166-13	24757-24762	theta	_	
166-14	24763-24768	power	_	
166-15	24769-24771	in	_	
166-16	24772-24775	the	_	
166-17	24776-24786	prefrontal	_	
166-18	24787-24793	cortex	_	
166-19	24794-24802	compared	_	
166-20	24803-24805	to	_	
166-21	24806-24817	prestimulus	_	
166-22	24818-24826	baseline	_	
166-23	24826-24827	.	_	

#Text=The principal estimated generator of theta oscillations is the ACC which is sensitive to response conflict during both, early and late processing stages.
167-1	24828-24831	The	_	
167-2	24832-24841	principal	_	
167-3	24842-24851	estimated	_	
167-4	24852-24861	generator	_	
167-5	24862-24864	of	_	
167-6	24865-24870	theta	_	
167-7	24871-24883	oscillations	_	
167-8	24884-24886	is	_	
167-9	24887-24890	the	_	
167-10	24891-24894	ACC	_	
167-11	24895-24900	which	_	
167-12	24901-24903	is	_	
167-13	24904-24913	sensitive	_	
167-14	24914-24916	to	_	
167-15	24917-24925	response	_	
167-16	24926-24934	conflict	_	
167-17	24935-24941	during	_	
167-18	24942-24946	both	_	
167-19	24946-24947	,	_	
167-20	24948-24953	early	_	
167-21	24954-24957	and	_	
167-22	24958-24962	late	_	
167-23	24963-24973	processing	_	
167-24	24974-24980	stages	_	
167-25	24980-24981	.	_	

#Text=These findings support the role of the ACC in monitoring for conflict in concordance with prominent accounts.
168-1	24982-24987	These	_	
168-2	24988-24996	findings	_	
168-3	24997-25004	support	_	
168-4	25005-25008	the	_	
168-5	25009-25013	role	_	
168-6	25014-25016	of	_	
168-7	25017-25020	the	_	
168-8	25021-25024	ACC	_	
168-9	25025-25027	in	_	
168-10	25028-25038	monitoring	_	
168-11	25039-25042	for	_	
168-12	25043-25051	conflict	_	
168-13	25052-25054	in	_	
168-14	25055-25066	concordance	_	
168-15	25067-25071	with	_	
168-16	25072-25081	prominent	_	
168-17	25082-25090	accounts	_	
168-18	25090-25091	.	_	

#Text=Thus, the aMEG method has provided a temporally-sensitive insight into the sustained engagement of the ACC during trials imposing higher load on cognitive control.
169-1	25092-25096	Thus	_	
169-2	25096-25097	,	_	
169-3	25098-25101	the	_	
169-4	25102-25106	aMEG	_	
169-5	25107-25113	method	_	
169-6	25114-25117	has	_	
169-7	25118-25126	provided	_	
169-8	25127-25128	a	_	
169-9	25129-25149	temporally-sensitive	_	
169-10	25150-25157	insight	_	
169-11	25158-25162	into	_	
169-12	25163-25166	the	_	
169-13	25167-25176	sustained	_	
169-14	25177-25187	engagement	_	
169-15	25188-25190	of	_	
169-16	25191-25194	the	_	
169-17	25195-25198	ACC	_	
169-18	25199-25205	during	_	
169-19	25206-25212	trials	_	
169-20	25213-25221	imposing	_	
169-21	25222-25228	higher	_	
169-22	25229-25233	load	_	
169-23	25234-25236	on	_	
169-24	25237-25246	cognitive	_	
169-25	25247-25254	control	_	
169-26	25254-25255	.	_	

#Text=Together with extensive anatomical connections between the ACC and distributed brain regions, this evidence corroborates its multifaceted role in self-regulation.
170-1	25256-25264	Together	_	
170-2	25265-25269	with	_	
170-3	25270-25279	extensive	_	
170-4	25280-25290	anatomical	_	
170-5	25291-25302	connections	_	
170-6	25303-25310	between	_	
170-7	25311-25314	the	_	
170-8	25315-25318	ACC	_	
170-9	25319-25322	and	_	
170-10	25323-25334	distributed	_	
170-11	25335-25340	brain	_	
170-12	25341-25348	regions	_	
170-13	25348-25349	,	_	
170-14	25350-25354	this	_	
170-15	25355-25363	evidence	_	
170-16	25364-25376	corroborates	_	
170-17	25377-25380	its	_	
170-18	25381-25393	multifaceted	_	
170-19	25394-25398	role	_	
170-20	25399-25401	in	_	
170-21	25402-25417	self-regulation	_	
170-22	25417-25418	.	_	

#Text=On that view, the ACC is a key hub in the neurofunctional system that subserves cognitive control by aligning goals and intentions with contextual and motivational constraints.
171-1	25419-25421	On	_	
171-2	25422-25426	that	_	
171-3	25427-25431	view	_	
171-4	25431-25432	,	_	
171-5	25433-25436	the	_	
171-6	25437-25440	ACC	_	
171-7	25441-25443	is	_	
171-8	25444-25445	a	_	
171-9	25446-25449	key	_	
171-10	25450-25453	hub	_	
171-11	25454-25456	in	_	
171-12	25457-25460	the	_	
171-13	25461-25476	neurofunctional	_	
171-14	25477-25483	system	_	
171-15	25484-25488	that	_	
171-16	25489-25498	subserves	_	
171-17	25499-25508	cognitive	_	
171-18	25509-25516	control	_	
171-19	25517-25519	by	_	
171-20	25520-25528	aligning	_	
171-21	25529-25534	goals	_	
171-22	25535-25538	and	_	
171-23	25539-25549	intentions	_	
171-24	25550-25554	with	_	
171-25	25555-25565	contextual	_	
171-26	25566-25569	and	_	
171-27	25570-25582	motivational	_	
171-28	25583-25594	constraints	_	
171-29	25594-25595	.	_	

#Text=Inferolateral prefrontal cortex, especially on the right, is another important area within that system which has been associated with inhibition of prepotent responses, attentional control, and working memory in the service of updating task representations.
172-1	25596-25609	Inferolateral	_	
172-2	25610-25620	prefrontal	_	
172-3	25621-25627	cortex	_	
172-4	25627-25628	,	_	
172-5	25629-25639	especially	_	
172-6	25640-25642	on	_	
172-7	25643-25646	the	_	
172-8	25647-25652	right	_	
172-9	25652-25653	,	_	
172-10	25654-25656	is	_	
172-11	25657-25664	another	_	
172-12	25665-25674	important	_	
172-13	25675-25679	area	_	
172-14	25680-25686	within	_	
172-15	25687-25691	that	_	
172-16	25692-25698	system	_	
172-17	25699-25704	which	_	
172-18	25705-25708	has	_	
172-19	25709-25713	been	_	
172-20	25714-25724	associated	_	
172-21	25725-25729	with	_	
172-22	25730-25740	inhibition	_	
172-23	25741-25743	of	_	
172-24	25744-25753	prepotent	_	
172-25	25754-25763	responses	_	
172-26	25763-25764	,	_	
172-27	25765-25776	attentional	_	
172-28	25777-25784	control	_	
172-29	25784-25785	,	_	
172-30	25786-25789	and	_	
172-31	25790-25797	working	_	
172-32	25798-25804	memory	_	
172-33	25805-25807	in	_	
172-34	25808-25811	the	_	
172-35	25812-25819	service	_	
172-36	25820-25822	of	_	
172-37	25823-25831	updating	_	
172-38	25832-25836	task	_	
172-39	25837-25852	representations	_	
172-40	25852-25853	.	_	

#Text=It has been established that theta oscillations mediate neural integration necessary for cognitive and affective processing.
173-1	25854-25856	It	_	
173-2	25857-25860	has	_	
173-3	25861-25865	been	_	
173-4	25866-25877	established	_	
173-5	25878-25882	that	_	
173-6	25883-25888	theta	_	
173-7	25889-25901	oscillations	_	
173-8	25902-25909	mediate	_	
173-9	25910-25916	neural	_	
173-10	25917-25928	integration	_	
173-11	25929-25938	necessary	_	
173-12	25939-25942	for	_	
173-13	25943-25952	cognitive	_	
173-14	25953-25956	and	_	
173-15	25957-25966	affective	_	
173-16	25967-25977	processing	_	
173-17	25977-25978	.	_	

#Text=Neural communication may thus rely on synchronized excitability of distant neuronal ensembles in theta band with nested fast rhythms mediating local processing.
174-1	25979-25985	Neural	_	
174-2	25986-25999	communication	_	
174-3	26000-26003	may	_	
174-4	26004-26008	thus	_	
174-5	26009-26013	rely	_	
174-6	26014-26016	on	_	
174-7	26017-26029	synchronized	_	
174-8	26030-26042	excitability	_	
174-9	26043-26045	of	_	
174-10	26046-26053	distant	_	
174-11	26054-26062	neuronal	_	
174-12	26063-26072	ensembles	_	
174-13	26073-26075	in	_	
174-14	26076-26081	theta	_	
174-15	26082-26086	band	_	
174-16	26087-26091	with	_	
174-17	26092-26098	nested	_	
174-18	26099-26103	fast	_	
174-19	26104-26111	rhythms	_	
174-20	26112-26121	mediating	_	
174-21	26122-26127	local	_	
174-22	26128-26138	processing	_	
174-23	26138-26139	.	_	

#Text=PLVs reflect phase consistency between cortical areas and are commonly used to estimate their oscillatory synchrony as it is assumed that two areas interact when they co-oscillate.
175-1	26140-26144	PLVs	_	
175-2	26145-26152	reflect	_	
175-3	26153-26158	phase	_	
175-4	26159-26170	consistency	_	
175-5	26171-26178	between	_	
175-6	26179-26187	cortical	_	
175-7	26188-26193	areas	_	
175-8	26194-26197	and	_	
175-9	26198-26201	are	_	
175-10	26202-26210	commonly	_	
175-11	26211-26215	used	_	
175-12	26216-26218	to	_	
175-13	26219-26227	estimate	_	
175-14	26228-26233	their	_	
175-15	26234-26245	oscillatory	_	
175-16	26246-26255	synchrony	_	
175-17	26256-26258	as	_	
175-18	26259-26261	it	_	
175-19	26262-26264	is	_	
175-20	26265-26272	assumed	_	
175-21	26273-26277	that	_	
175-22	26278-26281	two	_	
175-23	26282-26287	areas	_	
175-24	26288-26296	interact	_	
175-25	26297-26301	when	_	
175-26	26302-26306	they	_	
175-27	26307-26319	co-oscillate	_	
175-28	26319-26320	.	_	

#Text=Indeed, transient increases in PLV are observed in those intervals of neural activity that would be expected to necessitate synchronous interactions.
176-1	26321-26327	Indeed	_	
176-2	26327-26328	,	_	
176-3	26329-26338	transient	_	
176-4	26339-26348	increases	_	
176-5	26349-26351	in	_	
176-6	26352-26355	PLV	_	
176-7	26356-26359	are	_	
176-8	26360-26368	observed	_	
176-9	26369-26371	in	_	
176-10	26372-26377	those	_	
176-11	26378-26387	intervals	_	
176-12	26388-26390	of	_	
176-13	26391-26397	neural	_	
176-14	26398-26406	activity	_	
176-15	26407-26411	that	_	
176-16	26412-26417	would	_	
176-17	26418-26420	be	_	
176-18	26421-26429	expected	_	
176-19	26430-26432	to	_	
176-20	26433-26444	necessitate	_	
176-21	26445-26456	synchronous	_	
176-22	26457-26469	interactions	_	
176-23	26469-26470	.	_	

#Text=The present study confirms previous evidence and adds spatio-temporal refinement to the functional synchronization between the sources estimated to the ACC and the latPFC.
177-1	26471-26474	The	_	
177-2	26475-26482	present	_	
177-3	26483-26488	study	_	
177-4	26489-26497	confirms	_	
177-5	26498-26506	previous	_	
177-6	26507-26515	evidence	_	
177-7	26516-26519	and	_	
177-8	26520-26524	adds	_	
177-9	26525-26540	spatio-temporal	_	
177-10	26541-26551	refinement	_	
177-11	26552-26554	to	_	
177-12	26555-26558	the	_	
177-13	26559-26569	functional	_	
177-14	26570-26585	synchronization	_	
177-15	26586-26593	between	_	
177-16	26594-26597	the	_	
177-17	26598-26605	sources	_	
177-18	26606-26615	estimated	_	
177-19	26616-26618	to	_	
177-20	26619-26622	the	_	
177-21	26623-26626	ACC	_	
177-22	26627-26630	and	_	
177-23	26631-26634	the	_	
177-24	26635-26641	latPFC	_	
177-25	26641-26642	.	_	

#Text=Consistent with previous reports, the present results indicate that PLVs are increased and sustained on incongruous trials in the Stroop task.
178-1	26643-26653	Consistent	_	
178-2	26654-26658	with	_	
178-3	26659-26667	previous	_	
178-4	26668-26675	reports	_	
178-5	26675-26676	,	_	
178-6	26677-26680	the	_	
178-7	26681-26688	present	_	
178-8	26689-26696	results	_	
178-9	26697-26705	indicate	_	
178-10	26706-26710	that	_	
178-11	26711-26715	PLVs	_	
178-12	26716-26719	are	_	
178-13	26720-26729	increased	_	
178-14	26730-26733	and	_	
178-15	26734-26743	sustained	_	
178-16	26744-26746	on	_	
178-17	26747-26758	incongruous	_	
178-18	26759-26765	trials	_	
178-19	26766-26768	in	_	
178-20	26769-26772	the	_	
178-21	26773-26779	Stroop	_	
178-22	26780-26784	task	_	
178-23	26784-26785	.	_	

#Text=By quantifying phase synchronization between these two areas with high temporal precision, these findings extend the Conflict Monitoring account and indicate that their interaction is particularly prominent after ~350ms on incongruous trials.
179-1	26786-26788	By	_	
179-2	26789-26800	quantifying	_	
179-3	26801-26806	phase	_	
179-4	26807-26822	synchronization	_	
179-5	26823-26830	between	_	
179-6	26831-26836	these	_	
179-7	26837-26840	two	_	
179-8	26841-26846	areas	_	
179-9	26847-26851	with	_	
179-10	26852-26856	high	_	
179-11	26857-26865	temporal	_	
179-12	26866-26875	precision	_	
179-13	26875-26876	,	_	
179-14	26877-26882	these	_	
179-15	26883-26891	findings	_	
179-16	26892-26898	extend	_	
179-17	26899-26902	the	_	
179-18	26903-26911	Conflict	_	
179-19	26912-26922	Monitoring	_	
179-20	26923-26930	account	_	
179-21	26931-26934	and	_	
179-22	26935-26943	indicate	_	
179-23	26944-26948	that	_	
179-24	26949-26954	their	_	
179-25	26955-26966	interaction	_	
179-26	26967-26969	is	_	
179-27	26970-26982	particularly	_	
179-28	26983-26992	prominent	_	
179-29	26993-26998	after	_	
179-30	26999-27000	~	_	
179-31	27000-27005	350ms	_	
179-32	27006-27008	on	_	
179-33	27009-27020	incongruous	_	
179-34	27021-27027	trials	_	
179-35	27027-27028	.	_	

#Text=During this cognitive integration stage, the medial and lateral prefrontal cortices are likely to interact to support behavioral performance during more difficult task conditions imposing demands on attention, response inhibition, and working memory.
180-1	27029-27035	During	_	
180-2	27036-27040	this	_	
180-3	27041-27050	cognitive	_	
180-4	27051-27062	integration	_	
180-5	27063-27068	stage	_	
180-6	27068-27069	,	_	
180-7	27070-27073	the	_	
180-8	27074-27080	medial	_	
180-9	27081-27084	and	_	
180-10	27085-27092	lateral	_	
180-11	27093-27103	prefrontal	_	
180-12	27104-27112	cortices	_	
180-13	27113-27116	are	_	
180-14	27117-27123	likely	_	
180-15	27124-27126	to	_	
180-16	27127-27135	interact	_	
180-17	27136-27138	to	_	
180-18	27139-27146	support	_	
180-19	27147-27157	behavioral	_	
180-20	27158-27169	performance	_	
180-21	27170-27176	during	_	
180-22	27177-27181	more	_	
180-23	27182-27191	difficult	_	
180-24	27192-27196	task	_	
180-25	27197-27207	conditions	_	
180-26	27208-27216	imposing	_	
180-27	27217-27224	demands	_	
180-28	27225-27227	on	_	
180-29	27228-27237	attention	_	
180-30	27237-27238	,	_	
180-31	27239-27247	response	_	
180-32	27248-27258	inhibition	_	
180-33	27258-27259	,	_	
180-34	27260-27263	and	_	
180-35	27264-27271	working	_	
180-36	27272-27278	memory	_	
180-37	27278-27279	.	_	

#Text=Extensive evidence from MRI-based functional connectivity studies indicates that these cortical areas form a dynamic, interactive cingulo-opercular network that supports top-down cognitive control.
181-1	27280-27289	Extensive	_	
181-2	27290-27298	evidence	_	
181-3	27299-27303	from	_	
181-4	27304-27313	MRI-based	_	
181-5	27314-27324	functional	_	
181-6	27325-27337	connectivity	_	
181-7	27338-27345	studies	_	
181-8	27346-27355	indicates	_	
181-9	27356-27360	that	_	
181-10	27361-27366	these	_	
181-11	27367-27375	cortical	_	
181-12	27376-27381	areas	_	
181-13	27382-27386	form	_	
181-14	27387-27388	a	_	
181-15	27389-27396	dynamic	_	
181-16	27396-27397	,	_	
181-17	27398-27409	interactive	_	
181-18	27410-27427	cingulo-opercular	_	
181-19	27428-27435	network	_	
181-20	27436-27440	that	_	
181-21	27441-27449	supports	_	
181-22	27450-27458	top-down	_	
181-23	27459-27468	cognitive	_	
181-24	27469-27476	control	_	
181-25	27476-27477	.	_	

#Text=More broadly, the brain optimizes responding to environmental demands in an adaptive and coherent manner via flexible and dynamic synchronization of distributed neurofunctional systems.
182-1	27478-27482	More	_	
182-2	27483-27490	broadly	_	
182-3	27490-27491	,	_	
182-4	27492-27495	the	_	
182-5	27496-27501	brain	_	
182-6	27502-27511	optimizes	_	
182-7	27512-27522	responding	_	
182-8	27523-27525	to	_	
182-9	27526-27539	environmental	_	
182-10	27540-27547	demands	_	
182-11	27548-27550	in	_	
182-12	27551-27553	an	_	
182-13	27554-27562	adaptive	_	
182-14	27563-27566	and	_	
182-15	27567-27575	coherent	_	
182-16	27576-27582	manner	_	
182-17	27583-27586	via	_	
182-18	27587-27595	flexible	_	
182-19	27596-27599	and	_	
182-20	27600-27607	dynamic	_	
182-21	27608-27623	synchronization	_	
182-22	27624-27626	of	_	
182-23	27627-27638	distributed	_	
182-24	27639-27654	neurofunctional	_	
182-25	27655-27662	systems	_	
182-26	27662-27663	.	_	

#Text=The anatomically-constrained MEG approach used in the present study relies on a combination of complementary imaging methods.
183-1	27664-27667	The	_	
183-2	27668-27692	anatomically-constrained	_	
183-3	27693-27696	MEG	_	
183-4	27697-27705	approach	_	
183-5	27706-27710	used	_	
183-6	27711-27713	in	_	
183-7	27714-27717	the	_	
183-8	27718-27725	present	_	
183-9	27726-27731	study	_	
183-10	27732-27738	relies	_	
183-11	27739-27741	on	_	
183-12	27742-27743	a	_	
183-13	27744-27755	combination	_	
183-14	27756-27758	of	_	
183-15	27759-27772	complementary	_	
183-16	27773-27780	imaging	_	
183-17	27781-27788	methods	_	
183-18	27788-27789	.	_	

#Text=It can characterize the spatio-temporal sequence of neural activity and can provide insight into the dynamics of long-range interactions important for integrating top-down influences during engagement of cognitive control.
184-1	27790-27792	It	_	
184-2	27793-27796	can	_	
184-3	27797-27809	characterize	_	
184-4	27810-27813	the	_	
184-5	27814-27829	spatio-temporal	_	
184-6	27830-27838	sequence	_	
184-7	27839-27841	of	_	
184-8	27842-27848	neural	_	
184-9	27849-27857	activity	_	
184-10	27858-27861	and	_	
184-11	27862-27865	can	_	
184-12	27866-27873	provide	_	
184-13	27874-27881	insight	_	
184-14	27882-27886	into	_	
184-15	27887-27890	the	_	
184-16	27891-27899	dynamics	_	
184-17	27900-27902	of	_	
184-18	27903-27913	long-range	_	
184-19	27914-27926	interactions	_	
184-20	27927-27936	important	_	
184-21	27937-27940	for	_	
184-22	27941-27952	integrating	_	
184-23	27953-27961	top-down	_	
184-24	27962-27972	influences	_	
184-25	27973-27979	during	_	
184-26	27980-27990	engagement	_	
184-27	27991-27993	of	_	
184-28	27994-28003	cognitive	_	
184-29	28004-28011	control	_	
184-30	28011-28012	.	_	

#Text=The MEG signal reflects synaptic currents directly which allows for testing hypotheses about co-oscillatory interactions within and across neurofunctional systems with high temporal precision.
185-1	28013-28016	The	_	
185-2	28017-28020	MEG	_	
185-3	28021-28027	signal	_	
185-4	28028-28036	reflects	_	
185-5	28037-28045	synaptic	_	
185-6	28046-28054	currents	_	
185-7	28055-28063	directly	_	
185-8	28064-28069	which	_	
185-9	28070-28076	allows	_	
185-10	28077-28080	for	_	
185-11	28081-28088	testing	_	
185-12	28089-28099	hypotheses	_	
185-13	28100-28105	about	_	
185-14	28106-28120	co-oscillatory	_	
185-15	28121-28133	interactions	_	
185-16	28134-28140	within	_	
185-17	28141-28144	and	_	
185-18	28145-28151	across	_	
185-19	28152-28167	neurofunctional	_	
185-20	28168-28175	systems	_	
185-21	28176-28180	with	_	
185-22	28181-28185	high	_	
185-23	28186-28194	temporal	_	
185-24	28195-28204	precision	_	
185-25	28204-28205	.	_	

#Text=Furthermore, this method is suitable for pharmacological manipulations because it is not susceptible to vasoactive confounds.
186-1	28206-28217	Furthermore	_	
186-2	28217-28218	,	_	
186-3	28219-28223	this	_	
186-4	28224-28230	method	_	
186-5	28231-28233	is	_	
186-6	28234-28242	suitable	_	
186-7	28243-28246	for	_	
186-8	28247-28262	pharmacological	_	
186-9	28263-28276	manipulations	_	
186-10	28277-28284	because	_	
186-11	28285-28287	it	_	
186-12	28288-28290	is	_	
186-13	28291-28294	not	_	
186-14	28295-28306	susceptible	_	
186-15	28307-28309	to	_	
186-16	28310-28320	vasoactive	_	
186-17	28321-28330	confounds	_	
186-18	28330-28331	.	_	

#Text=Research from this lab and others indicates that prefrontally-mediated cognitive control functions are particularly vulnerable to alcohol intoxication.
187-1	28332-28340	Research	_	
187-2	28341-28345	from	_	
187-3	28346-28350	this	_	
187-4	28351-28354	lab	_	
187-5	28355-28358	and	_	
187-6	28359-28365	others	_	
187-7	28366-28375	indicates	_	
187-8	28376-28380	that	_	
187-9	28381-28402	prefrontally-mediated	_	
187-10	28403-28412	cognitive	_	
187-11	28413-28420	control	_	
187-12	28421-28430	functions	_	
187-13	28431-28434	are	_	
187-14	28435-28447	particularly	_	
187-15	28448-28458	vulnerable	_	
187-16	28459-28461	to	_	
187-17	28462-28469	alcohol	_	
187-18	28470-28482	intoxication	_	
187-19	28482-28483	.	_	

#Text=The present study shows that acute alcohol intoxication decreases activity in the prefrontal areas subserving response conflict.
188-1	28484-28487	The	_	
188-2	28488-28495	present	_	
188-3	28496-28501	study	_	
188-4	28502-28507	shows	_	
188-5	28508-28512	that	_	
188-6	28513-28518	acute	_	
188-7	28519-28526	alcohol	_	
188-8	28527-28539	intoxication	_	
188-9	28540-28549	decreases	_	
188-10	28550-28558	activity	_	
188-11	28559-28561	in	_	
188-12	28562-28565	the	_	
188-13	28566-28576	prefrontal	_	
188-14	28577-28582	areas	_	
188-15	28583-28593	subserving	_	
188-16	28594-28602	response	_	
188-17	28603-28611	conflict	_	
188-18	28611-28612	.	_	

#Text=Furthermore, alcohol disrupts synchronized co-oscillations which may underlie impaired or maladaptive response suppression.
189-1	28613-28624	Furthermore	_	
189-2	28624-28625	,	_	
189-3	28626-28633	alcohol	_	
189-4	28634-28642	disrupts	_	
189-5	28643-28655	synchronized	_	
189-6	28656-28671	co-oscillations	_	
189-7	28672-28677	which	_	
189-8	28678-28681	may	_	
189-9	28682-28690	underlie	_	
189-10	28691-28699	impaired	_	
189-11	28700-28702	or	_	
189-12	28703-28714	maladaptive	_	
189-13	28715-28723	response	_	
189-14	28724-28735	suppression	_	
189-15	28735-28736	.	_	

#Text=As a result, intoxicated individuals exhibit deficient self-control resulting in disinhibition which may contribute to compulsive drinking and the development of alcohol dependence.
190-1	28737-28739	As	_	
190-2	28740-28741	a	_	
190-3	28742-28748	result	_	
190-4	28748-28749	,	_	
190-5	28750-28761	intoxicated	_	
190-6	28762-28773	individuals	_	
190-7	28774-28781	exhibit	_	
190-8	28782-28791	deficient	_	
190-9	28792-28804	self-control	_	
190-10	28805-28814	resulting	_	
190-11	28815-28817	in	_	
190-12	28818-28831	disinhibition	_	
190-13	28832-28837	which	_	
190-14	28838-28841	may	_	
190-15	28842-28852	contribute	_	
190-16	28853-28855	to	_	
190-17	28856-28866	compulsive	_	
190-18	28867-28875	drinking	_	
190-19	28876-28879	and	_	
190-20	28880-28883	the	_	
190-21	28884-28895	development	_	
190-22	28896-28898	of	_	
190-23	28899-28906	alcohol	_	
190-24	28907-28917	dependence	_	
190-25	28917-28918	.	_	

#Text=In sum, estimates of synchronous co-oscillations can illuminate real-time interactions of the neural systems engaged by a particular cognitive demand and can inform a realistic brain-based model.
191-1	28919-28921	In	_	
191-2	28922-28925	sum	_	
191-3	28925-28926	,	_	
191-4	28927-28936	estimates	_	
191-5	28937-28939	of	_	
191-6	28940-28951	synchronous	_	
191-7	28952-28967	co-oscillations	_	
191-8	28968-28971	can	_	
191-9	28972-28982	illuminate	_	
191-10	28983-28992	real-time	_	
191-11	28993-29005	interactions	_	
191-12	29006-29008	of	_	
191-13	29009-29012	the	_	
191-14	29013-29019	neural	_	
191-15	29020-29027	systems	_	
191-16	29028-29035	engaged	_	
191-17	29036-29038	by	_	
191-18	29039-29040	a	_	
191-19	29041-29051	particular	_	
191-20	29052-29061	cognitive	_	
191-21	29062-29068	demand	_	
191-22	29069-29072	and	_	
191-23	29073-29076	can	_	
191-24	29077-29083	inform	_	
191-25	29084-29085	a	_	
191-26	29086-29095	realistic	_	
191-27	29096-29107	brain-based	_	
191-28	29108-29113	model	_	
191-29	29113-29114	.	_	

#Text=They can characterize the selective sensitivity to alcohol challenge across networks, and can serve as biomarkers of individual vulnerability to pharmacological effects.
192-1	29115-29119	They	_	
192-2	29120-29123	can	_	
192-3	29124-29136	characterize	_	
192-4	29137-29140	the	_	
192-5	29141-29150	selective	_	
192-6	29151-29162	sensitivity	_	
192-7	29163-29165	to	_	
192-8	29166-29173	alcohol	_	
192-9	29174-29183	challenge	_	
192-10	29184-29190	across	_	
192-11	29191-29199	networks	_	
192-12	29199-29200	,	_	
192-13	29201-29204	and	_	
192-14	29205-29208	can	_	
192-15	29209-29214	serve	_	
192-16	29215-29217	as	_	
192-17	29218-29228	biomarkers	_	
192-18	29229-29231	of	_	
192-19	29232-29242	individual	_	
192-20	29243-29256	vulnerability	_	
192-21	29257-29259	to	_	
192-22	29260-29275	pharmacological	_	
192-23	29276-29283	effects	_	
192-24	29283-29284	.	_	

#Text=Supplementary Material
#Text=DISCLOSURES:
#Text=The authors have nothing to disclose.
193-1	29285-29298	Supplementary	_	
193-2	29299-29307	Material	_	
193-3	29308-29319	DISCLOSURES	_	
193-4	29319-29320	:	_	
193-5	29321-29324	The	_	
193-6	29325-29332	authors	_	
193-7	29333-29337	have	_	
193-8	29338-29345	nothing	_	
193-9	29346-29348	to	_	
193-10	29349-29357	disclose	_	
193-11	29357-29358	.	_	

#Text=REFERENCES:
#Text=Neurocognitive mechanisms of cognitive control: the role of prefrontal cortex in action selection, response inhibition, performance monitoring, and reward-based learning
#Text=Dorsal anterior cingulate cortex and the value of control
#Text=Adaptive decision making and value in the anterior cingulate cortex
#Text=Dorsal Anterior Cingulate Cortex: A Bottom-Up View
#Text=Connections underlying the synthesis of cognition, memory, and emotion in primate prefrontal cortices
#Text=
#Text=Conflict monitoring and decision making: reconciling two perspectives on anterior cingulate function
#Text=Anterior cingulate cortex and conflict detection: an update of theory and data
#Text=
#Text=Effects of alcohol intoxication and gender on cerebral perfusion: an arterial spin labeling study
#Text=The role of phase synchronization in memory processes
#Text=Measuring phase synchrony in brain signals
#Text=Frontal theta as a mechanism for cognitive control
#Text=Control mechanisms in working memory: a possible function of EEG theta oscillations
#Text=Responses of human anterior cingulate cortex microdomains to error detection, conflict monitoring, stimulus-response mapping, familiarity, and orienting
#Text=Laminar profile of spontaneous and evoked theta: Rhythmic modulation of cortical processing during word integration
#Text=Alcohol hits you when it is hard: Intoxication, task difficulty, and theta brain oscillations
#Text=Theta oscillations are sensitive to both early and late conflict processing stages: effects of alcohol intoxication
#Text=Event-related theta power during lexical-semantic retrieval and decision conflict is modulated by alcohol intoxication: Anatomically-constrained MEG
#Text=When the brain changes its mind: Oscillatory dynamics of conflict processing and response switching in a flanker task during alcohol challenge
#Text=Alcohol: effects on neurobehavioral functions and the brain
#Text=Executive Functions, Memory, and Social Cognitive Deficits and Recovery in Chronic Alcoholism: A Critical Review to Inform Future Research
#Text=Acute alcohol intoxication impairs top-down regulation of Stroop incongruity as revealed by blood oxygen level-dependent functional magnetic resonance imaging
#Text=Effects of acute alcohol intoxication on saccadic conflict and error processing
#Text=Acute alcohol effects on inhibitory control and implicit cognition: implications for loss of control over drinking
#Text=Drug abuse as a problem of impaired control: current approaches and findings
#Text=Epidemiology and consequences of drinking and driving
#Text=A self-administered Short Michigan Alcoholism Screening Test (SMAST)
#Text=
#Text=Comparison of direct interview and family history diagnoses of alcohol dependence
#Text=
#Text=Impulsiveness and venturesomeness: their position in a dimensional system of personality description
#Text=
#Text=Development and validation of the Biphasic Alcohol Effects Scale
#Text=Functional Mapping with Simultaneous MEG and EEG
#Text=Mapping cortical dynamics using simultaneous MEG/EEG and anatomically-constrained minimum-norm estimates: an auditory attention example
#Text=How to detect amygdala activity with magnetoencephalography using source imaging
#Text=Gender and alcohol dosing: a procedure for producing comparable breath alcohol curves for men and women
#Text=Head position in the MEG helmet affects the sensitivity to anterior sources
#Text=Improved localization of cortical activity by combining EEG and MEG with MRI cortical surface reconstruction: A linear approach
#Text=Cortical surface-based analysis.
194-1	29359-29369	REFERENCES	_	
194-2	29369-29370	:	_	
194-3	29371-29385	Neurocognitive	_	
194-4	29386-29396	mechanisms	_	
194-5	29397-29399	of	_	
194-6	29400-29409	cognitive	_	
194-7	29410-29417	control	_	
194-8	29417-29418	:	_	
194-9	29419-29422	the	_	
194-10	29423-29427	role	_	
194-11	29428-29430	of	_	
194-12	29431-29441	prefrontal	_	
194-13	29442-29448	cortex	_	
194-14	29449-29451	in	_	
194-15	29452-29458	action	_	
194-16	29459-29468	selection	_	
194-17	29468-29469	,	_	
194-18	29470-29478	response	_	
194-19	29479-29489	inhibition	_	
194-20	29489-29490	,	_	
194-21	29491-29502	performance	_	
194-22	29503-29513	monitoring	_	
194-23	29513-29514	,	_	
194-24	29515-29518	and	_	
194-25	29519-29531	reward-based	_	
194-26	29532-29540	learning	_	
194-27	29541-29547	Dorsal	_	
194-28	29548-29556	anterior	_	
194-29	29557-29566	cingulate	_	
194-30	29567-29573	cortex	_	
194-31	29574-29577	and	_	
194-32	29578-29581	the	_	
194-33	29582-29587	value	_	
194-34	29588-29590	of	_	
194-35	29591-29598	control	_	
194-36	29599-29607	Adaptive	_	
194-37	29608-29616	decision	_	
194-38	29617-29623	making	_	
194-39	29624-29627	and	_	
194-40	29628-29633	value	_	
194-41	29634-29636	in	_	
194-42	29637-29640	the	_	
194-43	29641-29649	anterior	_	
194-44	29650-29659	cingulate	_	
194-45	29660-29666	cortex	_	
194-46	29667-29673	Dorsal	_	
194-47	29674-29682	Anterior	_	
194-48	29683-29692	Cingulate	_	
194-49	29693-29699	Cortex	_	
194-50	29699-29700	:	_	
194-51	29701-29702	A	_	
194-52	29703-29712	Bottom-Up	_	
194-53	29713-29717	View	_	
194-54	29718-29729	Connections	_	
194-55	29730-29740	underlying	_	
194-56	29741-29744	the	_	
194-57	29745-29754	synthesis	_	
194-58	29755-29757	of	_	
194-59	29758-29767	cognition	_	
194-60	29767-29768	,	_	
194-61	29769-29775	memory	_	
194-62	29775-29776	,	_	
194-63	29777-29780	and	_	
194-64	29781-29788	emotion	_	
194-65	29789-29791	in	_	
194-66	29792-29799	primate	_	
194-67	29800-29810	prefrontal	_	
194-68	29811-29819	cortices	_	
194-69	29821-29829	Conflict	_	
194-70	29830-29840	monitoring	_	
194-71	29841-29844	and	_	
194-72	29845-29853	decision	_	
194-73	29854-29860	making	_	
194-74	29860-29861	:	_	
194-75	29862-29873	reconciling	_	
194-76	29874-29877	two	_	
194-77	29878-29890	perspectives	_	
194-78	29891-29893	on	_	
194-79	29894-29902	anterior	_	
194-80	29903-29912	cingulate	_	
194-81	29913-29921	function	_	
194-82	29922-29930	Anterior	_	
194-83	29931-29940	cingulate	_	
194-84	29941-29947	cortex	_	
194-85	29948-29951	and	_	
194-86	29952-29960	conflict	_	
194-87	29961-29970	detection	_	
194-88	29970-29971	:	_	
194-89	29972-29974	an	_	
194-90	29975-29981	update	_	
194-91	29982-29984	of	_	
194-92	29985-29991	theory	_	
194-93	29992-29995	and	_	
194-94	29996-30000	data	_	
194-95	30002-30009	Effects	_	
194-96	30010-30012	of	_	
194-97	30013-30020	alcohol	_	
194-98	30021-30033	intoxication	_	
194-99	30034-30037	and	_	
194-100	30038-30044	gender	_	
194-101	30045-30047	on	_	
194-102	30048-30056	cerebral	_	
194-103	30057-30066	perfusion	_	
194-104	30066-30067	:	_	
194-105	30068-30070	an	_	
194-106	30071-30079	arterial	_	
194-107	30080-30084	spin	_	
194-108	30085-30093	labeling	_	
194-109	30094-30099	study	_	
194-110	30100-30103	The	_	
194-111	30104-30108	role	_	
194-112	30109-30111	of	_	
194-113	30112-30117	phase	_	
194-114	30118-30133	synchronization	_	
194-115	30134-30136	in	_	
194-116	30137-30143	memory	_	
194-117	30144-30153	processes	_	
194-118	30154-30163	Measuring	_	
194-119	30164-30169	phase	_	
194-120	30170-30179	synchrony	_	
194-121	30180-30182	in	_	
194-122	30183-30188	brain	_	
194-123	30189-30196	signals	_	
194-124	30197-30204	Frontal	_	
194-125	30205-30210	theta	_	
194-126	30211-30213	as	_	
194-127	30214-30215	a	_	
194-128	30216-30225	mechanism	_	
194-129	30226-30229	for	_	
194-130	30230-30239	cognitive	_	
194-131	30240-30247	control	_	
194-132	30248-30255	Control	_	
194-133	30256-30266	mechanisms	_	
194-134	30267-30269	in	_	
194-135	30270-30277	working	_	
194-136	30278-30284	memory	_	
194-137	30284-30285	:	_	
194-138	30286-30287	a	_	
194-139	30288-30296	possible	_	
194-140	30297-30305	function	_	
194-141	30306-30308	of	_	
194-142	30309-30312	EEG	_	
194-143	30313-30318	theta	_	
194-144	30319-30331	oscillations	_	
194-145	30332-30341	Responses	_	
194-146	30342-30344	of	_	
194-147	30345-30350	human	_	
194-148	30351-30359	anterior	_	
194-149	30360-30369	cingulate	_	
194-150	30370-30376	cortex	_	
194-151	30377-30389	microdomains	_	
194-152	30390-30392	to	_	
194-153	30393-30398	error	_	
194-154	30399-30408	detection	_	
194-155	30408-30409	,	_	
194-156	30410-30418	conflict	_	
194-157	30419-30429	monitoring	_	
194-158	30429-30430	,	_	
194-159	30431-30448	stimulus-response	_	
194-160	30449-30456	mapping	_	
194-161	30456-30457	,	_	
194-162	30458-30469	familiarity	_	
194-163	30469-30470	,	_	
194-164	30471-30474	and	_	
194-165	30475-30484	orienting	_	
194-166	30485-30492	Laminar	_	
194-167	30493-30500	profile	_	
194-168	30501-30503	of	_	
194-169	30504-30515	spontaneous	_	
194-170	30516-30519	and	_	
194-171	30520-30526	evoked	_	
194-172	30527-30532	theta	_	
194-173	30532-30533	:	_	
194-174	30534-30542	Rhythmic	_	
194-175	30543-30553	modulation	_	
194-176	30554-30556	of	_	
194-177	30557-30565	cortical	_	
194-178	30566-30576	processing	_	
194-179	30577-30583	during	_	
194-180	30584-30588	word	_	
194-181	30589-30600	integration	_	
194-182	30601-30608	Alcohol	_	
194-183	30609-30613	hits	_	
194-184	30614-30617	you	_	
194-185	30618-30622	when	_	
194-186	30623-30625	it	_	
194-187	30626-30628	is	_	
194-188	30629-30633	hard	_	
194-189	30633-30634	:	_	
194-190	30635-30647	Intoxication	_	
194-191	30647-30648	,	_	
194-192	30649-30653	task	_	
194-193	30654-30664	difficulty	_	
194-194	30664-30665	,	_	
194-195	30666-30669	and	_	
194-196	30670-30675	theta	_	
194-197	30676-30681	brain	_	
194-198	30682-30694	oscillations	_	
194-199	30695-30700	Theta	_	
194-200	30701-30713	oscillations	_	
194-201	30714-30717	are	_	
194-202	30718-30727	sensitive	_	
194-203	30728-30730	to	_	
194-204	30731-30735	both	_	
194-205	30736-30741	early	_	
194-206	30742-30745	and	_	
194-207	30746-30750	late	_	
194-208	30751-30759	conflict	_	
194-209	30760-30770	processing	_	
194-210	30771-30777	stages	_	
194-211	30777-30778	:	_	
194-212	30779-30786	effects	_	
194-213	30787-30789	of	_	
194-214	30790-30797	alcohol	_	
194-215	30798-30810	intoxication	_	
194-216	30811-30824	Event-related	_	
194-217	30825-30830	theta	_	
194-218	30831-30836	power	_	
194-219	30837-30843	during	_	
194-220	30844-30860	lexical-semantic	_	
194-221	30861-30870	retrieval	_	
194-222	30871-30874	and	_	
194-223	30875-30883	decision	_	
194-224	30884-30892	conflict	_	
194-225	30893-30895	is	_	
194-226	30896-30905	modulated	_	
194-227	30906-30908	by	_	
194-228	30909-30916	alcohol	_	
194-229	30917-30929	intoxication	_	
194-230	30929-30930	:	_	
194-231	30931-30955	Anatomically-constrained	_	
194-232	30956-30959	MEG	_	
194-233	30960-30964	When	_	
194-234	30965-30968	the	_	
194-235	30969-30974	brain	_	
194-236	30975-30982	changes	_	
194-237	30983-30986	its	_	
194-238	30987-30991	mind	_	
194-239	30991-30992	:	_	
194-240	30993-31004	Oscillatory	_	
194-241	31005-31013	dynamics	_	
194-242	31014-31016	of	_	
194-243	31017-31025	conflict	_	
194-244	31026-31036	processing	_	
194-245	31037-31040	and	_	
194-246	31041-31049	response	_	
194-247	31050-31059	switching	_	
194-248	31060-31062	in	_	
194-249	31063-31064	a	_	
194-250	31065-31072	flanker	_	
194-251	31073-31077	task	_	
194-252	31078-31084	during	_	
194-253	31085-31092	alcohol	_	
194-254	31093-31102	challenge	_	
194-255	31103-31110	Alcohol	_	
194-256	31110-31111	:	_	
194-257	31112-31119	effects	_	
194-258	31120-31122	on	_	
194-259	31123-31138	neurobehavioral	_	
194-260	31139-31148	functions	_	
194-261	31149-31152	and	_	
194-262	31153-31156	the	_	
194-263	31157-31162	brain	_	
194-264	31163-31172	Executive	_	
194-265	31173-31182	Functions	_	
194-266	31182-31183	,	_	
194-267	31184-31190	Memory	_	
194-268	31190-31191	,	_	
194-269	31192-31195	and	_	
194-270	31196-31202	Social	_	
194-271	31203-31212	Cognitive	_	
194-272	31213-31221	Deficits	_	
194-273	31222-31225	and	_	
194-274	31226-31234	Recovery	_	
194-275	31235-31237	in	_	
194-276	31238-31245	Chronic	_	
194-277	31246-31256	Alcoholism	_	
194-278	31256-31257	:	_	
194-279	31258-31259	A	_	
194-280	31260-31268	Critical	_	
194-281	31269-31275	Review	_	
194-282	31276-31278	to	_	
194-283	31279-31285	Inform	_	
194-284	31286-31292	Future	_	
194-285	31293-31301	Research	_	
194-286	31302-31307	Acute	_	
194-287	31308-31315	alcohol	_	
194-288	31316-31328	intoxication	_	
194-289	31329-31336	impairs	_	
194-290	31337-31345	top-down	_	
194-291	31346-31356	regulation	_	
194-292	31357-31359	of	_	
194-293	31360-31366	Stroop	_	
194-294	31367-31378	incongruity	_	
194-295	31379-31381	as	_	
194-296	31382-31390	revealed	_	
194-297	31391-31393	by	_	
194-298	31394-31399	blood	_	
194-299	31400-31406	oxygen	_	
194-300	31407-31422	level-dependent	_	
194-301	31423-31433	functional	_	
194-302	31434-31442	magnetic	_	
194-303	31443-31452	resonance	_	
194-304	31453-31460	imaging	_	
194-305	31461-31468	Effects	_	
194-306	31469-31471	of	_	
194-307	31472-31477	acute	_	
194-308	31478-31485	alcohol	_	
194-309	31486-31498	intoxication	_	
194-310	31499-31501	on	_	
194-311	31502-31510	saccadic	_	
194-312	31511-31519	conflict	_	
194-313	31520-31523	and	_	
194-314	31524-31529	error	_	
194-315	31530-31540	processing	_	
194-316	31541-31546	Acute	_	
194-317	31547-31554	alcohol	_	
194-318	31555-31562	effects	_	
194-319	31563-31565	on	_	
194-320	31566-31576	inhibitory	_	
194-321	31577-31584	control	_	
194-322	31585-31588	and	_	
194-323	31589-31597	implicit	_	
194-324	31598-31607	cognition	_	
194-325	31607-31608	:	_	
194-326	31609-31621	implications	_	
194-327	31622-31625	for	_	
194-328	31626-31630	loss	_	
194-329	31631-31633	of	_	
194-330	31634-31641	control	_	
194-331	31642-31646	over	_	
194-332	31647-31655	drinking	_	
194-333	31656-31660	Drug	_	
194-334	31661-31666	abuse	_	
194-335	31667-31669	as	_	
194-336	31670-31671	a	_	
194-337	31672-31679	problem	_	
194-338	31680-31682	of	_	
194-339	31683-31691	impaired	_	
194-340	31692-31699	control	_	
194-341	31699-31700	:	_	
194-342	31701-31708	current	_	
194-343	31709-31719	approaches	_	
194-344	31720-31723	and	_	
194-345	31724-31732	findings	_	
194-346	31733-31745	Epidemiology	_	
194-347	31746-31749	and	_	
194-348	31750-31762	consequences	_	
194-349	31763-31765	of	_	
194-350	31766-31774	drinking	_	
194-351	31775-31778	and	_	
194-352	31779-31786	driving	_	
194-353	31787-31788	A	_	
194-354	31789-31806	self-administered	_	
194-355	31807-31812	Short	_	
194-356	31813-31821	Michigan	_	
194-357	31822-31832	Alcoholism	_	
194-358	31833-31842	Screening	_	
194-359	31843-31847	Test	_	
194-360	31848-31849	(	_	
194-361	31849-31854	SMAST	_	
194-362	31854-31855	)	_	
194-363	31857-31867	Comparison	_	
194-364	31868-31870	of	_	
194-365	31871-31877	direct	_	
194-366	31878-31887	interview	_	
194-367	31888-31891	and	_	
194-368	31892-31898	family	_	
194-369	31899-31906	history	_	
194-370	31907-31916	diagnoses	_	
194-371	31917-31919	of	_	
194-372	31920-31927	alcohol	_	
194-373	31928-31938	dependence	_	
194-374	31940-31953	Impulsiveness	_	
194-375	31954-31957	and	_	
194-376	31958-31973	venturesomeness	_	
194-377	31973-31974	:	_	
194-378	31975-31980	their	_	
194-379	31981-31989	position	_	
194-380	31990-31992	in	_	
194-381	31993-31994	a	_	
194-382	31995-32006	dimensional	_	
194-383	32007-32013	system	_	
194-384	32014-32016	of	_	
194-385	32017-32028	personality	_	
194-386	32029-32040	description	_	
194-387	32042-32053	Development	_	
194-388	32054-32057	and	_	
194-389	32058-32068	validation	_	
194-390	32069-32071	of	_	
194-391	32072-32075	the	_	
194-392	32076-32084	Biphasic	_	
194-393	32085-32092	Alcohol	_	
194-394	32093-32100	Effects	_	
194-395	32101-32106	Scale	_	
194-396	32107-32117	Functional	_	
194-397	32118-32125	Mapping	_	
194-398	32126-32130	with	_	
194-399	32131-32143	Simultaneous	_	
194-400	32144-32147	MEG	_	
194-401	32148-32151	and	_	
194-402	32152-32155	EEG	_	
194-403	32156-32163	Mapping	_	
194-404	32164-32172	cortical	_	
194-405	32173-32181	dynamics	_	
194-406	32182-32187	using	_	
194-407	32188-32200	simultaneous	_	
194-408	32201-32204	MEG	_	
194-409	32204-32205	/	_	
194-410	32205-32208	EEG	_	
194-411	32209-32212	and	_	
194-412	32213-32237	anatomically-constrained	_	
194-413	32238-32250	minimum-norm	_	
194-414	32251-32260	estimates	_	
194-415	32260-32261	:	_	
194-416	32262-32264	an	_	
194-417	32265-32273	auditory	_	
194-418	32274-32283	attention	_	
194-419	32284-32291	example	_	
194-420	32292-32295	How	_	
194-421	32296-32298	to	_	
194-422	32299-32305	detect	_	
194-423	32306-32314	amygdala	_	
194-424	32315-32323	activity	_	
194-425	32324-32328	with	_	
194-426	32329-32351	magnetoencephalography	_	
194-427	32352-32357	using	_	
194-428	32358-32364	source	_	
194-429	32365-32372	imaging	_	
194-430	32373-32379	Gender	_	
194-431	32380-32383	and	_	
194-432	32384-32391	alcohol	_	
194-433	32392-32398	dosing	_	
194-434	32398-32399	:	_	
194-435	32400-32401	a	_	
194-436	32402-32411	procedure	_	
194-437	32412-32415	for	_	
194-438	32416-32425	producing	_	
194-439	32426-32436	comparable	_	
194-440	32437-32443	breath	_	
194-441	32444-32451	alcohol	_	
194-442	32452-32458	curves	_	
194-443	32459-32462	for	_	
194-444	32463-32466	men	_	
194-445	32467-32470	and	_	
194-446	32471-32476	women	_	
194-447	32477-32481	Head	_	
194-448	32482-32490	position	_	
194-449	32491-32493	in	_	
194-450	32494-32497	the	_	
194-451	32498-32501	MEG	_	
194-452	32502-32508	helmet	_	
194-453	32509-32516	affects	_	
194-454	32517-32520	the	_	
194-455	32521-32532	sensitivity	_	
194-456	32533-32535	to	_	
194-457	32536-32544	anterior	_	
194-458	32545-32552	sources	_	
194-459	32553-32561	Improved	_	
194-460	32562-32574	localization	_	
194-461	32575-32577	of	_	
194-462	32578-32586	cortical	_	
194-463	32587-32595	activity	_	
194-464	32596-32598	by	_	
194-465	32599-32608	combining	_	
194-466	32609-32612	EEG	_	
194-467	32613-32616	and	_	
194-468	32617-32620	MEG	_	
194-469	32621-32625	with	_	
194-470	32626-32629	MRI	_	
194-471	32630-32638	cortical	_	
194-472	32639-32646	surface	_	
194-473	32647-32661	reconstruction	_	
194-474	32661-32662	:	_	
194-475	32663-32664	A	_	
194-476	32665-32671	linear	_	
194-477	32672-32680	approach	_	
194-478	32681-32689	Cortical	_	
194-479	32690-32703	surface-based	_	
194-480	32704-32712	analysis	_	
194-481	32712-32713	.	_	

#Text=I.
195-1	32714-32715	I	_	
195-2	32715-32716	.	_	

#Text=Segmentation and surface reconstruction
#Text=Cortical surface-based analysis.
196-1	32717-32729	Segmentation	_	
196-2	32730-32733	and	_	
196-3	32734-32741	surface	_	
196-4	32742-32756	reconstruction	_	
196-5	32757-32765	Cortical	_	
196-6	32766-32779	surface-based	_	
196-7	32780-32788	analysis	_	
196-8	32788-32789	.	_	

#Text=II: Inflation, flattening, and a surface-based coordinate system
#Text=OpenMEEG: opensource software for quasistatic bioelectromagnetics
#Text=A common formalism for the integral formulations of the forward EEG problem
#Text=Dynamic statistical parametric mapping: combining fMRI and MEG for high-resolution imaging of cortical activity
#Text=Spatiotemporal dynamics of word processing in the human cortex
#Text=FieldTrip: Open source software for advanced analysis of MEG, EEG, and invasive electrophysiological data
#Text=EEGLAB: An open source toolbox for analysis of single-trial EEG dynamics
#Text=MNE software for processing MEG and EEG data
#Text=Spectral spatiotemporal imaging of cortical oscillations and interactions in the human brain
#Text=High-resolution intersubject averaging and a coordinate system for the cortical surface
#Text=Nonparametric statistical testing of EEG- and MEG-data
#Text=Spatiotemporal dynamics of modality-specific and supramodal word processing
#Text=Cognition and medial frontal cortex in health and disease
#Text=Optimal decision making and the anterior cingulate cortex
#Text=Inhibition and the right inferior frontal cortex: one decade on
#Text=A functional network perspective on response inhibition and attentional control
#Text=The cognitive neuroscience of working memory
#Text=Theta rhythm and the encoding and retrieval of space and time
#Text=Theta-activity in anterior cingulate cortex predicts task rules and their adjustments following errors
#Text=A mechanism for cognitive dynamics: neuronal communication through neuronal coherence
#Text=High gamma power is phase-locked to theta oscillations in human neocortex
#Text=The brainweb: phase synchronization and large-scale integration
#Text=The electrophysiological dynamics of interference during the Stroop task
#Text=Meta-analytic evidence for a superordinate cognitive control network subserving diverse executive functions
#Text=Functional Characterization of the Cingulo-Opercular Network in the Maintenance of Tonic Alertness
#Text=A dual-networks architecture of top-down control
#Text=The economy of brain network organization
#Text=The connectomics of brain disorders
#Text=Functional imaging of cognitive control during acute alcohol intoxication
#Text=Family history of alcoholism interacts with alcohol to affect brain regions involved in behavioral inhibition
#Text=fMRI differences between subjects with low and high responses to alcohol during a stop signal task
#Text=Alcohol affects neuronal substrates of response inhibition but not of perceptual processing of stimuli signalling a stop response
#Text=Alcohol-induced impairment of inhibitory control is linked to attenuated brain responses in right fronto-temporal cortex
#Text=Ethanol reduces the phase locking of neural activity in human and rodent brain
#Text=Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
#Text=Stroop task combines color naming and reading.
197-1	32790-32792	II	_	
197-2	32792-32793	:	_	
197-3	32794-32803	Inflation	_	
197-4	32803-32804	,	_	
197-5	32805-32815	flattening	_	
197-6	32815-32816	,	_	
197-7	32817-32820	and	_	
197-8	32821-32822	a	_	
197-9	32823-32836	surface-based	_	
197-10	32837-32847	coordinate	_	
197-11	32848-32854	system	_	
197-12	32855-32863	OpenMEEG	_	
197-13	32863-32864	:	_	
197-14	32865-32875	opensource	_	
197-15	32876-32884	software	_	
197-16	32885-32888	for	_	
197-17	32889-32900	quasistatic	_	
197-18	32901-32920	bioelectromagnetics	_	
197-19	32921-32922	A	_	
197-20	32923-32929	common	_	
197-21	32930-32939	formalism	_	
197-22	32940-32943	for	_	
197-23	32944-32947	the	_	
197-24	32948-32956	integral	_	
197-25	32957-32969	formulations	_	
197-26	32970-32972	of	_	
197-27	32973-32976	the	_	
197-28	32977-32984	forward	_	
197-29	32985-32988	EEG	_	
197-30	32989-32996	problem	_	
197-31	32997-33004	Dynamic	_	
197-32	33005-33016	statistical	_	
197-33	33017-33027	parametric	_	
197-34	33028-33035	mapping	_	
197-35	33035-33036	:	_	
197-36	33037-33046	combining	_	
197-37	33047-33051	fMRI	_	
197-38	33052-33055	and	_	
197-39	33056-33059	MEG	_	
197-40	33060-33063	for	_	
197-41	33064-33079	high-resolution	_	
197-42	33080-33087	imaging	_	
197-43	33088-33090	of	_	
197-44	33091-33099	cortical	_	
197-45	33100-33108	activity	_	
197-46	33109-33123	Spatiotemporal	_	
197-47	33124-33132	dynamics	_	
197-48	33133-33135	of	_	
197-49	33136-33140	word	_	
197-50	33141-33151	processing	_	
197-51	33152-33154	in	_	
197-52	33155-33158	the	_	
197-53	33159-33164	human	_	
197-54	33165-33171	cortex	_	
197-55	33172-33181	FieldTrip	_	
197-56	33181-33182	:	_	
197-57	33183-33187	Open	_	
197-58	33188-33194	source	_	
197-59	33195-33203	software	_	
197-60	33204-33207	for	_	
197-61	33208-33216	advanced	_	
197-62	33217-33225	analysis	_	
197-63	33226-33228	of	_	
197-64	33229-33232	MEG	_	
197-65	33232-33233	,	_	
197-66	33234-33237	EEG	_	
197-67	33237-33238	,	_	
197-68	33239-33242	and	_	
197-69	33243-33251	invasive	_	
197-70	33252-33272	electrophysiological	_	
197-71	33273-33277	data	_	
197-72	33278-33284	EEGLAB	_	
197-73	33284-33285	:	_	
197-74	33286-33288	An	_	
197-75	33289-33293	open	_	
197-76	33294-33300	source	_	
197-77	33301-33308	toolbox	_	
197-78	33309-33312	for	_	
197-79	33313-33321	analysis	_	
197-80	33322-33324	of	_	
197-81	33325-33337	single-trial	_	
197-82	33338-33341	EEG	_	
197-83	33342-33350	dynamics	_	
197-84	33351-33354	MNE	_	
197-85	33355-33363	software	_	
197-86	33364-33367	for	_	
197-87	33368-33378	processing	_	
197-88	33379-33382	MEG	_	
197-89	33383-33386	and	_	
197-90	33387-33390	EEG	_	
197-91	33391-33395	data	_	
197-92	33396-33404	Spectral	_	
197-93	33405-33419	spatiotemporal	_	
197-94	33420-33427	imaging	_	
197-95	33428-33430	of	_	
197-96	33431-33439	cortical	_	
197-97	33440-33452	oscillations	_	
197-98	33453-33456	and	_	
197-99	33457-33469	interactions	_	
197-100	33470-33472	in	_	
197-101	33473-33476	the	_	
197-102	33477-33482	human	_	
197-103	33483-33488	brain	_	
197-104	33489-33504	High-resolution	_	
197-105	33505-33517	intersubject	_	
197-106	33518-33527	averaging	_	
197-107	33528-33531	and	_	
197-108	33532-33533	a	_	
197-109	33534-33544	coordinate	_	
197-110	33545-33551	system	_	
197-111	33552-33555	for	_	
197-112	33556-33559	the	_	
197-113	33560-33568	cortical	_	
197-114	33569-33576	surface	_	
197-115	33577-33590	Nonparametric	_	
197-116	33591-33602	statistical	_	
197-117	33603-33610	testing	_	
197-118	33611-33613	of	_	
197-119	33614-33617	EEG	_	
197-120	33617-33618	-	_	
197-121	33619-33622	and	_	
197-122	33623-33631	MEG-data	_	
197-123	33632-33646	Spatiotemporal	_	
197-124	33647-33655	dynamics	_	
197-125	33656-33658	of	_	
197-126	33659-33676	modality-specific	_	
197-127	33677-33680	and	_	
197-128	33681-33691	supramodal	_	
197-129	33692-33696	word	_	
197-130	33697-33707	processing	_	
197-131	33708-33717	Cognition	_	
197-132	33718-33721	and	_	
197-133	33722-33728	medial	_	
197-134	33729-33736	frontal	_	
197-135	33737-33743	cortex	_	
197-136	33744-33746	in	_	
197-137	33747-33753	health	_	
197-138	33754-33757	and	_	
197-139	33758-33765	disease	_	
197-140	33766-33773	Optimal	_	
197-141	33774-33782	decision	_	
197-142	33783-33789	making	_	
197-143	33790-33793	and	_	
197-144	33794-33797	the	_	
197-145	33798-33806	anterior	_	
197-146	33807-33816	cingulate	_	
197-147	33817-33823	cortex	_	
197-148	33824-33834	Inhibition	_	
197-149	33835-33838	and	_	
197-150	33839-33842	the	_	
197-151	33843-33848	right	_	
197-152	33849-33857	inferior	_	
197-153	33858-33865	frontal	_	
197-154	33866-33872	cortex	_	
197-155	33872-33873	:	_	
197-156	33874-33877	one	_	
197-157	33878-33884	decade	_	
197-158	33885-33887	on	_	
197-159	33888-33889	A	_	
197-160	33890-33900	functional	_	
197-161	33901-33908	network	_	
197-162	33909-33920	perspective	_	
197-163	33921-33923	on	_	
197-164	33924-33932	response	_	
197-165	33933-33943	inhibition	_	
197-166	33944-33947	and	_	
197-167	33948-33959	attentional	_	
197-168	33960-33967	control	_	
197-169	33968-33971	The	_	
197-170	33972-33981	cognitive	_	
197-171	33982-33994	neuroscience	_	
197-172	33995-33997	of	_	
197-173	33998-34005	working	_	
197-174	34006-34012	memory	_	
197-175	34013-34018	Theta	_	
197-176	34019-34025	rhythm	_	
197-177	34026-34029	and	_	
197-178	34030-34033	the	_	
197-179	34034-34042	encoding	_	
197-180	34043-34046	and	_	
197-181	34047-34056	retrieval	_	
197-182	34057-34059	of	_	
197-183	34060-34065	space	_	
197-184	34066-34069	and	_	
197-185	34070-34074	time	_	
197-186	34075-34089	Theta-activity	_	
197-187	34090-34092	in	_	
197-188	34093-34101	anterior	_	
197-189	34102-34111	cingulate	_	
197-190	34112-34118	cortex	_	
197-191	34119-34127	predicts	_	
197-192	34128-34132	task	_	
197-193	34133-34138	rules	_	
197-194	34139-34142	and	_	
197-195	34143-34148	their	_	
197-196	34149-34160	adjustments	_	
197-197	34161-34170	following	_	
197-198	34171-34177	errors	_	
197-199	34178-34179	A	_	
197-200	34180-34189	mechanism	_	
197-201	34190-34193	for	_	
197-202	34194-34203	cognitive	_	
197-203	34204-34212	dynamics	_	
197-204	34212-34213	:	_	
197-205	34214-34222	neuronal	_	
197-206	34223-34236	communication	_	
197-207	34237-34244	through	_	
197-208	34245-34253	neuronal	_	
197-209	34254-34263	coherence	_	
197-210	34264-34268	High	_	
197-211	34269-34274	gamma	_	
197-212	34275-34280	power	_	
197-213	34281-34283	is	_	
197-214	34284-34296	phase-locked	_	
197-215	34297-34299	to	_	
197-216	34300-34305	theta	_	
197-217	34306-34318	oscillations	_	
197-218	34319-34321	in	_	
197-219	34322-34327	human	_	
197-220	34328-34337	neocortex	_	
197-221	34338-34341	The	_	
197-222	34342-34350	brainweb	_	
197-223	34350-34351	:	_	
197-224	34352-34357	phase	_	
197-225	34358-34373	synchronization	_	
197-226	34374-34377	and	_	
197-227	34378-34389	large-scale	_	
197-228	34390-34401	integration	_	
197-229	34402-34405	The	_	
197-230	34406-34426	electrophysiological	_	
197-231	34427-34435	dynamics	_	
197-232	34436-34438	of	_	
197-233	34439-34451	interference	_	
197-234	34452-34458	during	_	
197-235	34459-34462	the	_	
197-236	34463-34469	Stroop	_	
197-237	34470-34474	task	_	
197-238	34475-34488	Meta-analytic	_	
197-239	34489-34497	evidence	_	
197-240	34498-34501	for	_	
197-241	34502-34503	a	_	
197-242	34504-34517	superordinate	_	
197-243	34518-34527	cognitive	_	
197-244	34528-34535	control	_	
197-245	34536-34543	network	_	
197-246	34544-34554	subserving	_	
197-247	34555-34562	diverse	_	
197-248	34563-34572	executive	_	
197-249	34573-34582	functions	_	
197-250	34583-34593	Functional	_	
197-251	34594-34610	Characterization	_	
197-252	34611-34613	of	_	
197-253	34614-34617	the	_	
197-254	34618-34635	Cingulo-Opercular	_	
197-255	34636-34643	Network	_	
197-256	34644-34646	in	_	
197-257	34647-34650	the	_	
197-258	34651-34662	Maintenance	_	
197-259	34663-34665	of	_	
197-260	34666-34671	Tonic	_	
197-261	34672-34681	Alertness	_	
197-262	34682-34683	A	_	
197-263	34684-34697	dual-networks	_	
197-264	34698-34710	architecture	_	
197-265	34711-34713	of	_	
197-266	34714-34722	top-down	_	
197-267	34723-34730	control	_	
197-268	34731-34734	The	_	
197-269	34735-34742	economy	_	
197-270	34743-34745	of	_	
197-271	34746-34751	brain	_	
197-272	34752-34759	network	_	
197-273	34760-34772	organization	_	
197-274	34773-34776	The	_	
197-275	34777-34789	connectomics	_	
197-276	34790-34792	of	_	
197-277	34793-34798	brain	_	
197-278	34799-34808	disorders	_	
197-279	34809-34819	Functional	_	
197-280	34820-34827	imaging	_	
197-281	34828-34830	of	_	
197-282	34831-34840	cognitive	_	
197-283	34841-34848	control	_	
197-284	34849-34855	during	_	
197-285	34856-34861	acute	_	
197-286	34862-34869	alcohol	_	
197-287	34870-34882	intoxication	_	
197-288	34883-34889	Family	_	
197-289	34890-34897	history	_	
197-290	34898-34900	of	_	
197-291	34901-34911	alcoholism	_	
197-292	34912-34921	interacts	_	
197-293	34922-34926	with	_	
197-294	34927-34934	alcohol	_	
197-295	34935-34937	to	_	
197-296	34938-34944	affect	_	
197-297	34945-34950	brain	_	
197-298	34951-34958	regions	_	
197-299	34959-34967	involved	_	
197-300	34968-34970	in	_	
197-301	34971-34981	behavioral	_	
197-302	34982-34992	inhibition	_	
197-303	34993-34997	fMRI	_	
197-304	34998-35009	differences	_	
197-305	35010-35017	between	_	
197-306	35018-35026	subjects	_	
197-307	35027-35031	with	_	
197-308	35032-35035	low	_	
197-309	35036-35039	and	_	
197-310	35040-35044	high	_	
197-311	35045-35054	responses	_	
197-312	35055-35057	to	_	
197-313	35058-35065	alcohol	_	
197-314	35066-35072	during	_	
197-315	35073-35074	a	_	
197-316	35075-35079	stop	_	
197-317	35080-35086	signal	_	
197-318	35087-35091	task	_	
197-319	35092-35099	Alcohol	_	
197-320	35100-35107	affects	_	
197-321	35108-35116	neuronal	_	
197-322	35117-35127	substrates	_	
197-323	35128-35130	of	_	
197-324	35131-35139	response	_	
197-325	35140-35150	inhibition	_	
197-326	35151-35154	but	_	
197-327	35155-35158	not	_	
197-328	35159-35161	of	_	
197-329	35162-35172	perceptual	_	
197-330	35173-35183	processing	_	
197-331	35184-35186	of	_	
197-332	35187-35194	stimuli	_	
197-333	35195-35205	signalling	_	
197-334	35206-35207	a	_	
197-335	35208-35212	stop	_	
197-336	35213-35221	response	_	
197-337	35222-35237	Alcohol-induced	_	
197-338	35238-35248	impairment	_	
197-339	35249-35251	of	_	
197-340	35252-35262	inhibitory	_	
197-341	35263-35270	control	_	
197-342	35271-35273	is	_	
197-343	35274-35280	linked	_	
197-344	35281-35283	to	_	
197-345	35284-35294	attenuated	_	
197-346	35295-35300	brain	_	
197-347	35301-35310	responses	_	
197-348	35311-35313	in	_	
197-349	35314-35319	right	_	
197-350	35320-35335	fronto-temporal	_	
197-351	35336-35342	cortex	_	
197-352	35343-35350	Ethanol	_	
197-353	35351-35358	reduces	_	
197-354	35359-35362	the	_	
197-355	35363-35368	phase	_	
197-356	35369-35376	locking	_	
197-357	35377-35379	of	_	
197-358	35380-35386	neural	_	
197-359	35387-35395	activity	_	
197-360	35396-35398	in	_	
197-361	35399-35404	human	_	
197-362	35405-35408	and	_	
197-363	35409-35415	rodent	_	
197-364	35416-35421	brain	_	
197-365	35422-35433	Dysfunction	_	
197-366	35434-35436	of	_	
197-367	35437-35440	the	_	
197-368	35441-35451	prefrontal	_	
197-369	35452-35458	cortex	_	
197-370	35459-35461	in	_	
197-371	35462-35471	addiction	_	
197-372	35471-35472	:	_	
197-373	35473-35485	neuroimaging	_	
197-374	35486-35494	findings	_	
197-375	35495-35498	and	_	
197-376	35499-35507	clinical	_	
197-377	35508-35520	implications	_	
197-378	35521-35527	Stroop	_	
197-379	35528-35532	task	_	
197-380	35533-35541	combines	_	
197-381	35542-35547	color	_	
197-382	35548-35554	naming	_	
197-383	35555-35558	and	_	
197-384	35559-35566	reading	_	
197-385	35566-35567	.	_	

#Text=Trial examples for each of the three conditions along with the correct response color are presented.
198-1	35568-35573	Trial	_	
198-2	35574-35582	examples	_	
198-3	35583-35586	for	_	
198-4	35587-35591	each	_	
198-5	35592-35594	of	_	
198-6	35595-35598	the	_	
198-7	35599-35604	three	_	
198-8	35605-35615	conditions	_	
198-9	35616-35621	along	_	
198-10	35622-35626	with	_	
198-11	35627-35630	the	_	
198-12	35631-35638	correct	_	
198-13	35639-35647	response	_	
198-14	35648-35653	color	_	
198-15	35654-35657	are	_	
198-16	35658-35667	presented	_	
198-17	35667-35668	.	_	

#Text=In the congruent condition (CONG), font color is consistent with the word meaning, while incongruous trials (INC) elicit response conflict due to interference from word meaning.
199-1	35669-35671	In	_	
199-2	35672-35675	the	_	
199-3	35676-35685	congruent	_	
199-4	35686-35695	condition	_	
199-5	35696-35697	(	_	
199-6	35697-35701	CONG	_	
199-7	35701-35702	)	_	
199-8	35702-35703	,	_	
199-9	35704-35708	font	_	
199-10	35709-35714	color	_	
199-11	35715-35717	is	_	
199-12	35718-35728	consistent	_	
199-13	35729-35733	with	_	
199-14	35734-35737	the	_	
199-15	35738-35742	word	_	
199-16	35743-35750	meaning	_	
199-17	35750-35751	,	_	
199-18	35752-35757	while	_	
199-19	35758-35769	incongruous	_	
199-20	35770-35776	trials	_	
199-21	35777-35778	(	_	
199-22	35778-35781	INC	_	
199-23	35781-35782	)	_	
199-24	35783-35789	elicit	_	
199-25	35790-35798	response	_	
199-26	35799-35807	conflict	_	
199-27	35808-35811	due	_	
199-28	35812-35814	to	_	
199-29	35815-35827	interference	_	
199-30	35828-35832	from	_	
199-31	35833-35837	word	_	
199-32	35838-35845	meaning	_	
199-33	35845-35846	.	_	

#Text=Participants are instructed to press a button corresponding to the font color when words are written in color (CONG, INC) and to respond to the word meaning (Read) when they are written in gray.
200-1	35847-35859	Participants	_	
200-2	35860-35863	are	_	
200-3	35864-35874	instructed	_	
200-4	35875-35877	to	_	
200-5	35878-35883	press	_	
200-6	35884-35885	a	_	
200-7	35886-35892	button	_	
200-8	35893-35906	corresponding	_	
200-9	35907-35909	to	_	
200-10	35910-35913	the	_	
200-11	35914-35918	font	_	
200-12	35919-35924	color	_	
200-13	35925-35929	when	_	
200-14	35930-35935	words	_	
200-15	35936-35939	are	_	
200-16	35940-35947	written	_	
200-17	35948-35950	in	_	
200-18	35951-35956	color	_	
200-19	35957-35958	(	_	
200-20	35958-35962	CONG	_	
200-21	35962-35963	,	_	
200-22	35964-35967	INC	_	
200-23	35967-35968	)	_	
200-24	35969-35972	and	_	
200-25	35973-35975	to	_	
200-26	35976-35983	respond	_	
200-27	35984-35986	to	_	
200-28	35987-35990	the	_	
200-29	35991-35995	word	_	
200-30	35996-36003	meaning	_	
200-31	36004-36005	(	_	
200-32	36005-36009	Read	_	
200-33	36009-36010	)	_	
200-34	36011-36015	when	_	
200-35	36016-36020	they	_	
200-36	36021-36024	are	_	
200-37	36025-36032	written	_	
200-38	36033-36035	in	_	
200-39	36036-36040	gray	_	
200-40	36040-36041	.	_	

#Text=Trials are presented for 300 ms and then replaced by a fixation screen for 1700 ms.
201-1	36042-36048	Trials	_	
201-2	36049-36052	are	_	
201-3	36053-36062	presented	_	
201-4	36063-36066	for	_	
201-5	36067-36070	300	_	
201-6	36071-36073	ms	_	
201-7	36074-36077	and	_	
201-8	36078-36082	then	_	
201-9	36083-36091	replaced	_	
201-10	36092-36094	by	_	
201-11	36095-36096	a	_	
201-12	36097-36105	fixation	_	
201-13	36106-36112	screen	_	
201-14	36113-36116	for	_	
201-15	36117-36121	1700	_	
201-16	36122-36124	ms	_	
201-17	36124-36125	.	_	

#Text=Trial types are presented in a randomized order.
202-1	36126-36131	Trial	_	
202-2	36132-36137	types	_	
202-3	36138-36141	are	_	
202-4	36142-36151	presented	_	
202-5	36152-36154	in	_	
202-6	36155-36156	a	_	
202-7	36157-36167	randomized	_	
202-8	36168-36173	order	_	
202-9	36173-36174	.	_	

#Text=In this particular version, the CONG and INC conditions were equiprobable and were presented on 16.7% trials each out of 576 trials total.
203-1	36175-36177	In	_	
203-2	36178-36182	this	_	
203-3	36183-36193	particular	_	
203-4	36194-36201	version	_	
203-5	36201-36202	,	_	
203-6	36203-36206	the	_	
203-7	36207-36211	CONG	_	
203-8	36212-36215	and	_	
203-9	36216-36219	INC	_	
203-10	36220-36230	conditions	_	
203-11	36231-36235	were	_	
203-12	36236-36248	equiprobable	_	
203-13	36249-36252	and	_	
203-14	36253-36257	were	_	
203-15	36258-36267	presented	_	
203-16	36268-36270	on	_	
203-17	36271-36276	16.7%	_	
203-18	36277-36283	trials	_	
203-19	36284-36288	each	_	
203-20	36289-36292	out	_	
203-21	36293-36295	of	_	
203-22	36296-36299	576	_	
203-23	36300-36306	trials	_	
203-24	36307-36312	total	_	
203-25	36312-36313	.	_	

#Text=Co-registration of MEG and MRI.
204-1	36314-36329	Co-registration	_	
204-2	36330-36332	of	_	
204-3	36333-36336	MEG	_	
204-4	36337-36340	and	_	
204-5	36341-36344	MRI	_	
204-6	36344-36345	.	_	

#Text=Digitized points across the head collected during the MEG recording are used for co-registration with anatomical MRI images.
205-1	36346-36355	Digitized	_	
205-2	36356-36362	points	_	
205-3	36363-36369	across	_	
205-4	36370-36373	the	_	
205-5	36374-36378	head	_	
205-6	36379-36388	collected	_	
205-7	36389-36395	during	_	
205-8	36396-36399	the	_	
205-9	36400-36403	MEG	_	
205-10	36404-36413	recording	_	
205-11	36414-36417	are	_	
205-12	36418-36422	used	_	
205-13	36423-36426	for	_	
205-14	36427-36442	co-registration	_	
205-15	36443-36447	with	_	
205-16	36448-36458	anatomical	_	
205-17	36459-36462	MRI	_	
205-18	36463-36469	images	_	
205-19	36469-36470	.	_	

#Text=Morlet wavelet.
206-1	36471-36477	Morlet	_	
206-2	36478-36485	wavelet	_	
206-3	36485-36486	.	_	

#Text=Morlet wavelets are used to calculate complex power spectrum for each trial in 1 Hz frequency increments for the theta band frequency (4–7 Hz).
207-1	36487-36493	Morlet	_	
207-2	36494-36502	wavelets	_	
207-3	36503-36506	are	_	
207-4	36507-36511	used	_	
207-5	36512-36514	to	_	
207-6	36515-36524	calculate	_	
207-7	36525-36532	complex	_	
207-8	36533-36538	power	_	
207-9	36539-36547	spectrum	_	
207-10	36548-36551	for	_	
207-11	36552-36556	each	_	
207-12	36557-36562	trial	_	
207-13	36563-36565	in	_	
207-14	36566-36567	1	_	
207-15	36568-36570	Hz	_	
207-16	36571-36580	frequency	_	
207-17	36581-36591	increments	_	
207-18	36592-36595	for	_	
207-19	36596-36599	the	_	
207-20	36600-36605	theta	_	
207-21	36606-36610	band	_	
207-22	36611-36620	frequency	_	
207-23	36621-36622	(	_	
207-24	36622-36623	4	_	
207-25	36623-36624	–	_	
207-26	36624-36625	7	_	
207-27	36626-36628	Hz	_	
207-28	36628-36629	)	_	
207-29	36629-36630	.	_	

#Text=Cortical reconstruction and inflation.
208-1	36631-36639	Cortical	_	
208-2	36640-36654	reconstruction	_	
208-3	36655-36658	and	_	
208-4	36659-36668	inflation	_	
208-5	36668-36669	.	_	

#Text=Individual cortical surfaces are reconstructed using FreeSurfer and are used to constrain estimated source power.
209-1	36670-36680	Individual	_	
209-2	36681-36689	cortical	_	
209-3	36690-36698	surfaces	_	
209-4	36699-36702	are	_	
209-5	36703-36716	reconstructed	_	
209-6	36717-36722	using	_	
209-7	36723-36733	FreeSurfer	_	
209-8	36734-36737	and	_	
209-9	36738-36741	are	_	
209-10	36742-36746	used	_	
209-11	36747-36749	to	_	
209-12	36750-36759	constrain	_	
209-13	36760-36769	estimated	_	
209-14	36770-36776	source	_	
209-15	36777-36782	power	_	
209-16	36782-36783	.	_	

#Text=Here shown is an average cortical surface which is inflated to enhance visibility of the sources estimated to cortical sulci.
210-1	36784-36788	Here	_	
210-2	36789-36794	shown	_	
210-3	36795-36797	is	_	
210-4	36798-36800	an	_	
210-5	36801-36808	average	_	
210-6	36809-36817	cortical	_	
210-7	36818-36825	surface	_	
210-8	36826-36831	which	_	
210-9	36832-36834	is	_	
210-10	36835-36843	inflated	_	
210-11	36844-36846	to	_	
210-12	36847-36854	enhance	_	
210-13	36855-36865	visibility	_	
210-14	36866-36868	of	_	
210-15	36869-36872	the	_	
210-16	36873-36880	sources	_	
210-17	36881-36890	estimated	_	
210-18	36891-36893	to	_	
210-19	36894-36902	cortical	_	
210-20	36903-36908	sulci	_	
210-21	36908-36909	.	_	

#Text=Group-average timecourses of event-related theta source power estimates in selected regions of interest.
211-1	36910-36923	Group-average	_	
211-2	36924-36935	timecourses	_	
211-3	36936-36938	of	_	
211-4	36939-36952	event-related	_	
211-5	36953-36958	theta	_	
211-6	36959-36965	source	_	
211-7	36966-36971	power	_	
211-8	36972-36981	estimates	_	
211-9	36982-36984	in	_	
211-10	36985-36993	selected	_	
211-11	36994-37001	regions	_	
211-12	37002-37004	of	_	
211-13	37005-37013	interest	_	
211-14	37013-37014	.	_	

#Text=Incongruous stimuli (INC) elicited increased event-related theta power compared to congruent stimuli (CONG) in the anterior cingulate cortex (ACC; F(1,19) = 34.1, p < .0001) as well as the lateral prefrontal cortex (latPFC; F(1,19) = 11.0, p < .01), during 480–670 ms.
212-1	37015-37026	Incongruous	_	
212-2	37027-37034	stimuli	_	
212-3	37035-37036	(	_	
212-4	37036-37039	INC	_	
212-5	37039-37040	)	_	
212-6	37041-37049	elicited	_	
212-7	37050-37059	increased	_	
212-8	37060-37073	event-related	_	
212-9	37074-37079	theta	_	
212-10	37080-37085	power	_	
212-11	37086-37094	compared	_	
212-12	37095-37097	to	_	
212-13	37098-37107	congruent	_	
212-14	37108-37115	stimuli	_	
212-15	37116-37117	(	_	
212-16	37117-37121	CONG	_	
212-17	37121-37122	)	_	
212-18	37123-37125	in	_	
212-19	37126-37129	the	_	
212-20	37130-37138	anterior	_	
212-21	37139-37148	cingulate	_	
212-22	37149-37155	cortex	_	
212-23	37156-37157	(	_	
212-24	37157-37160	ACC	_	
212-25	37160-37161	;	_	
212-26	37162-37163	F	_	
212-27	37163-37164	(	_	
212-28	37164-37168	1,19	_	
212-29	37168-37169	)	_	
212-30	37170-37171	=	_	
212-31	37172-37176	34.1	_	
212-32	37176-37177	,	_	
212-33	37178-37179	p	_	
212-34	37180-37181	<	_	
212-35	37182-37187	.0001	_	
212-36	37187-37188	)	_	
212-37	37189-37191	as	_	
212-38	37192-37196	well	_	
212-39	37197-37199	as	_	
212-40	37200-37203	the	_	
212-41	37204-37211	lateral	_	
212-42	37212-37222	prefrontal	_	
212-43	37223-37229	cortex	_	
212-44	37230-37231	(	_	
212-45	37231-37237	latPFC	_	
212-46	37237-37238	;	_	
212-47	37239-37240	F	_	
212-48	37240-37241	(	_	
212-49	37241-37245	1,19	_	
212-50	37245-37246	)	_	
212-51	37247-37248	=	_	
212-52	37249-37253	11.0	_	
212-53	37253-37254	,	_	
212-54	37255-37256	p	_	
212-55	37257-37258	<	_	
212-56	37259-37262	.01	_	
212-57	37262-37263	)	_	
212-58	37263-37264	,	_	
212-59	37265-37271	during	_	
212-60	37272-37275	480	_	
212-61	37275-37276	–	_	
212-62	37276-37279	670	_	
212-63	37280-37282	ms	_	
212-64	37282-37283	.	_	

#Text=Conflict processing is particularly sensitive to alcohol intoxication as theta power to INC was attenuated by alcohol intoxication, F(1,19) = 9.9, p < .01).
213-1	37284-37292	Conflict	_	
213-2	37293-37303	processing	_	
213-3	37304-37306	is	_	
213-4	37307-37319	particularly	_	
213-5	37320-37329	sensitive	_	
213-6	37330-37332	to	_	
213-7	37333-37340	alcohol	_	
213-8	37341-37353	intoxication	_	
213-9	37354-37356	as	_	
213-10	37357-37362	theta	_	
213-11	37363-37368	power	_	
213-12	37369-37371	to	_	
213-13	37372-37375	INC	_	
213-14	37376-37379	was	_	
213-15	37380-37390	attenuated	_	
213-16	37391-37393	by	_	
213-17	37394-37401	alcohol	_	
213-18	37402-37414	intoxication	_	
213-19	37414-37415	,	_	
213-20	37416-37417	F	_	
213-21	37417-37418	(	_	
213-22	37418-37422	1,19	_	
213-23	37422-37423	)	_	
213-24	37424-37425	=	_	
213-25	37426-37429	9.9	_	
213-26	37429-37430	,	_	
213-27	37431-37432	p	_	
213-28	37433-37434	<	_	
213-29	37435-37438	.01	_	
213-30	37438-37439	)	_	
213-31	37439-37440	.	_	

#Text=The y-axis depicts baseline-corrected noise-normalized event-related theta source power.
214-1	37441-37444	The	_	
214-2	37445-37451	y-axis	_	
214-3	37452-37459	depicts	_	
214-4	37460-37478	baseline-corrected	_	
214-5	37479-37495	noise-normalized	_	
214-6	37496-37509	event-related	_	
214-7	37510-37515	theta	_	
214-8	37516-37522	source	_	
214-9	37523-37528	power	_	
214-10	37528-37529	.	_	

#Text=This figure has been modified from.
215-1	37530-37534	This	_	
215-2	37535-37541	figure	_	
215-3	37542-37545	has	_	
215-4	37546-37550	been	_	
215-5	37551-37559	modified	_	
215-6	37560-37564	from	_	
215-7	37564-37565	.	_	

#Text=Behavioral results on the Stroop task.
216-1	37566-37576	Behavioral	_	
216-2	37577-37584	results	_	
216-3	37585-37587	on	_	
216-4	37588-37591	the	_	
216-5	37592-37598	Stroop	_	
216-6	37599-37603	task	_	
216-7	37603-37604	.	_	

#Text=Stroop interference was reflected in decreased accuracy and longer response times to incongruous (INC) trials.
217-1	37605-37611	Stroop	_	
217-2	37612-37624	interference	_	
217-3	37625-37628	was	_	
217-4	37629-37638	reflected	_	
217-5	37639-37641	in	_	
217-6	37642-37651	decreased	_	
217-7	37652-37660	accuracy	_	
217-8	37661-37664	and	_	
217-9	37665-37671	longer	_	
217-10	37672-37680	response	_	
217-11	37681-37686	times	_	
217-12	37687-37689	to	_	
217-13	37690-37701	incongruous	_	
217-14	37702-37703	(	_	
217-15	37703-37706	INC	_	
217-16	37706-37707	)	_	
217-17	37708-37714	trials	_	
217-18	37714-37715	.	_	

#Text=Alcohol intoxication (Alc) impaired accuracy compared to placebo (Plac) but did not affect reaction times.
218-1	37716-37723	Alcohol	_	
218-2	37724-37736	intoxication	_	
218-3	37737-37738	(	_	
218-4	37738-37741	Alc	_	
218-5	37741-37742	)	_	
218-6	37743-37751	impaired	_	
218-7	37752-37760	accuracy	_	
218-8	37761-37769	compared	_	
218-9	37770-37772	to	_	
218-10	37773-37780	placebo	_	
218-11	37781-37782	(	_	
218-12	37782-37786	Plac	_	
218-13	37786-37787	)	_	
218-14	37788-37791	but	_	
218-15	37792-37795	did	_	
218-16	37796-37799	not	_	
218-17	37800-37806	affect	_	
218-18	37807-37815	reaction	_	
218-19	37816-37821	times	_	
218-20	37821-37822	.	_	

#Text=Error bars signify standard error of the mean.
219-1	37823-37828	Error	_	
219-2	37829-37833	bars	_	
219-3	37834-37841	signify	_	
219-4	37842-37850	standard	_	
219-5	37851-37856	error	_	
219-6	37857-37859	of	_	
219-7	37860-37863	the	_	
219-8	37864-37868	mean	_	
219-9	37868-37869	.	_	

#Text=This figure has been modified from.
220-1	37870-37874	This	_	
220-2	37875-37881	figure	_	
220-3	37882-37885	has	_	
220-4	37886-37890	been	_	
220-5	37891-37899	modified	_	
220-6	37900-37904	from	_	
220-7	37904-37905	.	_	

#Text=Group-average timecourses of phase-locking values (PLVs) in the theta band.
221-1	37906-37919	Group-average	_	
221-2	37920-37931	timecourses	_	
221-3	37932-37934	of	_	
221-4	37935-37948	phase-locking	_	
221-5	37949-37955	values	_	
221-6	37956-37957	(	_	
221-7	37957-37961	PLVs	_	
221-8	37961-37962	)	_	
221-9	37963-37965	in	_	
221-10	37966-37969	the	_	
221-11	37970-37975	theta	_	
221-12	37976-37980	band	_	
221-13	37980-37981	.	_	

#Text=Co-oscillatory synchrony between the anterior cingulate cortex (ACC) and lateral prefrontal cortex (latPFC) in theta band expressed as percent change from baseline for placebo (left) and alcohol (right) conditions.
222-1	37982-37996	Co-oscillatory	_	
222-2	37997-38006	synchrony	_	
222-3	38007-38014	between	_	
222-4	38015-38018	the	_	
222-5	38019-38027	anterior	_	
222-6	38028-38037	cingulate	_	
222-7	38038-38044	cortex	_	
222-8	38045-38046	(	_	
222-9	38046-38049	ACC	_	
222-10	38049-38050	)	_	
222-11	38051-38054	and	_	
222-12	38055-38062	lateral	_	
222-13	38063-38073	prefrontal	_	
222-14	38074-38080	cortex	_	
222-15	38081-38082	(	_	
222-16	38082-38088	latPFC	_	
222-17	38088-38089	)	_	
222-18	38090-38092	in	_	
222-19	38093-38098	theta	_	
222-20	38099-38103	band	_	
222-21	38104-38113	expressed	_	
222-22	38114-38116	as	_	
222-23	38117-38124	percent	_	
222-24	38125-38131	change	_	
222-25	38132-38136	from	_	
222-26	38137-38145	baseline	_	
222-27	38146-38149	for	_	
222-28	38150-38157	placebo	_	
222-29	38158-38159	(	_	
222-30	38159-38163	left	_	
222-31	38163-38164	)	_	
222-32	38165-38168	and	_	
222-33	38169-38176	alcohol	_	
222-34	38177-38178	(	_	
222-35	38178-38183	right	_	
222-36	38183-38184	)	_	
222-37	38185-38195	conditions	_	
222-38	38195-38196	.	_	

#Text=Following an early increase in PLVs during a stimulus processing stage (400–600 ms), a sustained increase in co-oscillations is observed on incongruous trials (INC) in response to increased cognitive control compared to congruent trials (CONG) under placebo, F(1,19) = 5.5, p < .05.
223-1	38197-38206	Following	_	
223-2	38207-38209	an	_	
223-3	38210-38215	early	_	
223-4	38216-38224	increase	_	
223-5	38225-38227	in	_	
223-6	38228-38232	PLVs	_	
223-7	38233-38239	during	_	
223-8	38240-38241	a	_	
223-9	38242-38250	stimulus	_	
223-10	38251-38261	processing	_	
223-11	38262-38267	stage	_	
223-12	38268-38269	(	_	
223-13	38269-38272	400	_	
223-14	38272-38273	–	_	
223-15	38273-38276	600	_	
223-16	38277-38279	ms	_	
223-17	38279-38280	)	_	
223-18	38280-38281	,	_	
223-19	38282-38283	a	_	
223-20	38284-38293	sustained	_	
223-21	38294-38302	increase	_	
223-22	38303-38305	in	_	
223-23	38306-38321	co-oscillations	_	
223-24	38322-38324	is	_	
223-25	38325-38333	observed	_	
223-26	38334-38336	on	_	
223-27	38337-38348	incongruous	_	
223-28	38349-38355	trials	_	
223-29	38356-38357	(	_	
223-30	38357-38360	INC	_	
223-31	38360-38361	)	_	
223-32	38362-38364	in	_	
223-33	38365-38373	response	_	
223-34	38374-38376	to	_	
223-35	38377-38386	increased	_	
223-36	38387-38396	cognitive	_	
223-37	38397-38404	control	_	
223-38	38405-38413	compared	_	
223-39	38414-38416	to	_	
223-40	38417-38426	congruent	_	
223-41	38427-38433	trials	_	
223-42	38434-38435	(	_	
223-43	38435-38439	CONG	_	
223-44	38439-38440	)	_	
223-45	38441-38446	under	_	
223-46	38447-38454	placebo	_	
223-47	38454-38455	,	_	
223-48	38456-38457	F	_	
223-49	38457-38458	(	_	
223-50	38458-38462	1,19	_	
223-51	38462-38463	)	_	
223-52	38464-38465	=	_	
223-53	38466-38469	5.5	_	
223-54	38469-38470	,	_	
223-55	38471-38472	p	_	
223-56	38473-38474	<	_	
223-57	38475-38478	.05	_	
223-58	38478-38479	.	_	

#Text=Acute alcohol intoxication selectively dysregulated the co-oscillations on INC trials, F(1,19) = 8.8, p <.01.
224-1	38480-38485	Acute	_	
224-2	38486-38493	alcohol	_	
224-3	38494-38506	intoxication	_	
224-4	38507-38518	selectively	_	
224-5	38519-38531	dysregulated	_	
224-6	38532-38535	the	_	
224-7	38536-38551	co-oscillations	_	
224-8	38552-38554	on	_	
224-9	38555-38558	INC	_	
224-10	38559-38565	trials	_	
224-11	38565-38566	,	_	
224-12	38567-38568	F	_	
224-13	38568-38569	(	_	
224-14	38569-38573	1,19	_	
224-15	38573-38574	)	_	
224-16	38575-38576	=	_	
224-17	38577-38580	8.8	_	
224-18	38580-38581	,	_	
224-19	38582-38583	p	_	
224-20	38584-38585	<	_	
224-21	38585-38588	.01	_	
224-22	38588-38589	.	_	

#Text=Activation maps (inset) show the incongruity effect (INC-CONG), which is prominent in the ACC and latPFC.
225-1	38590-38600	Activation	_	
225-2	38601-38605	maps	_	
225-3	38606-38607	(	_	
225-4	38607-38612	inset	_	
225-5	38612-38613	)	_	
225-6	38614-38618	show	_	
225-7	38619-38622	the	_	
225-8	38623-38634	incongruity	_	
225-9	38635-38641	effect	_	
225-10	38642-38643	(	_	
225-11	38643-38651	INC-CONG	_	
225-12	38651-38652	)	_	
225-13	38652-38653	,	_	
225-14	38654-38659	which	_	
225-15	38660-38662	is	_	
225-16	38663-38672	prominent	_	
225-17	38673-38675	in	_	
225-18	38676-38679	the	_	
225-19	38680-38683	ACC	_	
225-20	38684-38687	and	_	
225-21	38688-38694	latPFC	_	
225-22	38694-38695	.	_	

#Text=The color scale denotes baseline-corrected source power estimates at 480 ms after stimulus onset, with red (activity > .2) to yellow (activity > .3) indicating stronger theta power to INC trials compared to CONG trials.
226-1	38696-38699	The	_	
226-2	38700-38705	color	_	
226-3	38706-38711	scale	_	
226-4	38712-38719	denotes	_	
226-5	38720-38738	baseline-corrected	_	
226-6	38739-38745	source	_	
226-7	38746-38751	power	_	
226-8	38752-38761	estimates	_	
226-9	38762-38764	at	_	
226-10	38765-38768	480	_	
226-11	38769-38771	ms	_	
226-12	38772-38777	after	_	
226-13	38778-38786	stimulus	_	
226-14	38787-38792	onset	_	
226-15	38792-38793	,	_	
226-16	38794-38798	with	_	
226-17	38799-38802	red	_	
226-18	38803-38804	(	_	
226-19	38804-38812	activity	_	
226-20	38813-38814	>	_	
226-21	38815-38817	.2	_	
226-22	38817-38818	)	_	
226-23	38819-38821	to	_	
226-24	38822-38828	yellow	_	
226-25	38829-38830	(	_	
226-26	38830-38838	activity	_	
226-27	38839-38840	>	_	
226-28	38841-38843	.3	_	
226-29	38843-38844	)	_	
226-30	38845-38855	indicating	_	
226-31	38856-38864	stronger	_	
226-32	38865-38870	theta	_	
226-33	38871-38876	power	_	
226-34	38877-38879	to	_	
226-35	38880-38883	INC	_	
226-36	38884-38890	trials	_	
226-37	38891-38899	compared	_	
226-38	38900-38902	to	_	
226-39	38903-38907	CONG	_	
226-40	38908-38914	trials	_	
226-41	38914-38915	.	_	
